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Fluorinated organic compounds are increasingly important in many areas of our modern lives, 
especially in pharmaceutical and agrochemical applications where the incorporation of this 
element can have a major influence on biochemical properties. The introduction of the carbon-
fluorine bond into such systems is typically carried out using well established multistep, 
nucleophilic fluorination processes that usually lead to large waste streams. Despite the 
availability of alternative electrophilic fluorination methods which have found several 
applications on discovery scale, the direct transformation of C-H to C-F bonds on large scale is 
scarce. Elemental fluorine is the only electrophilic fluorinating reagent that is viable for 
manufacturing scale applications, but, in spite of the advances in this field in the past 25 years, 
there are only a handful of processes where it is used, most notably in the manufacturing of 5-
fluorouracil. 
 
Figure 1: Life-science related systems investigated in this thesis. 
In this thesis the direct fluorination of several industrially relevant organic systems was 
investigated with an aim to provide optimised, high yielding and scalable processes that could 
be compared with existing manufacturing methods using a green chemistry metrics package 
developed by the EU IMI Chem21 consortium. First, we found that the copper catalysed direct 
fluorination of simple malonate esters provided the desired 2-fluoromalonate derivatives in 
excellent yield and purity and upon comparison with halogen exchange methods from the 
literature we concluded that the process is comparable in efficiency and environmental impact, 
however, it achieves these results in a single step. The direct fluorination of a more complex 
aliphatic system, progesterone, highlighted that even though the desired reaction takes place 





to some extent, in such complex systems there are a large number of competing side reactions 
that prevent good conversion and simple isolation procedures. 
The direct fluorination of aromatic systems was one of the most important areas to investigate 
as fluorobenzene derivatives are the largest sub-group of fluorine containing life-science 
products. The assessment of this reaction in the case of a range of aromatic derivatives revealed 
that in order to avoid the formation of large amounts of polyfluorinated side products the 
reaction should only be progressed to 50-60 % conversion, but the separation of a two 
component mixture can be difficult using non-chromatographic methods because of the similar 
physical properties of the product and starting material. 
The direct fluorination of cytosine, to afford the WHO Essential Medicine Flucytosine, was 
successfully carried out under batch fluorination conditions, however, transferring the process 
to continuous flow showed a distinct improvement of selectivity and higher yields. This process 
was further evaluated on larger scale, in collaboration with Sanofi and MEPI the continuous 
fluorination reaction was demonstrated on over 100 g/h scale and following optimisation 
studies significant quantities of the product were isolated for further assessment. Green metrics 
analysis of this process demonstrated a large improvement in material usage and overall yield 
between the current manufacturing method (3 steps from 5-fluorouracil) and our process. 
Finally, the synthesis and reactions of previously unknown fluorinated acyl Meldrum’s acid 
derivatives are described, highlighting the potential of this system to be used as a polyfunctional 
intermediate in the synthesis of monofluorinated aliphatic compounds.  
  







First of all, I would like to thank Professor Graham Sandford for all his support, encouragement 
and patience throughout my time in Durham that helped me maintain my enthusiasm even in 
times when Chemistry was not in my favour. 
Working as part of the Chem21 consortium was an amazing experience where I had the 
opportunity to learn from and work with leading experts from both industry and academia and 
our collaborations within the project were some of the best experiences of my PhD. A special 
thank you is due to Catherine Alder (GSK) for green metrics discussions and Annelyse Conté 
(MEPI) for all her work during the Flucytosine project, and I would also like to thank the work 
and support of Nicky Willis, Joe Adams, John Hayler, Andy Wells, Alan Rabion, Sandrine Grenier, 
Kai Rossen, Jean-Paul Seuwin, Laurent Pichon, Rob McElroy and Louise Summerton in various 
Chem21 projects. 
My research in Durham would not have been possible without the excellent work of all the 
support staff especially the workshops and analytical services. Thank you to Malcolm and Aaron 
for always helping me out with my glassware requests also to Paul, Neil and Omer in the 
mechanical and electrical workshops. The work of Alan, Catherine and Juan in NMR, Dave and 
Pete in MS, Lenny in chromatography and Dima in crystallography is gratefully acknowledged, 
they were always available for discussions and to give me a helping hand when needed. 
I thoroughly enjoyed working with the friendliest group in the Department so a big thank you is 
due to all past and present members especially Rob, Ffion, Max, Jon, Dan, Marcus, Josh, Hedi, 
Etienne and Darren. I would like to mention Mr Craig Fisher separately for all the good times we 
had working on projects together in the past three years. Members of the Baxendale group were 
always up for helping me out with flow chemistry components and advice, therefore, I would 
like to thank Marcus, Laurens and Carl for all their help and friendship. In the past year working 
with Laura and Kate in the Postgraduate Events Committee was a great experience and hopefully 
we could give back something to the community in the Department. 
Finally, I would like to thank my family and friends for their continued support and 
encouragement. I could not list everything I would like to thank my wife Eszter for, so I am not 
even going to try, but it is much appreciated. 
  







The work described in this thesis was carried out at Durham University between October 2012 
and December 2015. This thesis is the work of the author, except where acknowledged by 
reference, and has not been submitted for any other degree. The copyright of this thesis rests 
with the author. No quotation from it should be published without the prior written consent and 
information derived from it should be acknowledged.  
Parts of this work have been the subject of the following publications: 
1) A. Harsanyi, G. Sandford, Green Chem. 2015, 17, 2081-2086, Organofluorine Chemistry: 
Applications, sources and sustainability. 
2) A. Harsanyi, G. Sandford, Green Chem. 2015, 17, 3000-3009, Fluorine gas for Life Science 
syntheses: Green metrics to assess selective direct fluorination for the synthesis of 2-
fluoromalonate esters. 
3) A. Harsanyi, G. Sandford, Org. Proc. Res. Dev. 2014, 18, 981-992, 2-Fluoromalonate 
Esters: Fluoroaliphatic Building Blocks for the Life Sciences. 
4) A. Harsanyi, G. Sandford, WO/2016/030662, 2016, Process for Producing Flucytosine 
and Flucytosine Derivatives. 
This work has been presented, in part, at: 
1) 21st International Symposium on Fluorine Chemistry and 6th International Symposium 
on Fluorous Technologies, 23-28 August 2015, Como, Italy, poster presentation, Poster 
Award of the German Fluorine Chemistry Working Group. 
2) 19th Annual ACS Green Chemistry and Engineering Conference, 13-17 July 2015, North 
Bethesda, MD, oral presentation. 
3) RSC Fluorine Subject Group Meeting, 16-17 April 2015, Durham, poster and oral 
presentations. 
4) RSC Fluorine and Carbohydrate Subject Group Meeting, 2-3 September 2013, 
Southampton, oral presentation, Prize for Oral Presentation. 
  





Nomenclature and abbreviations 
 
Ac  Acyl 
Accufluor™ 1-Fluoro-4-hydroxy-diazonia[2.2.2]bicyclooctane bis(tetrafluoroborate) 
ACS  American Chemical Society 
ACS GCI American Chemical Society Green Chemistry Institute 
AE  Atom economy 
aHF  Anhydrous hydrogen fluoride 
API  Active Pharmaceutical Ingredient 
ASAP  Atmospheric solid analysis probe 
BINOL  1,1’-Bi-2-naphtol 
b.p.  Boiling point 
Bu  Butyl 
t-Bu  Tertiary butyl 
CDI  Carbonyldiimidazole 
CFC  Chlorofluorocarbon 
COSY  Correlation spectroscopy 
DABCO  1,4-Diazabicyclo[2.2.2]octane 
DAST  Diethylaminosulfur trifluoride 
DBN  1,5-Diazabicyclo[4.3.0]non-5-ene 
DCC  Dicyclohexyl carbodiimide 
DCE  1,2-Dichloroethane 
DCM  Dichloromethane 
Deoxofluor™ Bis(2-methoxyethyl)aminosulfur trifluoride 
DMAc  N,N-Dimethylacetamide 
DMAP  4-(N,N-Dimethylamino)pyridine 
DME  1,2-Dimethoxyethane 
DMF  N,N-Dimethylformamide 
DMPU  1,3-Dimethyl-3,4,5,6-tetrahydro-2-pyrimidone 
DMSO  Dimethyl sulfoxide 
DSC  Differential scanning calorimetry 
EDG  Electron donating group 
E factor  Environmental factor 





EI  Electron impact (ionisation) 
ESI  Electrospray ionisation 
Et  Ethyl 
EWG  Electron withdrawing group 
FDA  (United States) Food and Drugs Administration 
FEP  Fluorinated ethylene-propylene copolymer 
5-FU  5-Fluorouracil 
Halex  Halogen exchange 
HCFC  Hydrochlorofluorocarbon 
HFC  Hydrofluorocarbon 
HFP  Hexafluoropropene 
HMBC  Heteronuclear multiple-bond correlation spectroscopy 
HPLC  High performance liquid chromatography 
HSQC  Heteronuclear single-quantum correlation spectroscopy 
IR  Infra-red 
LCA  Life cycle assessment 
Me  Methyl 
MEK  Methyl-ethyl ketone, 2-butanone 
MI  Mass intensity 
MIBK  Methyl-isobutyl ketone 
m.p.  Melting point 
MTBE  Methyl tert-butyl ether 
M.S.  Molecular sieves 
MW.  Molecular weight 
NFSI  N-Fluorodibenzenesulfonimide 
NME  New molecular entity 
NMP  N-Methyl-2-pyrrolidone 
NMR  Nuclear magnetic resonance 
OD  Outside diameter 
Ph  Phenyl 
PMI  Process mass intensity 
ppm  Part per million 
i-Pr  iso-Propyl 





PTFE  Poly(tetrafluoroethylene) 
RME  Reaction mass efficiency 
rt  Room temperature 
SDF  Selective direct fluorination 
Selectfluor™ 1-Chloromethyl-4-fluoro-diazonia[2.2.2]bicyclooctane bis(tetrafluoroborate) 
SM  Starting material 
SS  Stainless steel 
TEA  Triethylamine 
Tf  Trifluoromethanesulfonyl 
TFA  Trifluoroacetic acid 
THF  Tetrahydrofuran 
TMS  Trimethylsilyl- 
TLC  Thin layer chromatography 
UV  Ultra-violet 
XtalFluor™ (Diethylamino)difluorosulfonium tetrafluoroborate 
WHO  World Health Organisation 
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Chapter 1.: Green Chemistry Principles for Fluorination 
 
The research leading to this thesis is part of a large European public-private partnership, the EU 
IMI CHEM21 project which aims at delivering greener and more sustainable manufacturing 
methods to the pharmaceutical industry. The project members are six large pharmaceutical 
companies, five small and medium sized companies and thirteen European universities. The 
technologies in the project range from synthetic organic chemistry to bio-catalytic 
transformations and synthetic biology with a focus on the use of green chemistry tools to assess 
new synthetic methodologies for pharmaceutical manufacture. Our role in this project was to 
demonstrate whether elemental fluorine is a viable, greener reagent for the formation of C-F 
bonds in life science related compounds. This chapter will introduce the origin and role of 
fluorine in life sciences and methods for the use of F2 in organic synthesis, then will briefly 
discuss green chemistry principles and methods that were used in this research.  
1.1 Organofluorine chemistry 
Although fluorine is a very abundant element on our planet, it is much under-appreciated by the 
general public. Probably the most well-known uses are in toothpaste (usually as SnF2 or NaF) 
and in some places drinking water fluorination (in the form of H2SiF6), but these are 
complemented by the other uses of this fascinating element in essentially all areas of our lives.  
1.1.1 Origin of fluorine  
Even though fluorine is present in many different minerals in the Earth’s crust, only three of 
these are suitable for industrial scale mining. Cryolite (Na3AlF6) used to be mined for the 
manufacture of aluminium, but all large deposits have been depleted over the years.1  
 
 
Figure 2: Fluorine containing minerals: fluorapatite (Ca5(PO4)3F), fluorite (CaF2) and cryolite (Na3AlF6).2–4  
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Currently, most of the fluorine atoms that are used in commercial applications originate from 
fluorspar (CaF2) which is converted to anhydrous HF, but known reserves of this strategic mineral 
are estimated to last for only another 100 years.5 Fluorapatite (Ca5(PO4)3F) is a potential 
alternative fluoride source, because, this mineral is a contaminant in abundant phosphate rock. 
Therefore, the manufacturing of phosphoric acid for the fertiliser industry produces fluorosilicic 
acid (H2SiF6) as a side product which is not being used to a great extent for any synthetic 
purpose6,7 and could, in the future, provide anhydrous HF feedstock. 
 
Figure 3: Industrial uses of fluorspar.6 
Low purity fluorspar, also called metspar, is used as a flux material in iron smelting, while the 
high purity mineral is almost exclusively converted to anhydrous hydrogen fluoride (aHF), which 
is the key starting material to all synthetic fluorinated chemicals from inorganic fluorides to the 
most complex fluorinated organic systems (Figure 3.). 
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Figure 4: Common fluorinating reagents used in organofluorine chemistry. 
In organofluorine chemistry, hydrogen fluoride is by far the most important reagent, as 
essentially all fluorinating reagents are derived from it in a few steps and, generally, the more 
steps required to synthesise a reagent the more expensive it becomes. For these reasons, 
reagents other than HF, its amine complexes, inorganic fluorides and elemental fluorine are in 
general the only viable reagents for large scale manufacturing of fluorinated organic 
compounds. Other reagents that were developed to enable a number of useful transformations 
to be carried out without specialist equipment (for example Selectfluor™ or DAST) are rarely 
used on the manufacturing scale, mainly for economic reasons (Figure 4.), but have found 
widespread applications in, for example, drug discovery programmes.5 
1.1.2 Fluorine in pharmaceuticals 
Contemporary medicine benefits from over one hundred years of drug discovery and 
development and, consequently, today we have access to pharmaceuticals for the treatment of 
a range of diseases. Despite the advances, there is still extensive investment into new medicines 
as there are many untreated diseases and there is always need for safer and more effective 
pharmaceuticals. 
Incorporation of fluorine into biologically active organic compounds was first reported in the 
early 1950’s when Fried and Sabo discovered that introduction of a single fluorine atom to a 
corticosteroid system significantly increased its activity.8 This discovery was followed by FDA 
approval of Fludrocortisone in 1955. 




Figure 5: Fluorine containing drugs from the early years (year of FDA approval). 
The early years of fluorinated pharmaceuticals contributed significantly to the understanding of 
the biological effects of various fluorinated substituents. For example, Triflupromazine (3) was 
the first approved drug that contained a trifluoromethyl group in its structure and, in this case, 
the introduction of a CF3 group possibly leads to an increase in the lipophilicity of this 
antipsychotic compound to enable it to pass the blood-brain barrier more easily. 
Most fluorine containing drugs introduced during the 1950-1980’s were steroid and anti-
psychotic compounds structurally similar to the first examples above, however, some very 
important discoveries were also made in these decades. One drug, 5-fluorouracil (5), was found 
to be an effective treatment for various cancers and has been used extensively since and 
another, structurally related system, 5-fluorocytosine (6), was also introduced in this period for 
the treatment of fungal infections. The discovery of 6-fluoroquinolones, for example Norfloxacin 
(7), in the 1980’s led to a very successful class of compounds that are used for the treatment of 
bacterial infections. 9 
 
Figure 6: Significant fluorinated drugs form the 1960's - 80's. 
It was only in the 1990’s when fluorinated aromatic rings started becoming the most prominent 
fluorinated drug sub-unit, a trend that appears to have increased ever since. Fluorine atoms are 
frequently introduced to aromatic sub-units to increase metabolic stability as it is well 
documented that the incorporation of fluorine at metabolically labile positions blocks oxidative 
pathways, therefore, increasing the half-life of the molecule in an organism.10,11 Some notable 
examples of fluorobenzene substituted drugs include Atorvastatin (9), Linezolid (10) and 
Vemurafenib (11). 




Figure 7: Fluorobenzene structure containing drugs (FDA approval year). 
The diversity of fluorinated substituents has been increasing, with new functional groups, for 
example CF3CF2- and -CF2-, finding more use in commercially valuable drugs recently. Chiral 
fluorinated systems have also been used since the early days, but most of these compounds 
were fluorinated steroids, however, in the past 10 - 15 years, fluorine atoms attached to 
stereogenic centres have started appearing in different systems along with trifluoromethyl 
substituents at chiral centres (Figure 8).  
 
Figure 8: Chiral fluorinated drug structures (FDA approval year). 
In September 2015, the FDA of the United States listed over 1600 approved small molecule drugs 
(www.drugbank.ca) and approximately 10 % of these drugs (155) contain at least one fluorine 
atom. However, this ratio has been increasing over the years and in the last decade, 
approximately 25 % of all new small molecule drugs launched to the market contained 
fluorine.12–17 Amongst these drugs various fluorine containing functional groups are found, but 
there are a few types of systems that are dominant, for example, fluoro- and trifluoromethyl-
aromatics and alkyl fluorides (Figure 9). 




Figure 9: Distribution of fluorinated functional groups in FDA approved APIs. 
From a fluorine chemistry point of view, the variety of fluorine containing functionalities in drugs 
has been growing and this is certain to continue in the future. To attempt to predict the future 
of fluorinated pharmaceuticals, we assembled a collection of fluorinated drug candidates from 
Phase 2 and Phase 3 clinical trials, using the publically available pipeline details of the largest 
pharmaceutical companies (see Appendix III.). This list contains 49 original New Molecular 
Entities, which all together contain over 60 fluorinated structural elements showing that in the 
future it is going to be more common to have several different fluorinated functional groups 
present in the same molecule (Figure 10.). 
Figure 10: Late stage drug candidates containing several different fluorinated functionalities. 
Analysis of fluorinated drug systems by decade clearly supports the already described trends in 
the change in fluorinated structures. In the future, fluoroaromatic compounds are not going to 
lose their dominance, but most likely there will be more aliphatic and heteroaromatic systems 









CH2CF3, 5% CF2, 4%
Anaesthetics, 3% 18F, 2%
Other, 3%
DISTRIBUTION OF FLUORINE 
IN FDA APPROVED PHARMACEUTICALS 





Figure 11: Change of fluorine containing functional groups in FDA approved drugs in the past 60 years. 
To enable the emergence of fluorinated systems, synthetic methods for the incorporation of 
fluorine and fluorinated functional groups have been developed and, with the recent advances 
in late stage fluorination and fluoroalkylation methods, more complex systems are now 
accessible on the discovery scale than ever before.18–20 This advancement will, therefore, 
increase the need for scalable and economically viable methods for the synthesis of new 










1955-1965 1966-1975 1976-1985 1986-1995 1996-2005 2006-2015 Pipeline
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Ph-CF3 Ph-F Alkyl-CF3 Alkyl-F
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1.1.3 C-F bond formation for the synthesis of life science compounds 
Naturally occurring organofluorine compounds are extremely rare, only a handful of them have 
been isolated21 and most are derivatives of fluoroacetic acid, which is the metabolite of a 
fluorinated sugar derivative synthesised by the fluorinase enzyme.22,23 Therefore, essentially all 
organofluorine compounds rely on synthetic chemistry to form the carbon-fluorine bond. The 
formation of C-F bonds has been of interest for over a hundred years and the detailed discussion 
of existing methodologies is outside of the scope of this review, however, there are excellent 
books24–27 and review papers18,28–34 discussing this topic in detail. In this chapter some 
fluorination methods will be illustrated using syntheses of life-science products as target 
molecules to exemplify the use of various fluorinating systems and the types of transformations 
typically used in life science syntheses. 
1.1.3.1 Nucleophilic fluorination methods (C-X → C-F) 
One of the most widely used methods for the introduction of a C-F bond into an aliphatic 
structure is the nucleophilic substitution of a halogen with a fluoride source. Depending on the 
system this can be very efficient, but when acidic hydrogen atoms are in the  position to the 
halogen, elimination can lead to significant side product formation. One of the most important 
applications of this method is the synthesis of trifluoromethyl-aromatic compounds from the 
corresponding trichloromethyl derivatives using a Lewis acid catalyst to facilitate the 
transformation (Swarts process). This reaction is still the key step in the synthesis of a large 
number of trifluoromethylated pharmaceuticals and agrochemicals despite being discovered in 
the 1920’s. 
 
Figure 12: Synthesis of trifluoromethyl-chlorobenzene, a key intermediate in the synthesis of 
herbicides.35 
A specific case of nucleophilic fluorination is deoxofluorination. In this case, the fluorinating 
reagent, most often SF4 or a formal derivative of this reagent such as DAST, reacts with alcohols, 
carbonyl compounds and carboxylic acids to afford the corresponding mono-, di- and tri-
fluorinated products. The deoxofluorinating reagent not only acts as a fluoride source but, after 
reacting with the oxygen nucleophile, as a leaving group as well.  




Figure 13: Deoxofluorination of a key intermediate in the synthesis of Tafluprost.36 
Although direct addition of hydrogen fluoride to olefins looks like an attractive approach to form 
C-F bonds, this method is not used frequently on hydrocarbon systems, mainly because 
polymerisation and rearrangements can occur as side reactions. However, this hydrofluorination 
is used for the fluorination of partially halogenated olefins such as for the synthesis of an 
intermediate of Maraviroc (23), an anti-HIV drug developed by Pfizer. 
 
Figure 14: HF addition route to Maraviroc intermediate.37 
The most straightforward synthesis of 2-fluoro alcohols is the reaction of epoxides with a 
suitable fluoride source. This method has been used for decades for the synthesis of chiral 
fluorinated systems starting from the chiral epoxide and HF, especially in the case of 9-
fluorocorticosteroids. 
 
Figure 15: Synthesis of Fludrocortisone acetate from the corresponding epoxide.8 
As discussed in Chapter 1.1.2, fluorinated aromatic compounds are the single most frequent 
sub-units found in fluorinated pharmaceuticals and methods for the incorporation of fluorine 
into these structures have been subject to research for a long time.38  
It is without doubt that the most versatile and well known method for aromatic fluorination is 
the Balz-Schiemann reaction: the transformation of anilines to fluorobenzene derivatives via 
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diazotisation using either tetrafluoroboric acid (original method), pyridine.HF complex (Olah’s 
reagent) or anhydrous hydrofluoric acid (preferred for industrial scale).39 The main disadvantage 
of this reaction is that several synthetic steps are required to convert the aromatic substrate to 
the fluorinated derivative. 
 
Figure 16: Balz-Schiemann reaction to synthesise 2-fluoropurine intermediate of Fludarabine.40 
Although the Balz-Schiemann reaction has a broad substrate scope, this method has its 
limitations as well, for example, in the case of very electron deficient anilines (e.g. 
polyfluorinated anilines), introducing a fluorine atom using this procedure becomes more 
difficult and inefficient due to the reduced basicity of the starting anilines. 
A commonly used method to synthesise fluoroarenes with multiple electron withdrawing groups 
is the halogen exchange (Halex) reaction between an activated chlorinated aromatic compound 
and a nucleophilic fluoride source, most often KF. This method has found applications in the 
synthesis of poly- and perfluorinated heteroaromatic systems. Recently, several new, late stage 
aromatic fluorination methods have been developed41, but these remain in the toolbox of the 
discovery scientists as they are too expensive for large scale applications and are not discussed 
here in detail. 
 
Figure 17: Halex fluorination of pentachloropyridine in the synthesis of Fuoxypyr.42 
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1.1.3.2 Electrophilic fluorination methods (C-H → C-F) 
While nucleophilic fluorination methods are well established in the synthesis of life sciences, 
alternative electrophilic methods are rarely used in manufacturing. The main reason why 
electrophilic fluorination has not found many large scale applications is the perceived lack of 
easy to use, inexpensive and safe reagents for this transformation. For decades, the only 
available electrophilic fluorinating reagents were perchloryl fluoride (FClO3)43, fluorine gas29 and 
O-F reagents, for example, acetyl hypofluorite (CH3COOF) and trifluoromethyl hypofluorite 
(CF3OF)44. Although these reagents enabled valuable transformations, they require specialist 
equipment and precautions for scale up and only fluorine gas is used in the synthesis of a few 
drug compounds, which is discussed in a later chapter. 
In the early 1990’s several safe, bench-stable electrophilic reagents were developed belonging 
to the N-F reagent class. N-Fluoropyridinium salts, Selectfluor™ and NFSI (page 3) were the first 
commercially available reagents and they have made enormous contributions to synthetic 
chemistry since their discoveries.45–47 For example, the introduction of fluorine into electron rich 
aromatic and heterocyclic compounds is also possible48,49,50, but because of the high costs 
associated with these reagents, they are seldom used in large scale processes. Recently, a large 
scale enantioselective fluorination using NFSI was reported in the synthesis of kilogram 
quantities of preclinical drug candidate 34 (Figure 18).51 
 
Figure 18: Large scale enantioselective fluorination using NFSI.51 
In summary, current large-scale fluorination methods described above are typically multistep, 
nucleophilic fluorine source based reactions involving anhydrous HF, with varying overall yield 
and selectivity. In contrast, although a large number of electrophilic C-H fluorination processes 
have been developed for laboratory scale, most of these reactions suffer from expensive 
reagents with low atom economy, thus, not finding wide spread large scale applications. In 
theory, the simplest, most inexpensive and convenient C-H to C-F transformation could be 
achieved using fluorine gas in selective direct fluorination processes, which is the topic of the 
next section. 
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1.1.4 Selective direct fluorination  
The isolation of elemental fluorine was one of the greatest challenges of 19th century inorganic 
chemists, and after many failed attempts by the most prominent scientists of the time52, it was 
Henri Moissan who succeeded in 1886.53 Moissan’s original method, the electrolysis of HF in the 
presence of KF, forms the basis of modern, industrial scale F2 generation, the difference is that 
the expensive platinum electrodes have been replaced by high surface area carbon and the 
temperature is increased to 70-130 oC to keep the KF.2HF electrolyte in the molten phase.54 
Today, fluorine gas is commercially available in various forms (pure or diluted with an inert gas) 
and on different scales, however, large scale users prefer on-site generation. 
 
Figure 19: Solvay Fluor's fluorine gas product range55 and Linde's on-site fluorine generation system56. 
While the largest scale uses of elemental fluorine are in inorganic chemistry, mainly 
manufacturing of UF6 for nuclear energy and SF6 for the electronics industries, it is also used for 
the synthesis of organofluorine compounds.6 The first chemist to react organic compounds with 
fluorine gas was Moissan, but apart from explosions and the possible isolation of carbon 
tetrafluoride, not many useful reactions were performed in subsequent decades.53 The most 
significant development in perfluorination chemistry using elemental fluorine took place during 
the Manhattan Project during the Second World War, when the need for chemicals compatible 
with corrosive UF6 generated a lot of interest in perfluorocarbons.57 This application is still a 
major use of fluorine gas in organic chemistry and advances in this field have been reviewed29, 
but the topic is outside the scope of this chapter. 
The difficulty of selective direct fluorination reactions is the result of replacing weak fluorine-
fluorine (155 kJ/mol)58 and carbon-hydrogen bonds (440 kJ/mol for CH3-H) with stronger carbon-
fluorine (481 kJ/mol for CH3-F) and hydrogen-fluorine (569 kJ/mol) bonds.59 This large amount 
of reaction heat (H = 445 kJ/mol) needs to be removed from the reaction to minimise undesired 
side reactions, however, dilution of fluorine with nitrogen, and the use of appropriate, non-
reactive solvents is now known to facilitate SDF processes. 
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The early uses of fluorine gas focused on the direct functionalisation of unactivated C-H bonds 
in aliphatic systems and it was found that hydrogen atoms in the tertiary position are the most 
reactive sites.60–62 The mechanism of this process is described in the literature as an electrophilic 
aliphatic substitution which is facilitated by the solvent’s (for example, chloroform) fluoride 
acceptor properties.63 
 
Figure 20: Mechanism of the electrophilic aliphatic fluorination of a tertiary hydrocarbon.63 
This proposed mechanism is further supported by the fact that this C-H fluorination reaction 
proceeds with the complete retention of stereochemistry which was observed during the direct 
fluorination of various steroid derivatives.64–66 Secondary C-H bonds can also be functionalised, 
but the lack of selectivity of the reaction does not make this a synthetically useful method.67 
 
Figure 21: Direct fluorination of cis-decalin with the retention of stereochemistry.68 
An important C-H fluorination reaction is the direct fluorination of ethylene carbonate in the 
manufacturing of monofluorinated derivative 38 which is used in lithium batteries as an 
electrolyte solvent.69 
 
Figure 22: Direct fluorination of ethylene carbonate.69 
Active methylene compounds, especially 1,3-dicarbonyl derivatives, are some of the most 
widely used substrates to demonstrate the effectiveness of electrophilic fluorinating reagents, 
but elemental fluorine was found to be too reactive to be used for this transformation for a long 
time.70 One of the early methods, reported by Purrington, used TMS-enolates in CFCl3 at 
cryogenic temperatures with dilute (5 % in nitrogen) fluorine gas to successfully fluorinate 
malonate derivatives in good yield (59 – 73 %)71, however, the Montreal Protocol banned the 
use of chlorofluorocarbons (CFCs), making this process obsolete.  
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In the early 1990’s Chambers and co-workers discovered that the selective fluorination of 1,3-
dicarbonyl compounds can be achieved in formic acid solution using 10 % fluorine in nitrogen 
via electrophilic fluorination of their respective enolates. They found that the conversion 
depends on the enol content in equilibrium and kinetics of the enolisation of the carbonyl 
compound, for example, ethyl acetoacetate (fast enolisation) gives much higher conversion than 
ethyl 2-methylacetoacetate (slow enolisation).72 The introduction of a second fluorine atom to 
the 2-position is much slower than the first fluorination reaction, which makes it possible to 
isolate the monofluorinated products in good yields.73 This fluorination methodology was 
adopted by industry and is currently used in the manufacturing process of Pfizer’s antifungal 
drug Voriconazole (41).74 
 
Figure 23: Direct fluorination of methyl 3-oxopentanoate in the synthesis of Voriconazole.74 
Malonate derivatives do not enolise as easily as ketoesters or diketones, therefore, their 
fluorination was originally performed in the presence of a strong base in acetonitrile solvent 
and, depending on the amount of the base used in the reaction, mono- and difluorinated diethyl 
malonate esters were obtained as the major products.75 To improve the conversion of these 
fluorination processes, the Durham group developed a Lewis-acid catalysed method for the 
fluorination of 1,3-dicarbonyl compounds which also enabled the catalytic fluorination of 
malonate esters,76 but the use of chiral BINOL ligands in combination with the metal catalyst did 
not lead to any enantio-enrichment of the fluorinated product.77 
To gain better control over the fluorination process and to minimise polyfluorination, 
continuous flow micro-reactors were developed in Durham78 that allowed the fluorination of 
ethyl acetoacetate to progress in higher conversion and selectivity than in typical batch 
reactions.79  




Figure 24: Single- and multi-channel microreactors for continuous flow fluorination.79,80 
To increase the scale of operation from a single reaction channel, multi-channel reactors were 
designed (up to 30 channels) which allowed the fluorination of over 100 g of a dicarbonyl 
compound in 24 hours.80 Recently, continuous flow fluorination techniques were used in a two-
step fluorination-cyclisation process to synthesise 4-fluoropyrazole derivatives.81 
When the conditions of the dicarbonyl fluorination method were extended to TMS-enolates and 
enol acetates it was found that the latter are better substrates in this reaction because of their 
higher stability in acidic solution, but even with these substrates, the main side products were 
the parent ketones from the hydrolysis of the enolates.82 
 
Figure 25: Direct fluorination of cyclohexanone enol acetate.82 
Direct electrophilic aromatic fluorination has been the subject to research for a long time 
especially that it is the direct, attractive alternative of the multistep Balz-Schiemann reaction. 
Following the pioneering work of Grakauskas on the fluorination of benzene and a few 
derivatives,83 in the early 1980’s Misaki reported the direct fluorination of phenolic compounds 
and, while most reactions gave the expected mixture of o- and p-substituted phenols, the 
fluorination of p-cresol (44) led to a mixture of 2-fluoro-p-cresol (45) and de-aromatised product 
46.84,85 Although electron rich aromatic compounds react very efficiently with fluorine, the 
formation of large amounts of polymeric tar significantly reduced the isolated yields 86 which is 
not improved significantly by carrying out the reaction in continuous flow87. 




Figure 26: Direct fluorination of p-cresol.84 
When electron deficient benzene derivatives are subjected to direct fluorination, high 
conversion and good selectivity can be achieved by the use of appropriate, protic solvents, for 
example, formic and sulfuric acid.88,89 
Table 1: Direct fluorination of 1,4-disubstituted aromatic systems. 
 
Benzene derivative Solvent Reactor Conversion A Yield B Yield 
 
HCOOH Batch 100 % 60 % 8 % 
 
HCOOH Batch 83 % 41 % 7 % 
 
HCOOH Batch 67 % 40 % Trace 
 
HCOOH Batch 63 % 50 %  Trace 
 
H2SO4 Batch 75 % 81 %  2 % 
 
MeCN Flow 91 % 82 % 7 % 
 
Chambers and co-workers reported the fluorination of a range of 1,4-disubstituted benzene 
derivatives both in batch and continuous flow regimes (Table 1.),90–92 which demonstrated clear 
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trends for fluorination reactions. For example, under identical conditions, the electron donating 
group has a large effect on the conversion, giving 100 % conversion for 4-nitroacetanilide (47) 
compared with 63 % for 4-nitrotoluene (50), however, the large difference between conversion 
and yield suggests significant tar formation in the case of the acetanilide. Similar difference can 
be observed between the solvent that is used for this reaction, in the case of 4-nitrotoluene, 
sulfuric acid gives significantly higher conversion and yield. Carrying out the reactions has a 
distinct effect on selectivity, these reactions have noticeably less di-fluorinated side product in 
the crude reaction product. The low conversion of 1,3-dinitrobenzene suggests a very sluggish 
reaction between fluorine and very electron deficient aromatic systems. The fluorination of the 
benzene ring of quinoline systems is also possible, but to achieve good conversion, large excess 
of fluorine is required together with 30 % oleum as a reaction solvent.93 
Uracil and related pyrimidines were the first heteroaromatic compounds that were fluorinated 
using fluorine gas in the early 1970’s, and this synthesis of 5-fluorouracil was the first selective 
direct fluorination process that was operated on the manufacturing scale.94 
 
Figure 27: Direct fluorination of uracil.94 
Pyridines, on the other hand, when reacted with elemental fluorine at low temperatures, form 
N-fluoropyridinium fluorinating reagents which were described above. Other heteroaromatic 
systems that were successfully fluorinated using fluorine gas include purine95, 1,5-
naphthydrine96 (Figure 28) and flavones97. 
 
Figure 28: Direct fluorination of a 1,5-naphthydrine.96 
One of the most characteristic reactions of the halogen elements is their electrophilic addition 
to olefins and it is not surprising that this was one of the early reactions attempted with fluorine 
gas, but unlike chlorine or bromine, the direct addition of fluorine proceeds with syn stereo-
selectivity. This unexpected result was explained by a carbocationic intermediate and a fluoride 
ion coming from the same F2 molecule in a “tight ion pair” process. 




Figure 29: Proposed mechanism for the syn addition of fluorine to olefins.98 
This mechanism also explains the presence of trifluorinated side products, where the first 
carbocation eliminates a proton to give a fluoroolefin which then reacts with another F2 
molecule.98 This mechanism was confirmed by a recent mechanistic and computational study 
using transannular dienes by Fokin and co-workers.99 Direct addition of fluorine can also be used 
to synthesise tetrafluoroethyl-benzenes from phenylacetylenes100 and di- and 
trifluoronucleosides101. 
In conclusion, over the past 40 years, elemental fluorine has been shown to be a viable reagent 
for direct fluorination of organic systems and a lot of understanding of the mechanism of SDF 
processes has been gained. Despite the advances in the safe handling of this reagent, such as 
the introduction of continuous flow reactors, fluorine is still generally regarded as an unsafe, 
non-selective reagent by the organic chemistry community and only a handful of processes are 
operated on the manufacturing scale.  
From a green chemistry perspective, to the best of our knowledge there is no literature available 
on metrics analysis of C-F bond formation, however, there is no significant difference between 
methods from a safety point of view, as essentially all C-F bonds are derived from anhydrous HF. 
The selective direct fluorination approach offers the formation of the C-F bond in a single step, 
therefore should, in theory, be more efficient and less wasteful than the alternative multi-step 
processes. This thesis aims to assess the use of F2 as a viable, greener reagent for the 
construction of C-F bonds in compounds using green chemistry methodologies and also an 
introduction to the principles of green chemistry and metrics based analysis follows. 
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1.2 Green Chemistry Toolkit 
Green chemistry is concerned with the design of safer, less wasteful and environmentally benign 
chemical products and processes. As a field of chemistry, it emerged at the end of the 20th 
century, as a response to deleterious environmental issues caused by the chemical industry 
during a period of exceptional growth following the Second World War and it has been the focus 
of intensive research over the past twenty years. It is important to mention that green chemistry 
not only includes the manufacture and use of chemical products, but involves the whole life-
cycle, therefore, several metrics have been developed to numerically assess the impact of 
chemical manufacturing methods on the environment. 
This chapter aims to provide an introduction to this field with a special focus on the synthesis of 
APIs, solvents and methods to measure and compare different processes from a green chemistry 
point of view. 
1.2.1 Green chemistry principles 
In the late 1990’s Anastas and Warner were the first to summarise the field of green chemistry 
in their monograph “Green Chemistry: Theory and Practice” where they introduced their 12 
Principles of Green Chemistry that highlight key areas of interest in the development of 
environmentally benign processes.102 
 
Figure 30: Keywords describing the 12 principles of green chemistry.102 
These principles are a clear representation of all the issues that lead to the emergence of green 
chemistry, with safety being the number one area of concern, from safer processes to safer 
chemical products. The second most important message from these principles is efficiency, 
where waste prevention, less derivatisation and atom economy clearly emphasise the need for 
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more efficient synthetic processes that, in turn, will be more profitable. Interestingly, 
sustainability is not in the centre of these principles, bio-renewable feedstocks being the only 
reference to this important topic. Although the principles represent a holistic view on how a 
greener chemical process should be designed, they are often taken out of context and misused 
by synthetic chemists assuming that focusing on one aspect of green chemistry makes the whole 
process greener while, in general, this is not the case.103 
1.2.2 Green chemistry in the pharmaceutical industry 
The chemical industry is one of the largest contributors to global environmental pollution and 
this is in part due to the manufacturing processes that transform simple hydrocarbons to 
sophisticated organic systems. Depending on the complexity of the target molecule, 
manufacturing of APIs can involve up to several dozens of synthetic steps which all add up to a 
large waste to product ratio.104  
Table 2: Typical E factor values in the chemicals industry.104 
Industry segment Volume (t/y) E factor (kgwaste/kgproduct) 
Bulk chemicals 104 - 106 <1 – 5 
Fine chemicals 102 - 104 5 – 50< 
Pharmaceuticals 10 - 103 25 – 100< 
 
The syntheses of Active Pharmaceutical Ingredients (APIs) are some of the smallest scale 
manufacturing processes in the chemical industry, often due to the very high bio-activity or the 
small number of patients in some rare disease areas, but because of the multistep nature of 
these reactions APIs produce the largest amount of waste per kg of product manufactured 
(Table 2). To address this issue, in the past 10-15 years pharmaceutical companies have been 
investing into various green chemistry programs, for example the ACS Green Chemistry 
Institute’s Pharmaceutical Roundtable, where industry-wide benchmarking methods are 
developed in a non-competitive environment.105 The main areas where the pharmaceutical 
industry has contributed significantly to the advancement of green chemistry are green metrics 
and qualitative guidelines to facilitate the selection of greener solvents, reagents and processes 
and these issues are discussed next. 
1.2.3 Solvents  
A recent cradle-to-gate Life Cycle Assessment (LCA) of a typical pharmaceutical product 
highlighted that solvents alone are the largest contributor to the environmental impact.106 They 
are not only responsible for 75 % of the energy use, but contribute over 80 % of life cycle mass 
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(excluding water), 70 % of Photochemical Ozone Creation Potential and 50 % of Green House 
gas emissions. When process water is included in the mass input analysis of a manufacturing 
process, solvents account for over 50 % of the total mass (Figure 31).107 
 
Figure 31: Composition of input materials by mass in the synthesis of an API.107 
Environmental impact is only one of the areas where solvents have a large contribution with 
safety and health hazards being other, even more important aspects. These three factors form 
the basis of several solvent guides that were published by Pfizer108, GSK107 and Sanofi109 and the 
EU IMI Chem21 network110.  In a recent review of solvent guides111 it was highlighted that there 
is an agreement between the surveyed guides about over 65 % of the commonly used solvents, 
showing that different methodologies and priorities lead to similar classification of solvents. 
In general, alcohols, esters and ketones are the most acceptable ‘green’ solvents, with only the 
very volatile systems having some safety issues. On the other hand, hydrocarbons, haloalkanes 
and ethers are usually in the undesirable category, mostly because of health and safety reasons, 
for example, peroxide formation in ethers or low ignition point. Dipolar aprotic solvents are very 
often used in the synthesis of polar APIs, but several of these have acute toxicity that makes 
them undesirable, therefore, finding safer replacements for such solvents is a key area of green 
chemistry research.112 Also, there are solvents that are in the hazardous or highly hazardous 
categories, for example, benzene, chloroform or carbon tetrachloride for their known 
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Table 3: Overall ranking of solvents based on 5 different guides.111 
Recommended 
Water, EtOH, i-PrOH, n-BuOH, EtOAc, 
 i-PrOAc, n-BuOAc, anisole, sulfolane 
Recommended or 
Problematic 
MeOH, t-BuOH, benzyl alcohol, ethylene glycol, acetone, 
MEK, MIBK, cyclohexanone, MeOAc, AcOH, Ac2O 
Problematic 
Me-THF, heptane, Me-cyclohexane, toluene, xylenes, 
chlorobenzene, acetonitrile, DMPU, DMSO 
Problematic or Hazardous MTBE, THF, cyclohexane, DCM, formic acid, pyridine 
Hazardous 
Diisopropyl ether, 1,4-dioxane, DME, pentane, hexane, 
DMF, DMAc, NMP, methoxy ethanol, TEA 
Highly Hazardous 
Diethyl ether, benzene, CCl4, chloroform, DCE, 
nitromethane 
 
While these guidelines have been developed to help scientists find safer, more acceptable 
solvents for the reactions they are carrying out, there are no strict rules and every case should 
be properly assessed to find the most suitable solvent for a given process. Implementing these 
guides in discovery laboratories can also make a significant difference, for example, replacing 
DCM - methanol mixtures used for chromatography with ethyl acetate - ethanol at Amgen’s 
Drug Discovery Department lead to a 60 % reduction in the use of DCM between 2010 and 
2013.113 
1.2.4 Assessing and measuring greenness 
Yield has been used as a measure of success of chemical reactions for hundreds of years but a 
detailed comparison of different processes is now required to assess the environmental impact 
of competing possible manufacturing routes.  
Atom Economy (AE) was the first alternative metric that is capable of comparing different 
transformations. It was introduced in 1991 by Trost to evaluate the efficiency of synthetic 
transformations based on how many atoms of the starting materials are actually incorporated 
into the final product. 114 However, as a metric, AE has serious limitations as it only compares 
the net reactions, does not include solvent usage, stoichiometry, work-up, yield and other very 
important process parameters. The advantage of this metric is that it allows quick assessment 
of alternative synthetic routes without conducting any experiments and shows the best possible 
outcome (100% yield, 1 : 1 stoichiometry) for the reactions. 
 





𝑀𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑊𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑃𝑟𝑜𝑑𝑢𝑐𝑡





× 100 = 𝟕𝟎  
𝑅𝑀𝐸 =
𝑀𝑎𝑠𝑠 𝑜𝑓 𝐼𝑠𝑜𝑙𝑎𝑡𝑒𝑑 𝑃𝑟𝑜𝑑𝑢𝑐𝑡





× 100 = 𝟒𝟐  
Figure 32: AE and RME calculations of a single step reaction.115 
Reaction Mass Efficiency (RME) is a variation of atom economy, where yield and reactant 
stoichiometry are taken into account in the calculations. In the literature there are several ways 
to calculate RME116–118 but in this thesis the simplest and generally accepted method is used: 
dividing the isolated product mass by the sum of the masses of reactants appearing in the 
reaction equation (Figure 32). Even though RME gives a better indication of the real efficiency 
of a reaction than AE, it does not account for the work-up chemicals, solvents and other 
auxiliaries which are the largest contributors to the reaction mass and waste.  
The first quantitative metric that took all materials involved in a synthesis into consideration was 
Sheldon’s Environmental Factor (𝐸 =
𝑚 𝑤𝑎𝑠𝑡𝑒
𝑚 𝑝𝑟𝑜𝑑𝑢𝑐𝑡
) which found wide spread application in process 
development.119 The minimum theoretical value for E factor is 0, meaning that no waste is 
generated in the synthesis of a compound but process water is generally not included because 
the quantities used would mask the effect of all other factors.  
Process Mass Intensity is a very similar metric to the E factor, the only difference is that it 
includes all input material in the equation (𝐸 =
𝑡𝑜𝑡𝑎𝑙 𝑚 𝑖𝑛 𝑝𝑟𝑜𝑐𝑒𝑠𝑠
𝑚 𝑝𝑟𝑜𝑑𝑢𝑐𝑡
) meaning it can be expressed 
easily from the E factor just by adding 1.120 Members of the ACS GCI Pharmaceutical Roundtable 
have argued that PMI is a better method to describe processes mostly from a philosophical point 
of view as it does not focus on waste but on materials used for the production of the high value 
commercial product. This has also been supported by LCA analysis that shows that the input 
materials have a much larger contribution to life cycle impacts than waste and waste treatment. 
Consequently, lowering the amount of all input materials is more important than minimising 
waste.120 While E factor and PMI are both useful tools to analyse and improve processes, neither 
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of these metrics give qualitative information on the chemicals used in the process. The most 
complete assessment of any chemical product is Life Cycle Assessment (LCA) which includes 
mass balances, energy usage and CO2 emission measurements not only for the manufacturing 
process but also for transport, formulation and waste treatment. 
Although there exist some complex metrics packages121–123, to address the need for a metrics 
system that provides both qualitative and quantitative data on processes, the Chem21 network 
developed a new, holistic metrics package.124 The package consists of four different levels of 
complexity: ‘Zero Pass’ evaluates screening level reactions, ‘First Pass’ is to compare optimised 
reactions with literature alternatives, ‘Second’ and ‘Third Pass’ are for pilot and manufacturing 
scale operations. The ‘First Pass’ metrics package is the most appropriate for the assessment of 
laboratory scale, therefore, in this thesis it is used for the assessment of fluorination reactions. 
This metrics package was developed as an internal Chem21 website based spreadsheet (Table 
4), which is automatically populated and analysed from uploaded experimental and safety data. 
Yield, Conversion and Selectivity have pre-set values for the colour coding, the solvents are 
ranked based on the Chem21 selection guide110 while health and safety ranking is based on the 
data obtained from material safety data forms of the chemicals used. The colour coding is not 
intended to make decisions on certain aspects of the reaction, but are to raise attention and 
highlight areas for improvement or concern. A very useful aspect of the database is the 
breakdown of the PMI numbers into different sub-values which further helps process 
improvement by showing areas where the largest contribution to the overall value come from. 
Even though this package is easy to handle and very informative for the assessment of single 
step reactions, in this form, it is not easy to use for the assessment of multi-step reactions. The 
assessment of these reactions can, however, be helped significantly by this toolkit by analysing 
them in single steps and combining the data. 
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Table 4: First Pass metrics datasheet for a single step reaction. 
 
In conclusion, the analysis and comparison of chemical processes from a green chemistry point 
of view is possible now that there are a number of methods available for the practicing chemists, 
however, it is very important to use the right tools for a given problem. When comparing in-
house reactions with literature data, it is crucial to select the benchmark carefully and to be 
consistent when making assumptions on material usage in processes when data is not available. 
Property Value Flags 
Yield x % 
 
Conversion x % 
 
Selectivity x % 
 
Reaction Mass Efficiency X  
Atom Economy X  
Solvents  
 
Health and Safety  
 
Mass Intensity: Total    
Mass Intensity: Reaction    
Mass Intensity: Reaction chemicals    
Mass Intensity: Reaction solvents   
Mass Intensity: Workup    
Mass Intensity: Workup chemicals   
Mass Intensity: Workup solvents    
Catalysts used  
 








Work up  
 




The growing abundance of fluorinated systems in drug discovery and life science products 
increases the demand for greener, scalable and economically viable methods for the formation 
of C-F bonds.112 Elemental fluorine has the potential to fulfil these requirements as it is a 
potentially atom economic, inexpensive reagent produced routinely on the manufacturing scale, 
even though, it’s use in organic synthesis has not been widely adopted. 
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Chapter 2.: Direct Fluorination of Malonate Esters 
 
2.1 Aims 
This thesis aims to establish whether elemental fluorine is a viable green fluorinating reagent 
for the direct transformation of C-H bonds to C-F bonds using a quantitative green metrics 
approach. To achieve this, selective direct fluorination methods will be developed for a range of 
model substrates. During the optimisation of these processes special emphasis will be placed on 
the green chemistry aspects, for example, solvent selection, work-up, process intensification 
and the potential for catalysis. The optimised processes will be assessed using the green 
chemistry tools described in Chapter I.: mass based metrics calculations and qualitative 
comparison of chemicals used in the processes.  
 
Figure 33: Potential routes to aliphatic fluorinated compounds. 
For aliphatic fluorinated compounds direct fluorination reactions (Route 2) will be compared 
with alternative nucleophilic fluorination methods (Route 1) that have been reported in the 
literature and are used in large scale manufacturing processes. These typically multistep 
processes (Figure 33) should, in theory, be less atom economic and potentially more wasteful 
than direct fluorination reactions. The difference in step-count is even larger for the synthesis 
of fluorinated aromatic compounds as these are almost exclusively manufactured using the Balz-
Schieman reaction which starts with the nitration of the parent compound followed by 
reduction, diazotation and fluorination using HF. 
 
Figure 34: Direct fluorination and Balz-Schiemann approaches to aromatic fluorination. 
In principle, selective direct fluorination is the most straightforward and atom-economic 
approach for the transformation of C-H bonds to C-F bonds, therefore, if a simple isolation and 
purification method can be developed, SDF processes may be able to compete with the 
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alternative syntheses. In this thesis, appropriate life-science starting materials will be used in 
the studies, for example, malonate esters, aromatic and heterocyclic compounds and steroid 
derivatives. Once optimised, the processes will be compared to existing manufacturing 
processes using green chemistry metrics, to establish whether direct fluorination could be used 
as a realistic alternative. To the best of our knowledge, no such comparative study exists in the 
literature on C-F bond forming reactions and hopefully these analyses will facilitate the 
acceptance of fluorine as a viable reagent by the wider chemistry community. 
2.2 Selective direct fluorination of malonate esters 
Malonate esters are very important building blocks in organic synthesis, their chemistry is very 
well developed125 and a wide range of alkylation, acylation, Knoevenagel, aldol, reduction, 
Michael addition, nucleophilic substitution and annelation processes are utilised in many 
important syntheses. They frequently appear in retrosynthetic planning strategies from 
University sophomore classes onwards. In comparison, however, corresponding chemistry of 
dialkyl fluoromalonate esters is not developed to any great extent and only a few examples of 
various alkylation126–128, Michael addition129–132 and heterocycle formation133–136 processes have 
been described previously, providing an indication of the potential synthetic utility of this multi-
functional, selectively fluorinated system. We reviewed the synthesis and reactions of 
fluoromalonate esters recently.137 
Figure 35: 2-Fluoromalonate esters used in the synthesis of Fluoxastrobin and TAK-733. 
A growing number of patents utilising fluoromalonate as a substrate for the synthesis of a range 
of biologically active systems have been published recently138–141 and reviewed137. For example, 
Fluoxastrobin (Fandango®), a fungicide marketed by Bayer CropScience that has achieved global 
annual sales of over €140m since its launch in 2005142,143, and TAK-733, an anti-cancer drug 
candidate144, employ 2-fluoromalonate esters as the key fluorinated starting material (Figure 
35). 
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The relatively recent developments in fluoromalonate chemistry are most probably due to the 
commercial availability of dimethyl and diethyl fluoromalonate at reasonable prices from 
speciality chemical suppliers. No special handling procedures are required when using 
fluoromalonate esters for synthetic processes beyond employing the usual laboratory and 
industrial safety precautions. 
Given the existing use of fluoromalonate esters in commercial manufacturing processes, our 
initial studies in the use of a green metric approach to fluorination concerned the comparison 
of current fluorination methodologies for the synthesis of 2-fluoromalonate esters with a direct 
fluorination approach. 
2.3 Synthesis of dialkyl 2-fluoromalonate esters137 
The synthesis of 2-fluoro-1,3-dicarbonyl systems is possible using electrophilic and nucleophilic 
fluorination methodologies but not all methods are suitable for the large scale manufacture of 
these compounds. Below, methods for the preparation of fluoromalonate esters is briefly 
reviewed with a focus on identifying synthetic routes with a potential for large scale application. 
2.3.1 Electrophilic fluorination of malonate enol derivatives 
Replacement of methylene hydrogen atoms of malonate esters by fluorine using an electrophilic 
fluorinating agent offers the most direct method for the synthesis of fluoromalonate esters and, 
over the last 60 years, several procedures have been developed using the fluorinating reagents 
available at the time. The first example of fluorination of malonate esters using perchloryl 
fluoride (FClO3) was published in 1958.145 When FClO3 was passed through an ethanolic solution 
of sodium diethyl malonate, a 50 : 50 mixture of diethyl malonate and diethyl 2,2-
difluoromalonate was obtained rather than the expected diethyl 2-fluoromalonate while two 
equivalents of NaOEt and FClO3 gave pure diethyl 2,2-difluoromalonate in high yield. 
Fluorination of a small range of 2-substituted malonic esters gave the corresponding 
fluoromalonate product, however, this fluorination methodology was not widely adopted 
because of the highly oxidising and potentially explosive nature of perchloryl fluoride. 
In the 1980’s, the development of novel electrophilic fluorinating reagents of the O-F and N-F 
class allowed the synthesis of a wider range of 2-fluoro-1,3-dicarbonyl systems. Acetyl 
hypofluorite (CH3COOF), developed by Rozen, was the first successful reagent to monofluorinate 
1,3-dicarbonyl systems in reasonable yield and purity (Figure 36a).146 N-Fluoro-2-pyridone can 
conveniently be prepared from 2-trimethylsiloxy pyridine with elemental fluorine (5% in N2)147 
and is capable of fluorinating sodium dialkyl malonates, but yields are poor, reaching only 39% 
in the case of diethyl 2-phenylmalonate (69, Figure 36b). N-Fluoro-N-alkylsulfonamides, 
introduced by Barnette148 in the early 1980s, were prepared by passing dilute (3-5 % in N2) 
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fluorine gas through a solution of the corresponding sulfonamide in an inert solvent and their 
fluorinating power was demonstrated by reaction with a series of carbanion systems, most of 
which gave the desired monofluorinated product in good yield.148 Similarly, DesMarteau 
synthesised a range of N-fluoro-perfluoroalkylsulfonimides149 from elemental fluorine that 
readily react with carbanionic substrates and essentially give the fluorinated product in 
quantitative yield (96 % for diethyl 2-methylmalonate) but their hazardous preparation (use of 
neat fluorine that is liquefied during the reaction) precludes widespread use of these reagents. 
More recently another class of N-fluorosulfonamide was developed that uses oxathiazione 
dioxides as easily accessible starting materials.150 The most stable and promising fluorinating 
reagent is benz-1,2,3-oxathiazin-4-(3-F)-one 2,2-dioxide which fluorinates various carbon 
nucleophiles (Figure 36c). Similarly, for the fluorination of carbanions, N-fluoro-2,4,6-
trimethylpyridinium triflate (trifluoromethanesulfonate) was found to react with the diethyl 
malonate sodium salt to give diethyl 2-fluoromalonate and other, substituted malonates 
provided access to the corresponding fluorinated products in high yield.45 Recently a 
hypervalent iodine reagent based synthesis has also been published (Figure 36d).151 
 
Figure 36: Initial processes for the synthesis of 2-fluoromalonate esters using (a) acetyl hypofluorite; 
 (b) N-fluoropyridone; (c) benz-1,2,3-oxathiazin-4-(3-F)-one 2,2-dioxide, 
 (d) iodosobenzene and Et3N.5HF. 
In the past twenty years, N-fluorobenzenesulfonimide (NFSI) and SelectfluorTM have emerged as 
the most popular electrophilic fluorinating reagents of the N-F class because they are shelf 
stable, solid, commercially available reagents that do not require any additional handling 
Chapter 2.: Direct Fluorination of Malonate Esters 
31 
 
procedures beyond the usual precautions taken in a research laboratory. NFSI was used, for 
example, in the asymmetric fluorination of prochiral malonate esters152 (Figure 37.) and reaction 
of SelectfluorTM with diethyl 2-phenylmalonate salt afforded the fluorinated product 67 in 
almost quantitative yield (93 %)153. Similarly, several fluoromalonate derivatives have been 
prepared using SelectfluorTM, for use as liquid crystal compounds154 and potential 
pharmaceutical targets (Figure 37.).155 
 
Figure 37: Synthesis of fluoromalonate derivatives using NFSI and SelectfluorTM. 
The direct fluorination of malonates with elemental fluorine gas was believed to be impractical 
until it was demonstrated by Purrington that it is possible to selectively fluorinate trimethylsilyl-
malonate derivatives.71 The starting material in this case was the corresponding silyl enol ether 
that was fluorinated with dilute (5% in N2) fluorine gas in an inert Freon solvent (Figure 38a). 
The use of elemental fluorine for the synthesis of fluoromalonate esters was further developed 
by Chambers.75 Fluorination of several dialkyl sodio-malonates in acetonitrile solution gave a 
product mixture that contains mono and difluorinated product and their relative ratio depends 
on the quantity of base used. With one equivalent of NaH, 37 % mono- and 23 % difluorinated 
malonate esters were obtained while, when adding 2.25 equivalents of NaH, the difluorinated 
product was the major product (37 %) along with 14 % monofluoro malonate. Substituted dialkyl 
malonate salts react with elemental fluorine to provide high yields of the corresponding 
fluorinated derivatives (Figure 38b).75  
Fluorination of diethyl malonate in a continuous flow microreactor using acetonitrile as reaction 
medium gave several mono- and difluorinated products but with low selectivity.156 The change 
of substrate to Meldrum’s acid followed by treatment of the crude reaction mixture with ethanol 
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before the work-up stage gave mono- and difluoromalonate derivatives which could be easily 
separated (Figure 38c). However, the selectivity problem for direct fluorination of malonate 
substrates was solved when it was discovered that the addition of a catalytic amount of copper 
nitrate (Cu(NO3)2.2.5 H2O) could activate the malonate substrate towards direct fluorination 
(Figure 38d) in 78 % yield.76 
 
Figure 38: Synthesis of fluoromalonate esters using fluorine gas.  
As an alternative approach, dialkyl 2-formyl malonates readily react with elemental fluorine to 
yield dialkyl 2-fluoro-2-formyl malonates that can easily be deformylated to yield exclusively the 
monofluorinated product in good yield (Scheme 38e).157 
2.3.2 Halogen exchange reactions 
Halogen exchange of chlorine by fluorine using a suitable source of fluoride ion offers an 
alternative approach to the synthesis of fluoromalonate derivatives. In the early 2000s’ several 
patents were filed by Bayer158,159 and Solvay160  concerning reactions of amine-hydrogen fluoride 
complexes with diethyl chloromalonate (88, Figure 39). 
 




Figure 39: Synthesis of fluoromalonates by Halogen exchange processes. 
Bayer’s procedure uses trimethylamine tris(hydrofluoride) to give diethyl 2-fluoromalonate in 
82 % yield while Solvay’s process uses DBN.HF complex as the fluoride ion source to give 59 in 
91% conversion on a large scale, as stated in the relevant patent descriptions.  
2.3.3 Miscellaneous preparations  
The condensation of fluoroacetic acid derivatives with alkyl chloroformate is another possible 
route for the synthesis of dialkyl fluoromalonate derivatives, but these reactions give diethyl 2-
fluoromalonate in low yield (21 %).133 A similar procedure was developed using less toxic ethyl 
bromofluoroacetate which was reacted with tributylphosphine to form an ylid that was acylated 
using ethyl chloroformate, to give diethyl 2-fluoromalonate (Figure 40).161 
 
Figure 40: Acylation of ethyl bromofluoroacetate. 
A method involving sequential solvolysis of hexafluoropropene to give dialkyl 2-fluoromalonates 
in good yield was published by Ishikawa and co-workers in the early 1980s (Figure 41).162,163 Since 
hexafluoropropene (HFP, 91) is manufactured on a very large scale for the production of various 
fluoropolymers, it is a relatively inexpensive starting material. When HFP is reacted with an 
alcoholic solution of sodium alkoxide, conjugate addition of an alcohol leads to an ether that can 
be hydrolysed by concentrated sulfuric acid to give alkyl 2,3,3,3-tetrafluoropropanoate. When 
this ester is reacted with an alcoholic sodium alkoxide solution, elimination of HF gives the 
corresponding acrylic acid derivative that immediately undergoes further addition followed by 
acidic hydrolysis to give the desired dialkyl fluoromalonate. 




Figure 41: Sequential solvolysis of hexafluoropropene.163 
In conclusion, there are several methods for the synthesis of fluoromalonate esters and 
derivatives, but only three methods are viable for large scale preparation. In this chapter, the 
direct fluorination of diethyl malonate, catalysed by copper nitrate, is reassessed and optimised 
with a view to intensifying this transformation and reducing its overall environmental impact. 
Upon optimisation, a comparison of the green metrics of selective direct fluorination with 
corresponding literature HFP and Halex routes for the synthesis of fluoromalonates to 
determine the relative merits of the three possible routes (Figure 42). 
 
Figure 42. Potentially scalable fluoromalonate syntheses. 
2.4 Optimisation of the fluorination of malonate esters 
Before a comparison of the green metrics between the three possible large scale processes for 
the synthesis of fluoromalonate esters (Figure 42) could be carried out, some primary goals for 
the optimisation of a selective direct fluorination process for the synthesis of dialkyl 2-
fluoromalonate esters were targeted following the principles of green chemistry. Complete 
conversion of the starting material is essential because it can be difficult to separate the starting 
material from the desired monofluorinated product by simple distillation. Fluorine gas usage 
should be minimised because neutralisation of excess reagent could potentially generate 
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significant amounts of hazardous waste. In order to reduce waste streams and intensify the 
fluorination process, replacement and/or reduction of all environmentally harmful solvents was 
targeted. The effects of temperature, catalyst and reactant (malonate ester and fluorine gas) 
concentration were investigated. 
 
Figure 43: Small scale direct fluorination equipment (left) and 100 mL glass reactor (right). 
In our laboratory fluorine is supplied from a commercial cylinder containing 20 % v/v F2 in 
nitrogen, which is transferred and, if required, diluted with nitrogen in stand-alone cylinders 
with an overall pressure not exceeding 5 bars. Fluorine is dispensed from these storage cylinders 
at regulated flow rates using Brooks mass-flow controllers, typically in the range of 20-100 
mL/min and introduced under the liquid surface in the reactor through a narrow bore (1/8” OD) 
FEP tube. The reaction mixture is stirred vigorously using a large, cross shaped magnetic stirrer 
bar to ensure maximum gas-liquid surface as the reaction takes place at the phase boundary. 
Exhaust gasses, containing residual fluorine, HF and solvent, are directed to a solid scrubber 
filled with granular soda lime (mixture of CaO and CaCO3) to neutralise all corrosive and volatile 
waste.76  
To better understand the relationship between fluorine gas introduction and rate of conversion, 
real time IR spectroscopic monitoring of the reaction was chosen as the most suitable technique. 
The use of ReactIR apparatus164 was enabled by a sufficient difference in the carbonyl group 
stretching frequencies (1734 cm-1 for diethyl malonate 70 and 1775 cm-1 for diethyl 2-
fluoromalonate 59) and provided an in situ reaction profile (Figure 44). 






Figure 44: Top: IR spectra of the fluorination reaction at 0 % (light blue), 50 % (dark blue) and 100 % 
(red) conversions; bottom: in situ monitoring of the fluorination of diethyl malonate. 
The real time reaction monitoring of the reaction between diethyl malonate and fluorine in 
acetonitrile solution in the presence of Cu(NO3)2 catalyst (Figure 44) revealed that the reaction 
begins instantly upon initiation of fluorine introduction and the reaction conversion is directly 
proportional to the amount of fluorine gas passed into the reaction vessel. When the intensity 
of the fluoromalonate carbonyl peak (1775 cm-1) reached a maximum, the introduction of 
fluorine gas was stopped, the sample was poured into a larger volume of water (150 mL) and 
extracted three times with ethyl acetate. The organic phase was washed with water, NaHCO3 
solution and brine, then dried and evaporated to leave a crude product which was analysed by 
1H and 19F NMR spectroscopy.  
The effect of concentration of fluorine in nitrogen, reaction temperature, copper nitrate catalyst 
loading and concentration of malonate substrate in acetonitrile were varied to optimise the 
fluorination process (Table 5). Additionally, reactions described in Table 5 allowed an 
assessment of various factors that have a major influence on the environmental impact of the 
process such as solvent usage, reaction temperature and the amount and composition of waste 
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generated. In each case 20 mmol (3.20 g) of diethyl malonate was used as substrate in the above 
described 100 mL fluorination reactor. First, the starting malonate and the catalyst were 
weighed in the reactor then acetonitrile was added, the reactor lid was closed, the mixture 
cooled to the desired temperature and nitrogen was introduced to the mixture for 5-10 minutes 
with stirring. After purging the system with nitrogen, fluorine was introduced at a prescribed 
rate using the mass-flow controller for the desired length of time, then, the fluorine flow was 
stopped and the vessel was purged again with nitrogen to remove traces of fluorine. The mixture 
was worked up as above, in the case of the ReactIR experiment, the isolated mass of crude 
material was obtained and analysed by 1H and 19F NMR spectroscopy to determine the 
conversion of starting material and yield of fluorinated products (Table 5). 

















1 0-5 1.0 10 10 100 % 93.5/4.5/2 3.37 g 
2 0-5 1.5 10 10 100 % 94/4/2 3.30 g 
3 0-5 1.0 5 10 97 % 95/4/1 3.53 g 
4 0-5 1.0 2.5 10 82 % 95/4/1 3.51 g 
5 RT 1.0 10 10 56 % 97.5/1.5/1 3.33 g 
6 0-5 1.0 10 15 85 % 97.5/1.5/1 3.47 g 
7 0-5 1.0 10 20 100 % 94/3/3 3.50 g 
8 0-5 2.0 5 20 52 % 92/5/3 3.40 g 
 
Complete conversion of the starting material was observed and diethyl fluoromalonate was 
formed with 93 % selectivity after introducing 1.1 equivalents of fluorine into the reaction 
mixture. The small excess of fluorine explains the unexpectedly small amount of difluorinated 
side products 96 (4.5 %) and 97 (2.5 %) which were the major impurities (6.5 and 9.0 % 
respectively) when a larger excess of fluorine gas (1.8 eq.) was used. 
In all cases, small quantities of side products were formed which were identified by 19F NMR and 
these originate from two different processes: difluoromalonate 96 is produced from the 
enolisation of diethyl fluoromalonate which is much slower than the enolisation of the diethyl 
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malonate substrate, while the fluoroethyl derivative 97 is postulated to form via a cyclic 
electrophilic process.68 
The data in Table 5 suggest that the concentration of the malonate ester substrate in acetonitrile 
has no apparent effect on the outcome of the reaction although solvent is required for these 
reactions because diethyl malonate does not dissolve the catalyst. Additionally, the use of high 
dielectric constant media, such as acetonitrile, have been found to be beneficial for the control 
of selectivity of electrophilic direct fluorination processes.89 For convenience, a 1.5 M 
concentration of malonate in acetonitrile was chosen for further reactions which is 
approximately 5 mL solvent per 1 mL of diethyl malonate. 
The concentration of fluorine gas, between 10 – 20 % v/v in nitrogen, does not affect the 
selectivity of the reaction and the quality of the product either, as exemplified by the product 
mixtures obtained from reactions 1, 2 and 7 (Table 5) which have identical compositions. In 
contrast, carrying out the fluorination reactions at room temperature rather than cooling the 
reaction mixture to 0-5 °C leads to increased catalyst decomposition which results in an insoluble 
copper species that on occasion blocked the fluorine gas inlet tube. In addition, without cooling, 
the exothermic nature of this fluorination reaction led to a slight reaction temperature increase 
(from 20 to 29 °C in a small scale laboratory experiment) resulting in loss of some solvent and 
some decomposition of the catalyst and product degradation. 
Lowering the concentration of the copper nitrate catalyst led to a significantly slower reaction, 
as would be expected, and required the use of a larger excess of fluorine gas to enable 
sufficiently high conversion. For example, the reaction proceeded in the presence of only 2.5 
mol % catalyst, but in this case 40 % excess fluorine was required to reach 100 % conversion.  
Typical literature work-up procedures for direct fluorination reactions involve pouring the 
reaction mixture into 3 to 5 volumes of water and extracting the resulting mixture three times 
with dichloromethane. The combined organic fraction is typically washed with water, saturated 
sodium bicarbonate solution and dried over sodium sulfate before evaporation of the solvent to 
give the crude reaction product. We sought to improve the literature work-up to enable 
recycling of the reaction solvent and substitute the use of environmentally harmful 
dichloromethane in the reaction work-up stage. Upon completion of fluorine gas addition, 
acetonitrile was evaporated for reuse and then the residue was partitioned between ethyl 
acetate and water, the organic phase was washed with water, saturated Na2CO3 solution and 
saturated brine and dried prior to evaporation under reduced pressure. Modification of the 
workup procedure in this manner enables the recovery of acetonitrile and ethyl acetate and 
significantly reduces the amount of aqueous waste generated. When direct reuse of the 
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recovered acetonitrile was attempted without any further purification of the recycled solvent, a 
copper containing precipitate was formed presumably because of the high HF content of the 
solvent (0.63 M by titration). Therefore, before reuse of the solvent, HF must be removed. 
Stirring the recovered reaction solvent with solid Na2CO3 lowered the acid content to an 
acceptable level (0.04 M) and when a second fluorination reaction was carried out in the 
recovered, neutralised acetonitrile, no change in the fluorination product profile was observed. 
Upon completion of these optimisation studies, the reaction was scaled up using the best 
conditions: 40 g of diethyl malonate and 5.8 g copper nitrate (10 mol %) were dissolved in 200 
mL of acetonitrile in a 500 mL fluorination reactor. The mixture was stirred using a mechanical 
stirrer at 650 rpm to ensure efficient mixing of the phases and 20 % v/v fluorine was introduced 
at 80 mL/min 6.5 hours (1.1 eq.). To reduce the volume of solvent used in the workup, the 
acetonitrile was first evaporated in vacuum, then ethyl acetate and water were added, the 
aqueous phase extracted once more with EtOAc then the extracts were washed with saturated 
NaHCO3 solution and brine. After drying and evaporation of the solvent, 44.4 g of 95 % pure 
diethyl fluoromalonate was obtained, which was distilled under vacuum (102-103 oC at 18 mbar) 
to yield 34.7 g of high purity (99 %+) material. 
Related malonate esters were also subjected to direct fluorination using the optimised 
conditions established above. In the case of di-tert-butyl malonate (98), fluorination was carried 
out on 12 g scale and 100 % conversion was achieved after the introduction of 1.2 equivalents 
of fluorine gas affording the desired product 99 in 96 % isolated yield. The purity of the crude 
product was higher than 97 % by 1H and 19F NMR spectroscopy without any further purification 
and as expected, the only side product was the 2,2-difluorinated product.  
 
Figure 45: Fluorination of dimethyl and di-tert-butyl malonates. 
From an atom economy point of view, methyl ester derivatives are preferable substrates 
compared to ethyl or other higher alkyl esters since they lead to smaller quantities of waste and 
so the fluorination of dimethyl malonate was investigated. Using 10 % catalyst and 1.1 
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equivalents of fluorine, 20 g of dimethyl malonate (100) was fluorinated to afford dimethyl 
fluoromalonate in 97 % yield and 95 % purity after isolation by simple work-up and no further 
purification. In this case, the only side product was dimethyl 2,2-difluoromalonate which was 
separated from 63 by fractional distillation to afford high purity dimethyl fluoromalonate which 
crystallises at room temperature (Figure 46). 
  
Figure 46: Dimethyl malonate molecular structure and crystal packing. 
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2.5 Synthesis of fluorinated heterocycles from fluoromalonate esters 
 
Condensation of fluoromalonate esters with dinucleophiles is a convenient route to 
multifunctional fluorinated heterocyclic scaffolds.137 A number of nitrogen dinucleophiles were 
reacted with the crude diethyl fluoromalonate product synthesised above (92-95 % purity) to 
afford pyrimidine and diazepane derivatives which could be purified readily by recrystallization 
and demonstrates the usefulness of 95 % purity fluoromalonate material for further synthesis.  
Table 6: Synthesis of fluorinated heterocycles using crude (95% pure) diethyl fluoromalonate ester. 
 














In particular, crude diethyl fluoromalonate prepared above reacts efficiently with formamidine 
to give fluoropyrimidine 60, a key intermediate in the synthesis of Fluoxastrobin, in good yield 
(64 %) and purity, which is comparable with previously reported optimised 61-78 % yields.158 




Figure 47: 19F and 13C NMR spectra of 5-fluoro-4,6-dihydroxypyrimidine. 
2.6 Green metrics assessment 
To compare the metrics of the optimised direct fluorination process with other methods for the 
synthesis of fluoromalonate esters, the Chem21 “First Pass” metrics package, was implemented 
as described in Chapter 1.124  
2.6.1 Direct fluorination metrics 
 
Figure 48: Direct fluorination method for the synthesis of diethyl fluoromalonate. 
For the calculation of atom economy, only a balanced reaction equation and the molecular 
weights of the reactants are necessary, as this metric does not involve catalysts, reagents or 
solvents. In this case, the calculation is very simple, the molecular weight of diethyl 
fluoromalonate (178.16 g/mol) is divided by the sum of the molecular weights of diethyl 
malonate and fluorine (160.17 + 38.00 = 198.17) giving 89.9 % as the atom economy of this 
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reaction meaning that almost 90 % of the atoms involved in the reaction are incorporated into 




× 100 = 𝟖𝟗. 𝟗 
Reaction mass efficiency is a more useful tool than atom economy, as it takes yield and 
stoichiometry into consideration. For the calculation of RME, the product weight is divided by 
the combined mass of the reactants, which gives 88.6 % for the crude product and 69.3 % for 
the distilled, high purity material. RME can be used together with AE in a way that AE is the 
theoretical maximum, as these two metrics will be equal in the case of one to one stoichiometry 
and 100 % yield, therefore, the closer the RME value is to the AE, the better the reaction is. In 
this case (RME = 88.6), the crude product is very close to the AE (89.9), meaning that the yield is 




× 100 = 𝟖𝟖. 𝟔 
𝑅𝑀𝐸(𝐷𝑖𝑟𝑒𝑐𝑡 𝐹𝑙𝑢𝑜𝑟𝑖𝑛𝑎𝑡𝑖𝑜𝑛 𝐷𝑖𝑠𝑡𝑖𝑙𝑙𝑒𝑑) =
34.7
40.0 + 10.1
× 100 = 𝟔𝟗. 𝟑 
The most comprehensive metric used in this thesis is mass intensity (MI), which describes how 
much material is used in the synthesis for every kg of product obtained. To calculate the MI of 
the direct fluorination step, the weight of diethyl fluoromalonate is divided by the sum of all 
components from the reaction and the workup: reactants, catalyst, solvents and aqueous 
washes. The MI calculated for the crude product is 9.0 kgmaterial/kgproduct which is a relatively low 
number, and only increases to 11.6 when it is calculated for the distilled, 99%+ pure product. It 
is often useful to calculate the MI for different stages of a reaction, this way it is easy to highlight 
the problematic areas of a process, where more improvement is needed. In this reaction, 
solvents are the largest contributors to MI, but with recycling and reuse of solvents, this number 
could be lowered further. 
𝑀𝐼(𝐷𝑖𝑟𝑒𝑐𝑡 𝐹𝑙𝑢𝑜𝑟𝑖𝑛𝑎𝑡𝑖𝑜𝑛) =
40.0 + 5.8 + 157 + 10.1 + 50 + 90 + 25 + 24
44.4
= 𝟗. 𝟎 
𝑀𝐼(𝐷𝑖𝑟𝑒𝑐𝑡 𝐹𝑙𝑢𝑜𝑟𝑖𝑛𝑎𝑡𝑖𝑜𝑛 𝐷𝑖𝑠𝑡𝑖𝑙𝑙𝑒𝑑) =
40.0 + 5.8 + 157 + 10.1 + 50 + 90 + 49
34.7
= 𝟏𝟏. 𝟔 
𝑀𝐼(𝐷𝑖𝑟𝑒𝑐𝑡 𝐹𝑙𝑢𝑜𝑟𝑖𝑛𝑎𝑡𝑖𝑜𝑛 𝑅𝑒𝑎𝑐𝑡𝑖𝑜𝑛) =
40.0 + 5.8 + 10.1 + 157
44.4
= 𝟒. 𝟔 
𝑀𝐼(𝐷𝑖𝑟𝑒𝑐𝑡 𝐹𝑙𝑢𝑜𝑟𝑖𝑛𝑎𝑡𝑖𝑜𝑛 𝑅𝑒𝑎𝑐𝑡𝑖𝑜𝑛 𝐷𝑖𝑠𝑡𝑖𝑙𝑙𝑒𝑑) =
40.0 + 5.8 + 10.1 + 157
34.7
= 𝟓. 𝟕 
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𝑀𝐼(𝐷𝑖𝑟𝑒𝑐𝑡 𝐹𝑙𝑢𝑜𝑟𝑖𝑛𝑎𝑡𝑖𝑜𝑛 𝑆𝑜𝑙𝑣𝑒𝑛𝑡𝑠) =
157 + 50 + 90
44.4
= 𝟔. 𝟕 
𝑀𝐼(𝐷𝑖𝑟𝑒𝑐𝑡 𝐹𝑙𝑢𝑜𝑟𝑖𝑛𝑎𝑡𝑖𝑜𝑛 𝑆𝑜𝑙𝑣𝑒𝑛𝑡𝑠 𝐷𝑖𝑠𝑡𝑖𝑙𝑙𝑒𝑑) =
157 + 50 + 90
34.7
= 𝟖. 𝟔 
𝑀𝐼(𝐷𝑖𝑟𝑒𝑐𝑡 𝐹𝑙𝑢𝑜𝑟𝑖𝑛𝑎𝑡𝑖𝑜𝑛 𝑊𝑜𝑟𝑘𝑢𝑝) =
50 + 90 + 24 + 25
44.4
= 𝟒. 𝟑 
𝑀𝐼(𝐷𝑖𝑟𝑒𝑐𝑡 𝐹𝑙𝑢𝑜𝑟𝑖𝑛𝑎𝑡𝑖𝑜𝑛 𝑊𝑜𝑟𝑘𝑢𝑝 𝐷𝑖𝑠𝑡𝑖𝑙𝑙𝑒𝑑) =
50 + 90 + 24 + 25
34.7
= 𝟓. 𝟓 
2.6.2 Halogen exchange method metrics 
The halogen exchange reaction requires the industrial synthesis of high purity chloromalonate 
ester since the purity of the final fluoromalonate product largely depends on the efficiency and 
selectivity of this step. The chlorination reaction with sulfuryl chloride is reasonably selective 
and pure diethyl chloromalonate can be obtained in good yield165 after vacuum distillation and 
it is reasonable to assume that this reaction is suitable for large scale synthesis. The halogen 
exchange reaction is also very efficient since HF.amine systems are convenient, reactive sources 
of fluoride ion and additionally, they can be handled safely since they are less volatile than aHF 
and are commercially available on the multi-ton scale. 
Figure 49: Halogen exchange method for the synthesis of diethyl fluoromalonate. 
The assessment of a literature processes requires more attention as not all the necessary data 
is reported in typical synthetic procedures and in these cases, realistic assumptions about the 
quantities have to be made. In the case of the halogen exchange method the data was sufficient, 
but to simplify the calculations the chlorination step was “scaled up” on paper from the reported 
100 g scale to give the exact amount of diethyl chloromalonate required in the second steps in 
the reported yield. 
The metrics calculations are very similar to the direct fluorination step, but this is a two-step 
procedure, therefore, the molecular weight and the mass of the intermediate diethyl 
chloromalonate is not included. For the two steps, the atom economy of this reaction is only 
39.2 %, which is mainly due to the high molecular weight of sulfuryl chloride and Et3N.3HF, 
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however, the RME value of 33.0 % shows that the reaction is high yielding and is not using large 
excesses of the reagents. 
𝐴𝐸(𝐻𝑎𝑙𝑒𝑥) =
178.16
160.17 + 134.96 + 161.21
× 100 = 𝟑𝟗. 𝟐 
𝑅𝑀𝐸(𝐻𝑎𝑙𝑒𝑥) =
156 
181 + 154 + 137
× 100 = 𝟑𝟑. 𝟎 
In this case, the mass intensity calculation was also relatively straightforward and, again, the 
intermediate chloromalonate ester has to be left out of the calculations. The PMI of this reaction 
is very low, only 6.9, which is the result of a solventless first step and a very concentrated 
halogen exchange reaction. In this reaction the solvents were also important contributors, but 
with recycling the xylenes used for extraction, this number could be lowered further. 
𝑃𝑀𝐼(𝐻𝑎𝑙𝑒𝑥) =
181 + 154 + 137 + 86 + 300 + 215
156
= 𝟔. 𝟗 
𝑃𝑀𝐼(𝐻𝑎𝑙𝑒𝑥 𝑅𝑒𝑎𝑐𝑡𝑖𝑜𝑛) =
181 + 154 + 137 + 86 + 300
156








= 𝟑. 𝟑 
2.6.3 HFP method metrics 
Hexafluoropropene (HFP) is an important, inexpensive perfluorinated building block used for the 
synthesis of various well known fluoropolymers and refrigerant gases and is, therefore, available 
on the industrial scale.166 In the literature, it was reported that HFP can be reacted with various 
alcohols to yield the corresponding fluoromalonate ester derivatives in a multistep process and 
the synthesis of methyl ester 63 was described in detail. Yields for diethyl fluoromalonate and 
its intermediate precursors were also reported and for the metrics calculations, the same scale 
was used using ethanol as in the reaction with methanol.163 From the experimental procedures 
only the mass balances are needed for metrics calculations, but in some instances data was 
missing. For example, in the first stage of the reaction, a concentrated sulphuric acid solution 
(approximately 500 mL total volume) was quenched in ice-water, but the quantity of ice was not 
reported, thus, we assumed that 3.5 kg was used, which is approximately 500 g of ice for 100 g 
of the acid. When estimating other unquantified materials, a very conservative approach was 
applied to avoid artificial inflation of the metrics results. 




Figure 50: HFP solvolysis method for the synthesis of diethyl fluoromalonate. 
The atom economy of this reaction (39.1) is comparable to that of the Halex method (39.2), but 
in this case a different, more complex starting material was used which would imply that this 
process is less likely to be greener than the alternative. The comparison of RME values gives the 
same conclusion, as because of the lower yield of the HFP route it is only 20.6 which means that 
close to 80 wt% of the reactants is lost in this process. 
𝐴𝐸(𝐻𝐹𝑃 𝑚𝑒𝑡ℎ𝑜𝑑) =
178.16
150.02 + 4 × 68.05 + 2 × 18.02
× 100 = 𝟑𝟗. 𝟏 
𝑅𝑀𝐸(𝐻𝐹𝑃 𝑚𝑒𝑡ℎ𝑜𝑑) =
156.4
255 + 403 + 100
× 100 = 𝟐𝟎. 𝟔 
The biggest difference between the HFP route and the other alternative syntheses is in the PMI, 
where the alternative routes are almost an order of magnitude better. The high PMI of this 
process (62.1) is mostly due to the use of concentrated sulfuric acid solvent and its aqueous 
quench as shown by the PMI of the workup (44.1). 
𝑃𝑀𝐼(𝐻𝐹𝑃 𝑚𝑒𝑡ℎ𝑜𝑑) =
255 + 403 + 6100 + 1026 + 736 + 300 + 292 + 597
156.4
= 𝟔𝟐. 𝟏 
𝑃𝑀𝐼(𝐻𝐹𝑃 𝑅𝑒𝑎𝑐𝑡𝑖𝑜𝑛) =
255 + 403 + 100 + 1026 + 736 + 292
156.4
= 𝟏𝟖. 𝟎 
𝑃𝑀𝐼(𝐻𝐹𝑃 𝑆𝑜𝑙𝑣𝑒𝑛𝑡𝑠) =
6000 + 1026 + 357 + 240
156.4
= 𝟒𝟖. 𝟖 
𝑃𝑀𝐼(𝐻𝐹𝑃 𝑊𝑜𝑟𝑘𝑢𝑝) =
6000 + 300 + 240 + 356
156.4
= 𝟒𝟒. 𝟏 
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In conclusion, the synthesis of fluoromalonates by reaction of HFP with ethanol and H2SO4 
affords good purity product in fair yield, but, from an environmental impact point of view, this 
is a very wasteful and low-atom economy process. Firstly, the synthesis of the starting material 
requires many steps, ultimately by reaction of low molecular weight hydrocarbons with chlorine 
gas and subsequent halogen exchange in a very energy intensive process and, secondly, a 
significant amount of hazardous, strongly acidic waste is generated in the reaction of HFP with 
ethanol. 
Besides quantitative metrics, the Chem21 First Pass metrics package includes qualitative 
assessment for several factors, for example, solvents, catalysis, energy and safety. When 
comparing the three processes, only the HFP method uses an undesirable solvent, diethyl ether, 
for an extraction, however, in a manufacturing environment this could easily be replaced with a 
safer and environmentally benign alternative. The other solvents in the reactions are acceptable 
from a green chemistry point of view and most of them have potential for recovery and reuse.  
The only catalytic process is the direct fluorination reaction which uses hydrated copper nitrate 
to catalyse the enolisation of malonate esters. This catalyst is not only inexpensive, but the 
catalyst metal is easily separated into the aqueous stream and, in theory, could be recovered 
using conventional inorganic chemistry methods. 
The energy requirement for these reactions is very difficult to assess under laboratory conditions 
and the only guideline in the First Pass metrics package is that between 0 - 70 oC the reaction is 
flagged green, anywhere outside this range, but between -20 – 140 oC is amber and outside that 
range is red.124 Considering these guidelines both the HFP and the Halex method are marked 
amber, while the direct fluorination without distillation is green and when the distillation is 
included it is amber because of the energy intensity and the relatively high temperatures of the 
vacuum-distillation process. The qualitative assessment of downstream processing classifies 
isolation and purification procedures into green, amber and red groups, which usually 
corresponds to the amount of material and energy required for the given method. Aqueous 
workup followed by extraction and vacuum distillations are present in all three methods, 
therefore, in this regard there is no significant difference between these processes. The 
comparison of the health and safety aspects does not show any difference either, all reactions 
involve HF either as starting material or byproduct meaning that they are all classified as highly 
corrosive and very toxic. 
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Table 7: Comparative green metrics of fluoromalonate syntheses. 
Fluoromalonate 
synthesis 
HFP method Halex cumulative 
Cu catalysed direct 
fluorination (distilled) 
Yield [Purity %] 52 % [n/a] 77 [96 %] 99 [95 %] (77 [99%+]) 
Atom Economy (AE) 39.1 39.2 89.9 
Reaction Mass 
Efficiency (RME) 
20.6 33.0 88.6 (69.3) 
Step MI/PMI Total 62.1 6.9 9.0 (11.6) 
PMI/MI Reaction 18.0 5.5 4.6 (6.1) 
PMI/MI Solvents 48.8 3.3 6.7 (8.6) 












Catalyst -  -  Cu(NO3)2.2.5H2O  











































In conclusion, the green chemistry assessment of the potential synthetic methods for the 
production of fluoromalonate esters clearly demonstrates that the direct fluorination and the 
Halex methods are superior to the HFP based synthesis which is most apparent in the 
comparison of the industrially most used PMI metric. However, it is not possible to make a 
decision between the other two methods, as they are both very efficient and produce only a 
small amount of waste. 




The selective direct fluorination (SDF) process for the synthesis of 2-fluoromalonate esters has 
been re-evaluated and optimised on a reasonable scale in the laboratory (50 g scale) both in 
terms of product yield, purity (99 % crude yield, 95 % purity, after distillation 77 % yield and 99% 
purity) and green reaction metrics. The PMI value of the SDF process is, even at this relatively 
small scale, under 10, an industry benchmark figure that demonstrates an efficient and effective, 
environmentally benign chemical syntheses. A comparison of green metrics between the SDF 
process and established multi-step syntheses derived from hexafluoropropene ethanolysis and 
halogen exchange chemistry shows that SDF compares very favourably in terms of 
environmental impact for the synthesis of important fluorinated building blocks on larger scale.
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In the previous section it was demonstrated that using elemental fluorine for the selective direct 
fluorination of malonate esters is a viable and potentially greener synthetic method than the 
alternative halogen exchange route. However, pharmaceutical compounds are usually 
structurally more complex and have fluorine substituents in diverse positions, therefore, to 
establish the viability of selective direct fluorination processes of drug-like systems, in this 
chapter, the direct fluorination of pharmaceutically relevant steroids and aromatic compounds 
will be discussed. Similarly to the previously described work, the aim was to identify and 
optimise processes for comparative green metrics analysis between SDF and alternative routes. 
3.1 6-Fluorocorticosteroids 
In the history of the development of small molecular drug substances fluorine containing 
steroids made a big difference. Sabo and co-workers discovered in the early 1950’s that the 
introduction of a single fluorine atom into a corticosteroid increased its potency tenfold8 and 
since then several fluorinated steroids have been introduced to the marketplace for the 
treatment of various conditions. 
Figure 51: Existing fluorocorticosteroid drugs. 
3.1.1 Literature methods for the synthesis of fluorosteroids 
The incorporation of fluorine into steroid systems is typically carried out using conventional 
nucleophilic fluorination strategies, especially at the 9position where ring opening of the 
corresponding epoxide with HF gives the desired product. 
 
 Figure 52: Synthesis of 9-fluorocortisone acetate.8 
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The early syntheses of 6-fluorosteroids involved a long, multi-step procedure where a double 
bond at the 5-6 position was oxidised to the corresponding epoxide which was opened with a 
fluoride source then, subsequently, the 5-hydroxy group was eliminated to give the fluorinated 
4,5-unsaturated product (Figure 53).167,168 While this method enabled the synthesis of 6-
fluorocorticosteroids from readily available starting materials, this is a very wasteful and 
inefficient way to synthesise these compounds. 
 
Figure 53: Epoxide ring opening based introduction of the 6-fluoro functionality into steroid systems. 
Electrophilic fluorination reactions have been of interest for a long time and over the past 50 
years several reagents have been developed which have been shown to be useful for the 
synthesis of 6-fluorosteroids. Early examples of this transformation included the use of 
perchloryl fluoride169 and trifluoroacetyl hypofluorite (CF3COOF)170, but these reagents are not 
suitable for large scale use because of their high reactivity and potential to form explosive 
mixtures. In more recent years, several N-F reagents, for example N-fluoropyridinium salts45, 
Selectfluor49 or Accufluor171 have been used for the fluorination of steroid enolate derivatives 
and because of the high value of fluorosteroids, this is an area where they found larger scale 
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Table 8: Electrophilic fluorination of steroid enolate systems. 
 





72 1 : 2 
 
 
70 1 : 1.5 
  
95 1 : 1.5 
 
 
89 1 : 2.2 
 
Even though most electrophilic fluorinating reagents are synthesised using elemental fluorine, 
there have only been very few examples in the literature where fluorine gas was reacted with 
steroid substrates and all these examples focused on the fluorination of tertiary C-H positions.64–
66 Rozen and co-workers observed that the regio-selectivity of the fluorination reaction can be 
influenced by substituents in the vicinity of the tertiary C-H positions as electron withdrawing 
groups decrease electron density in the C-H bond, lowering their reactivity towards elemental 
fluorine. 




Figure 54: Direct fluorination of 5-cholanic acid-3-ol acetate methyl ester. 
Given the importance of 6-fluorosteroids in medicinal applications, it is surprising that elemental 
fluorine has not been investigated as a potential reagent for the synthesis of these systems. In 
this chapter the selective direct fluorination of progesterone enol acetate is discussed, which 
was chosen as a relatively simple model substrate that contains the necessary enolisable  
unsaturated ketone system that directs the fluorination at the 6 position. 
3.1.2 Synthesis of progesterone derivatives 
It was shown in a previous chapter that fluorine gas can react with enolate systems to form -
fluoroketones in reasonable yield and good selectivity, but only structurally very simple systems 
have been fluorinated using this methodology. In this study we aimed to investigate whether 
elemental fluorine is a viable reagent for the synthesis of 6-fluorosteroids via the direct 
fluorination of their enolate derivatives. 
 
Figure 55: Synthesis of progesterone enol acetate. 
The synthesis of the enol acetate of progesterone was performed following a modified literature 
procedure.172 Progesterone was dissolved in the mixture of acetyl chloride and acetic anhydride 
and was heated to 100 °C for 1 h. After confirming full conversion of the starting material with 
TLC analysis, the mixture was allowed to cool to room temperature and concentrated to one 
third of the original volume under reduced pressure at 25 °C when a white precipitate formed. 
The product was filtered, washed with cold acetonitrile and dried under vacuum at 35 °C to 
afford progesterone enol acetate in 65 % yield and satisfactory purity for further synthesis as 
shown by 1H and 13C NMR spectroscopic analysis. The structure was confirmed by the 
assignment of all 1H and 13C peaks using COSY, HSQC and HMBC NMR spectroscopic techniques 
which were in agreement with previously reported values173. 




Figure 56: 1H NMR spectrum of progesterone enol acetate. 
For the analysis of a product mixture following direct fluorination, 1H NMR spectroscopy was 
deemed unsuitable because of the complexity of the 1H NMR spectra of steroid compounds (e.g. 
Figure 56), therefore, a HPLC method was sought. To achieve accurate analysis results, analytical 
samples of both 6-fluoroprogesterone isomers were synthesised to be used as standards. These 
compounds were synthesised using Selectfluor™ in a mixture of acetonitrile and acetone 
adopting a method previously reported in the literature.49  
 
Figure 57: Fluorination of progesterone enol acetate using Selectfluor. 
After simple aqueous workup, the crude reaction product was a mixture of two isomers (1 : 2 
ratio: -183 and -166 ppm in the 19F NMR spectrum), of which, the major product (-166 ppm) was 
isolated using column chromatography in good yield and purity. As NMR spectroscopic analysis 
was not sufficient to establish the stereochemistry of the major isomer, crystals suitable for X-
ray crystallography were grown by slowly evaporating a pure sample dissolved in acetone and 
subsequent analysis (Figure 60) confirmed that this isomer was 6-fluoroprogesterone (122). 




Figure 58: 19F NMR spectrum of the crude fluorinated product. 
Even though the  and  isomers were separable by column chromatography, a larger sample 
of the  isomer was obtained by the enolisation of the crude product mixture with dry HCl in 
acetic acid to transform the mixture into the thermodynamically more stable  form (123).174  
Figure 59: Synthesis of 6-fluoroproesterone.  
The crude product contained a small amount of  isomer, but after recrystallisation from 
methanol, pure crystals of 6-fluoroprogesterone were isolated in good yield (74 %) and the 
structure of the -isomer was also confirmed using NMR spectroscopy and by X-ray 
crystallography.  
  
Figure 60: Molecular structure of 6- and 6-fluoroprogesterone as determined by X-ray 
crystallography. 
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3.1.2 Quantitative analysis method development 
With analytical samples of 6 and 6-fluoroprogesterone isomers in hand we were able to 
establish a reliable HPLC method for product analysis. It is described in the literature that the 
side-product of enol-acetate fluorination is the hydrolysed, non-fluorinated ketone, therefore, 
the HPLC method was developed to give good separation of three proposed main components 
of a fluorination crude product: progesterone, 6- and 6-fluoroprogesterone. The separation 
of such non-polar compounds is best carried out using reverse-phase chromatography, thus, the 
analysis was optimised on a Waters C18 column using water and acetonitrile as mobile phase 
with 0.1 % formic acid additive. Base-line separation was achieved using the following method: 
after injection, the sample was eluted at 1.5 ml/min flow rate for 3 minutes with a mixture of 60 
% water (0.1 % HCOOH) and 40 % acetonitrile (0.1 % HCOOH) then the acetonitrile was increased 
to 95 % over 15 minutes and this was maintained for a further 3 minutes. The UV detection was 
carried out at 237 nm, as all desired compounds have strong absorption at this wavelength. 
 
Figure 61: HPLC-UV chromatogram of a mixture of progesterone, 6a- and 6b-fluoroprogesterone. 
To accurately determine the amount of the desired products in a crude reaction mixture, 
calibration curves were measured for the three known components. The concentration range 
where these compounds can be accurately measured with HPLC was between 0.1 and 0.5 
mg/mL and, therefore the calibration was carried out in this range using 5 data points for each 
component.  






Figure 62: Calibration curves for the determination of progesterone, 6- and 6-fluoroprogesterone. 
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All three calibration curves give excellent linear relation (R2≥0.99) between product 
concentration and they were validated by analysing an artificial sample of known concentration 
of each component which confirmed the accuracy of the method (Table 9). The results clearly 
show that this method is suitable for the determination of the amounts of the three desired 
components in a reaction product mixture with the relative error of the measurement being less 
than 5 %. 




Measured concentration (mg/mL) 
(average of 5 injections) 
Progesterone 0.3370 0.3197±0.0090 
6-Fluoroprogesterone 0.3232 0.3059±0.0128 
6-Fluoroprogesterone 0.3021 0.2953±0.0210 
 
3.1.4 Direct fluorination of progesterone enol acetate 
Direct fluorination was carried out in formic acid solution as it was shown in the literature to be 
the preferred solvent for the fluorination of enolate systems.82 Progesterone enol acetate (1.06 
g) was dissolved in formic acid and reacted with a small excess of fluorine gas (1.4 equivalents); 
after evaporation of the solvent 1.02 g of yellow oily material was obtained which was dissolved 




Figure 63: HPLC-UV chromatogram of the crude product from the direct fluorination of progesterone 
enol acetate. 
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The chromatogram showed full conversion of the starting material and the presence of the 
desired products as main components along with some minor impurities, but integration 
revealed that only half of the product mass could be accounted for by these three compounds. 
Interestingly, the selectivity of the direct fluorination ( to , 1 : 2) is similar to that of the 
SelectfluorTM reaction, but most likely, the conjugated -bond system responsible for the UV 
detection is destroyed under these conditions making several side products undetectable. When 
a larger excess of fluorine gas (2.1 eq.) was used, the amount of product observed by HPLC was 
even less (400 mg from a 1 g sample). 
Table 10: Quantitative analysis of the reaction products by HPLC-UV. 
Product Retention time (min) Calculated amount (mg) 
6-Fluoroprogesterone 4.78 80.1 
6-Fluoroprogesterone 5.33 158.2 
Progesterone 5.72 272.9 
 
After HPLC analysis, 1.02 g of the product was recovered from solution by evaporating the 
solvent and was subjected to normal phase column chromatography initially using toluene and 
ethyl acetate then ethyl acetate and methanol to maximise material recovery from the silica 
phase. Four different fractions were collected and analysed by NMR spectroscopy.  
 
Figure 64: 19F NMR spectra of the various fractions from the purification of a progesterone enol acetate 
fluorination mixture. 
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The first fraction (0.10 g) contained several unidentified fluorinated compounds, the second 
(0.19 g) was mainly a mixture of progesterone and 6-fluoroprogesterone with only minor 
fluorinated contaminations. The third and largest fraction (0.47 g) contained a small amount of 
6- and 6-fluoroprogesterone along with several unidentified non-fluorinated species while 
the final fraction (0.19 g) only contained unknown partially fluorinated material. Attempts to 
further purify any of the fractions was unsuccessful. The unidentified material could potentially 
contain other C-H fluorinated compounds, F2 addition derivatives or possible carbon skeleton 
rearrangement products as it is known that HF can facilitate these transformations.  
3.1.5 Conclusion 
The direct fluorination approach to 6-fluorosteroid systems was investigated in this chapter 
using progesterone as a model substrate. Pure analytical samples of 6- and 6-
fluorprogesterone were synthesised using SelectfluorTM and were used to develop a HPLC-UV 
method for the quantitative analysis of reaction mixtures. Direct fluorination led to full 
conversion of the starting material, however, HPLC-UV analysis showed that only 50 % of the 
material was converted to known compounds and the remaining material was as unidentifiable 
mixture of compounds that were not detected by the detection method used for the HPLC 
analysis. Efforts to purify and isolate pure products from the mixture were unsuccessful. 
Consequently, synthesis of 6-fluorosteroids needs to be carried out using alternative 
electrophilic reagents, such as Selectfluor™ or NFSI, as fluorine gas leads to large amount of 
unidentified material that cannot be separated from the desired products using conventional 
purification methods. 
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3.2 Fluoroaromatic derivatives 
 
Fluorobenzene derivatives are present in a wide range of life science products with over 35 % of 
fluorine containing pharmaceuticals contains at least one fluorine atom attached to an aromatic 
ring (Chapter 1.), however, the synthesis of these systems still heavily relies on wasteful, multi-
step processes such as the Balz-Schiemann reaction or nucleophilic halogen exchange methods.  
 
Figure 65: Aromatic fluorination methods. 
3.2.1 Aims 
Direct fluorination methods have been developed for aromatic fluorination previously at 
Durham and it was found that 1,4-disubstituted benzene derivatives bearing both an electron 
withdrawing and an electron donating group are good substrates for this reaction, giving 3-
fluoro-1,4-disubstituted benzene derivatives in good yield following chromatographic 
purification. Such fluorinated aromatic systems, in which the fluorine substituent is in the meta 
position to an electron withdrawing group, appear in the synthesis of various biologically active 
systems such as Losmapimod or Linezolid (Figure 66). 
In this chapter, the direct fluorination of model 1,4-disubstituted benzene systems is 
reinvestigated with an aim to identify substrates where the isolation and purification can be 
achieved without the use of chromatography and on a reasonable scale. After finding the 
optimal reaction conditions, the reactions will be scaled up to synthetically useful scale (10-20 
g) and purified to provide data for green metrics analysis and comparison with Balz-Schiemann 
processes.  




Figure 66: Active pharmaceutical ingredients containing a 3-fluorobenzene structure. 
3.2.2 Fluorination of aromatic substrates 
For the direct fluorination study a number of compounds were selected based on literature use 
in pharmaceutical syntheses and consultation with colleagues from pharmaceutical companies 
participating in the Chem21 project. 3,4-Difluorobenzonitrile and 3,4-difluoronitrobenzene 
were identified as pharmaceutically relevant systems where the synthesis is potentially possible 
using fluorine gas and the known synthetic routes are available from the literature. All 
fluorination reactions were performed in the already described batch fluorination apparatus 
mainly using mechanically stirred larger (250 mL) reactors. 
 
Figure 67: Larger scale baffled batch reactors used for fluorination. 
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3.2.3 Fluorination of 4-fluorobenzonitrile 
Direct fluorination of 4-fluorobenzonitrile has been reported90 to proceed with good conversion 
in formic and sulfuric acid solvents, therefore, this reaction was investigated in more detail to 
meet the aims discussed above.  
In a typical reaction, 1.21 g of 4-fluorobenzonitrile was dissolved in the reaction solvent in a 
fluorination reactor, the mixture was purged with nitrogen for 5-10 minutes then fluorine was 
introduced at 40 mL/min (10 mmol/h) rate. After the introduction of the desired amount of 
fluorine, the fluorine flow was stopped, the mixture was purged with nitrogen to remove traces 
of fluorine and, following an aqueous workup, the crude product was isolated either by filtration 
(H2SO4 reactions) or by extraction with ethyl acetate (formic acid reactions). The crude product 
was analysed by 19F NMR spectroscopy to determine the composition of the isolated material. 











1 1.5 H2SO4 22 % 0.79 g solid, 131 + 49 (hydrolysed) 
2 2.5 H2SO4 30 % 0.75 g solid, 131 + 49 (hydrolysed) 
3 3.5 H2SO4 54 % 0.72 solid, 131 + 49 (hydrolysed)+2% trifluoro 
4 4.5 H2SO4 82 % 
0.34 g solid, 131 + 49 (hydrolysed)+10 % 
trifluoro 
5 1.5 HCOOH 37 % 0.80 g oil, 131 + 49 (hydrolysed) + unknown  
6 2.5 HCOOH 55 % 
0.63 g oil, 131 + 49 (hydrolysed), tri-F, 
unknown 
7 3.5 HCOOH 70 %+ 
0.88 g oil, 131 + 49 (hydrolysed), lot of small 
side products 
8 4.5 HCOOH 85 %+ 
0.75 g oil, 131 + 49 (hydrolysed), trifluoro, lot 
of other imps. 
 
At lower conversions (entries 1-2) the selectivity of the reaction is good and only the hydrolysed 
starting material and the desired product 131 were observed both in sulphuric and formic acid 
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solution. However, with increasing the conversion by using a further excess of F2, other 
polyfluorinated side products appeared. The recovery of the product was significantly better 
from formic acid solutions, but the selectivity of the reaction was higher in the case of sulfuric 
acid, therefore, the latter was chosen as the reaction solvent for subsequent experiments. 
To establish purification methods, the reaction was carried out on larger scale (5 g) in sulfuric 
acid using 20 % fluorine gas in nitrogen (3 equivalents) and after standard workup only a small 
amount of product was isolated (0.2 g). Neutralisation of the aqueous solution with ammonia 
precipitated a crystalline material which was recovered (3.9 g) by vacuum filtration. 19F NMR 
analysis of the product showed that it was a mixture of amide 131 with hydrolysed starting 
material and some minor impurities. 
 
Figure 68: 19F NMR spectrum of the crude product of the larger scale fluorination. 
In order to separate the difluorinated product from the mono- and polyfluoro impurities, 1 g 
samples of the crude product were recrystallized from various solvents, but no improvement in 
purity was observed in solvents with varying polarity (Figure 69). It is possible that these amides 
crystallise in a dimeric hydrogen bonded form and the pair formation is not selective.  
Given the difficulties in simple purification of this substrate, a different approach was sought 
and 3,4-difluorobenzoic acid was identified as a target that is the precursor of the desired nitrile. 




Figure 69: 19F NMR spectra of crude and recrystallized 3,4-difluorobenzamide from ethanol, 50% 
aqueous ethanol and methylcyclohexane.  
3.2.4 Fluorination of 4-fluorobenzoic acid 
An alternative approach to 3,4-difluorobenzonitrile is to convert the difluorinated benzoic acid 
to the benzamide and then dehydrate the amide to the corresponding nitrile. The fluorination 
of 4-fluorobenzoic acid was one of the early examples of successful aromatic fluorination 
reactions and it was reported to produce the desired 3,4-difluorobenzoic acid product along 
with other polyfluorinated products.89 
 
Figure 70: Alternative approach to 3,4-difluorobenzonitrile. 
To investigate the viability of this route 4-fluorobenzoic acid (14 g scale) was fluorinated in 
concentrated sulfuric acid using two equivalents of fluorine (20 %v/v in nitrogen) at room 
temperature to achieve 40 % conversion of the starting material with relatively small amount of 
side products (<4 %).  The crude product (13.8 g) was isolated after quenching the reaction 
mixture in a large excess of ice and extraction into ethyl acetate.  
 




Figure 71: 19F NMR spectrum of the crude product from the direct fluorination of 4-fluorobenzoic acid. 
As recrystallization would possibly lead to similar problems as in the case of the benzamide, the 
crude acid was esterified with methanol to produce the methyl ester derivative of the mixture 
(11.6 g) and this mixture distilled under vacuum to assess this purification method. 
 
 
Figure 72: 19F NMR spectrum of crude methyl 3,4-difluorobenzoate. 
Vacuum distillation of the mixture of methyl ester derivatives was carried out using a Fischer 
micro Spaltrohr® MMS 255 distillation apparatus equipped with a valve to control the reflux 
ratio and a fraction collector for eight separate 1.5 mL fractions (Figure 73). 




Figure 73: Fischer Spaltrohr® distillation setup (left) with condenser (1), reflux valve (2), vacuum 
connection (3), thermocouple well (4 and 8), vacuum jacketed column (5), fraction collector (6, also on 
the right) and distillation flask (7). 
The crude mixture of fluorinated methyl benzoates was distilled at 19 mbar pressure and the 
product boiled at 88-89 oC. After collecting eight, approximately 1 mL samples, the distillation 
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difluorobenzoate % Others % 
Fraction 
mass / g 
Starting mixture 59 37 4 11.46 
Fr. 1 66 33 1 0.95 
Fr. 2 66 33 1 1.08 
Fr. 3 66 33 1 1.1 
Fr. 4 65 33 2 1.03 
Fr. 5 65 33 2 1.02 
Fr. 6 66 33 1 1.38 
Fr. 7 65 34 1 1.16 
Fr. 8 64 34 2 1.69 
Residue 52 36 12 1.27 
Total recovered    10.68 
 
The excellent mass recovery (93 %) shows that the distillation column retains only a small 
amount of material and fortunately most of the impurities are less volatile than the starting 
material or the product. However, the two main components, methyl 4-fluorobenzoate and 
methyl 3,4-difluorobenzoate, possibly form an azeotrope, as their relative ratio in all distillation 
fractions remains constant within the error of the measurement, therefore, their separation was 
not possible under these distillation conditions.  
In conclusion, although the direct fluorination approach to 3,4-difluorobenzonitrile seems 
viable, the fluorination reaction is selective only at low conversions (up to 50 %) and the 
separation of the various products is very difficult using non-chromatographic methods. These 
results encouraged the assessment of other similar compounds and fluorination of 4-
fluoronitrobenzene was selected as another potentially viable substrate. 
3.2.5 Fluorination of 4-fluoronitrobenzene 
4-Fluoronitrobenzene is less reactive under similar reaction conditions than 4-fluorobenzonitrile 
or 4-fluorobenzoic acid and since, in formic acid, only 13% conversion was achieved and on small 
scale (1.4 g, 10 mmol) even in sulphuric acid only 48 % of the starting material was converted 
when four equivalents of fluorine was used (Figure 74). 





Figure 74: 19F NMR spectrum of the small scale fluorination of 4-fluoronitrobenzene. 
The low conversion was mainly attributed to inefficient mixing, as concentrated sulfuric acid has 
high viscosity and the magnetic stirrer used was not powerful enough. In order to improve 
mixing, a mechanical stirrer was used in all later experiments instead of magnetic stirring, but 
to efficiently use this, the reaction had to be scaled to 40 mmol (5.6 g) scale for which 50 mL of 
solvent was used in a 250 mL glass reactor. To shorten reaction time, concentration of fluorine 
was also increased to 20 % from the initial 10 % as from previous experience, the concentration 
of fluorine does not have large effect on the selectivity of these reactions. Under these 
conditions, multiple batches were fluorinated to obtain sufficient quantity of material for a 
fractional vacuum distillation. During these reactions, a noticeable exotherm was detected, 
which may explain the formation of tar.  
The results from these separate experiments demonstrate the reproducibility of this fluorination 
reaction as the quantity and the composition of the obtained product was very consistent 
throughout the batches. Steam distillation as an alternative isolation methodology was also 
investigated in one case and although the isolated amount was approximately 20 % less, this 
product was a transparent yellow oil while the product isolated by solvent extraction was a dark 
brown viscous oil heavily contaminated with tar. 
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Table 13: High conversion fluorination of 4-fluoronitrobenzene. 
 







5.71 g / 4.5 eq. EtOAc extraction 5.42 g 
74 % 130, 5 % 137, 7 % 138, 14 % 
other trifluoro isomers, tar 
5.75 g / 4.5 eq. Steam distillation 4.10 g 
75 % 130, 9 % 137, 5 % 138, 11 % 
other trifluoro isomers, no tar 
5.66 g / 4.5 eq. EtOAc extraction 5.50 g 
75 % 130, 8 % 137, 5 % 138, 12 % 
other trifluoro isomers, tar 
5.74 g / 4.5 eq. EtOAc extraction 5.46 g 
76 % 130, 6 % 137, 5 % 138, 13 % 
other trifluoro isomers, tar 
 
The four batches were combined and 20.2 g of material was subjected to fractional vacuum 
distillation using the above described Fischer Spaltrohr® equipment. At 1 mbar pressure seven 
fractions (11.3 g) were obtained at 65-70 °C and were analysed by 19F NMR spectroscopy. Some 
volatile material also condensed in the dry-ice trap of the vacuum pump and a significant 
amount (8.61 g) of non-volatile, viscous tar residue remained. 
 
Figure 75: High vacuum distillation of 3,4-difluoronitrobenzene obtained by direct fluorination. 
Even though the purification of the product under these conditions was not achieved, the 































Distillation of 3,4-difluoronitrobenzene at 1 mbar
137 130 138 Others
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138 (grey line) is slightly more volatile than the desired product 130 (orange line), therefore, 
even if it is formed in higher quantity, separation should be possible under optimised distillation 
conditions on an industrial distillation column. The separation of the lower boiling starting 
material (blue line) from the desired product should also be possible by vacuum distillation. The 
problem of isolating pure product is the presence of other, unidentified di- and 
trifluoronitrobenzene isomers which do not separate easily by distillation. Overall, the pressure 
in the distillation needs to be increased to allow better separation of the components and the 
composition of the crude product should be limited to a maximum of three major, separable 
components, also, tar should be separated before distillation to reduce the amount of reactive 
material in the distillation flask. 
Consequently, in the next set of experiments the fluorination was carried out at lower 
temperature (0 °C) to decrease side product and tar formation and the scale of the reaction was 
increased to 100 mmol (14.1 g in 70 mL cc H2SO4) scale to give distillable quantities of product 
in shorter time. To improve gas-liquid mixing a new 250 mL reactor was designed with four, 
larger bafflers and used in the further reactions. Fluorination was carried out as usual, the crude 
product was isolated by extraction and the material from two batches was combined, dissolved 
in hexane and filtered to remove a significant amount of tar. This crude product (17.7 g, 53 % 4-
F, 43 % 3,4-diF, 4 % others) was distilled (19 mbar, 88 - 92 °C) to obtain 12.6 g of material in a 
total of 8 fractions.  
 
Figure 76: Vacuum distillation of a partially converted fluorination mixture. 
Figure 76 shows the composition of the fractions and, although, the 3,4,5-trifluoronitrobenzene 
side product is present in significant quantity, it can be separated from the rest of the mixture 
as it is almost exclusively present in the 1st distillation fraction. This chart also shows that the 































Distillation of mixture at 45% conversion
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are enriched in the difluorinated product. In order to gain further understanding of the optimal 
distillation conditions, distillations were carried out on artificial mixtures of 4-
fluoronitrobenzene and 3,4-difluoronitrobenzene under vacuum using the Fischer MMS 255 
fractionating column.  
 
Figure 77: Distillation of an artificial mixture of 4-fluoronitrobenzene and 3,4-difluoronitrobenzene. 
Although the distillation was carried out carefully, allowing the best possible separation of 
components, none of the fractions contained pure difluoronitrobenzene. In this distillation 93 % 
of the distilled material was recovered in various fractions which shows that the column used 
retains only a very small amount of material. The highest purity fraction was 92 % pure, which 
is promising result for a mixture of two compounds that have very similar boiling point (Fraction 
1 boiled at 105-107 °C while fraction 8 at 110-112 °C at 50 mbar pressure).  
To assess the potential safe temperature range for the distillation step, DSC measurements were 
conducted on pure samples of 4-fluoronitrobenzene and 3,4-difluoronitrobenzene (Figure 78). 
These measurements revealed that both compounds begin to decompose above 150 °C with a 
significant exotherm (392 and 384 J/g respectively). These results clearly limit the possible 





































Figure 78: Differential Scanning Calorimetric analysis of 3,4-difluoronitrobenzene. 
A major issue of using concentrated sulfuric acid as the only reaction solvent is that it will 
eventually give a large waste stream after the aqueous workup. In order to control this, other 
solvent systems were investigated on larger, 100 mmol scale using two equivalents of fluorine. 
To obtain comparable results, the crude product was subjected to steam or vacuum distillations 
to remove tar and the volatile fractions were weighed and analysed by 19F NMR spectroscopy. 
As the choice of solvents for direct fluorinations is limited, most viable solvents were 
investigated either in pure form or in combination with sulfuric acid. Sulfuric acid in acetonitrile 
gave high conversions of the starting material, but unfortunately this reactive mixture lead to a 
large amount of tar which decreased the mass of the isolated volatile material. The fluorination 
proceeds to moderate conversion (35-40 %) in acetonitrile without any additive, but tar 
formation was an issue in this case as well. Other, more unconventional solvents such as 
methanol or propionic acid did not prove suitable for this reaction probably because of the 
reaction of fluorine gas with the solvents.  
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Table 14: Solvent screening for the direct fluorination of 4-fluoronitrobenzene. 
 





H2SO4 0 °C Extraction Vac. dist. 11.60 g 
56 % 130, 40 % 
137, 4% others 
H2SO4 0 °C Extraction Vac. dist. 11.56 g 
58 % 130, 37 % 
137, 5 % others 
H2SO4/MeCN 
1/6 
-10 °C Extraction Kugelrohr 4.57 g 
79% 130, 13 % 
137, 8 % others* 
H2SO4/MeCN 
1/6 




14 % 137, 70 % 
130, 4 % 138, 12 
% others 
MeCN -10 °C Evaporation Vac. Dist. 3.07 g 
63 % 137, 34 % 
130, 3% others* 




60 % 137, 36 % 
130, 3% others 
Propionic acid -10 °C Evaporation 
Steam dist. 
(in) 
8.02 g 95 % 137, 5 % 130 
H2SO4/MeOH 
1/9 
-10 °C Evaporation 
Steam Dist. 
(in) 
10.26 g 96 % 137, 4 % 130 
* Significant amount of tarry distillation residue; ** (in): 150 mL water added and product 
collected in Dean-Stark trap; (ext): external steam generator used with standard distillation 
setup. 
3.2.6 Conclusion 
Based on the results discussed in this chapter it is not possible to carry out a detailed green 
metrics analysis of any of these aromatic direct fluorination processes, moreover, the lack of 
literature data for the alternative Balz-Schiemann syntheses of such simple fluoroaromatic 
systems makes benchmarking difficult and highly inaccurate in these cases. The only metric that 
could be used is Atom Economy, which does not require any experimental data, but this metric 
alone does not provide a meaningful basis for comparison, therefore, the calculations are not 
discussed here. In conclusion, direct fluorination of aromatic substrates may be viable in cases 
where isolation and purification of the desired product is easily achievable and, in such a case, 
the process should be comparable with the alternative Balz-Schiemann route using green 
metrics packages.
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Chapter 4.: Synthesis of Flucytosine 
 
Fluorinated heterocyclic systems are a very important class of compounds that are present in a 
number of pharmaceutical and agrochemical products and 5-fluoropyrimidines are one of the 
most frequent member of this class. In this chapter, a direct fluorination approach to the 
synthesis of 5-fluorocytosine (Flucytosine) will be investigated with the aim of providing a more 
efficient synthesis than the existing methods to this important API. 
4.1 Flucytosine: an essential medicine 
Flucytosine is an important medicine for the treatment of various fungal infections which was 
discovered in the 1960’s at Hoffman la Roche and was introduced to the US market in 1971. 
Flucytosine itself shows no antifungal activity, but in fungal cells it is transformed to 5-
fluorouracil (5-FU) by the enzyme cytosine deaminase and it is 5-fluorouracil that inhibits various 
protein synthesis processes inside these cells.175 In 2013, Flucytosine was re-included to the core 
list of WHO Essential Medicines for the treatment of cryprococcal meningitis in HIV patients 
which is the most common cause for the disease and accounts for 20-25 % of AIDS related 
mortality in sub-Saharan Africa. The combination of high dose (100 mg/kg/day) Flucytosine and 
Amphotericin B form the initial treatment of cryptococcal meningitis recommended by WHO 
and is considered as the gold standard, achieving significantly higher survival rates then the most 
widely used fluconazole monotherapy. The main reasons for the low use of Flucytosine in sub-
Saharan African countries are the lack of registration with local authorities and the high cost of 
the medicine176, therefore, an inexpensive large scale synthesis of this important drug is much 
needed to facilitate availability in these countries. 
The 5-fluorocytosine structure is also found in two other active pharmaceutical ingredients: 
Capecitabine, an oral chemotherapy drug for the treatment of various cancers and 
Emtricitabine, a nucleoside reverse transcriptase inhibitor for the treatment of HIV, which is 
marketed in various combination therapies such as Atripla® and Truvada® by Gilead, with annual 
sales of over $5 bn. 
 
Figure 79: 5-Fluorocytosine containing drugs. 
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It is difficult to estimate global production of Flucytosine, but clearly, the use of this 
fluoropyrimidine derivative as a constituent of several drugs and drug combination therapies 
presents significant commercial and environmental opportunities, if step-change improvements 
in the production of Flucytosine can be developed at a competitive price and using sustainable 
solvents and feedstock. It is estimated that hundreds of thousands of deaths in Sub-Saharan 
Africa occur on an annual basis from cryptococcal meningitis, so given a treatment of 
approximately 70 g per person, potentially up to 30t of Flucytosine is required every year to 
treat all patients. 
4.1.1 Current synthetic routes to Flucytosine  
Although there are several nucleophilic aromatic substitution based synthetic methods for the 
synthesis of 5-fluorocytosine177–179, we believe that only the route using 5-fluorouracil (5-FU) as 
starting material is implemented on the manufacturing scale.180 This process relies on the large 
scale availability of 5-FU, which is prepared on the manufacturing scale via direct fluorination of 
uracil94,181–185, a process that has been in operation for over 40 years. 
 
Figure 80: Flucytosine manufacturing route.186,187 
While it is difficult to assess routes to Flucytosine due to commercial sensitivity, the Hoffmann-
la-Roche patent discussing a potential synthetic process shows that 5-FU is treated with POCl3 
and N,N-dimethylaniline to yield 2,4-dichloro-5-fluoropyrimidine in good yield after distillation. 
This intermediate was reacted with aqueous ammonia solution and hydrolysed in concentrated 
hydrochloric acid, to yield 5-fluorocytosine from 5-fluorouracil in an overall 64 % yield (3 steps 
from 5-FU, Figure 80). 
As the direct fluorination of uracil was shown to be a scalable, selective process, it is reasonable 
to assume that the electrophilic fluorination of cytosine, a more activated system, should 
proceed just as easily. In the literature, there are a few examples for the fluorination of cytosine 
and derivatives, for example using CF3OF, a highly toxic electrophilic fluorinating reagent.188 The 
direct fluorination of cytosine with fluorine gas was reported on several occasions, but in most 
cases incomplete conversion and low yields were observed. 189–191 The only successful direct 
fluorination reaction was reported in anhydrous HF at -50 oC, but the difficulty of carrying this 
reaction out on larger scale makes it unlikely to be used in production. 192 In another publications 
fluorine was used to examine the mechanism of direct fluorination of cytosine in acetic acid with 
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radiolabelled [18F] fluorine. The formation of Flucytosine was observed in low (20-25 %) 
radiochemical yield along with various other fluorinated heterocycles. 193,194 
In this chapter, we revisited the direct fluorination of cytosine with an aim to transfer the batch 
reaction to a continuous flow process suitable for scale-up and to compare the green metrics of 
the direct fluorination approach with the competing 5-fluorouracil based synthesis. 
4.2 Direct fluorination of cytosine: proof of concept study 
4.2.1 Laboratory scale studies 
Literature reports discussed above suggested that direct fluorination of cytosine in acidic 
solvents should be feasible and we found that solubility of cytosine in formic acid, a preferred 
solvent for SDF processes, was relatively high, up to 12 % w/w, which enables the reaction to be 
run at higher than 1 mol/L concentrations. To assess the reaction, 1.1 g of cytosine was dissolved 
in formic acid and fluorinated in a 100 mL glass fluorination reactor using 10 % fluorine gas in 
nitrogen. 
Table 15: Batch fluorination of cytosine.  
 
F2 equivalents Conversion (1H NMR) 
6 to 144 ratio in crude 
product (19F NMR) 
1.0 80 % 2.5 : 1 
1.5 98 % 1 : 1.1 
1.75 99 %+ 1 : 1.3 
 
The fluorination reaction progresses easily under the reaction conditions, and high conversion 
of cytosine was achieved with one equivalent of fluorine, but to reach complete conversion, an 
excess of fluorine was required leading to a low isolated yield (38 %). However, significant 
amounts of polyfluorinated products were also observed by 19F NMR spectroscopic analysis of 
the crude product. The difluorinated product was described in the literature before and is 
possibly formed in the reaction of fluorine and the desired product 5-fluorocytosine (Figure 
81).193,194  




Figure 81: Possible mechanism of the fluorination of fluorocytosine to the difluorinated side product. 
 
Figure 82: 19F NMR spectrum of the crude product from the direct fluorination of cytosine in batch. 
In the 19F NMR spectrum the two fluorine atom chemical shifts show that the aromaticity of the 
pyrimidine ring is no longer present and the fluorine atoms are in axial and equatorial positions, 
hence the large geminal F-F coupling. Our attempts to isolate and purify this side product have 
been unsuccessful, but it was observed that, depending on the work-up solvents, several 5,5-
difluoro-4,5-dihydropyrimidine-2-one species were present in solution. 
The separation of Flucytosine from all other side-products was easily achieved by 
recrystallisation of the crude reaction product from water, however, the separation of 
unreacted starting material from the flucytosine product was not possible. In order to minimise 
the amount of cytosine in the final product, 100 % conversion is required and in this case (entry 
3, Table 15), after recrystallisation, the desired mono-fluorinated product was isolated as the 
only product in 38 % yield.  





Figure 83: 1H NMR (D2O+DCl) spectrum of pure Flucytosine synthesised by direct fluorination (top), IR 
spectra of Flucytosine from literature (bottom left) and from direct fluorination (bottom right). 
Based on 19F NMR spectroscopic experiments, the recovery of 5-fluorocytosine from the 
aqueous recrystallization is excellent, as the liquor only contains trace amounts of the desired 
product. The purified product was fully characterised using all available analytical methods, for 
example, the 1H NMR spectrum recorded in D2O with a drop of DCl in Figure 83 shows that the 
final product does not contain any significant amount of cytosine or formic acid from the direct 
fluorination reaction. Also, comparison of a literature IR spectrum (Figure 83 bottom left) 
obtained from the SDBS database shows excellent correlation with the spectrum of the product 
obtained by direct fluorination (Figure 83 bottom right).  
In conclusion, these preliminary findings demonstrated that batch fluorination processes can be 
used to synthesise Flucytosine in acceptable yield, but the formation of significant quantities of 
di-fluorinated product leads to lower isolated yields. In order to overcome this limitation, the 
use of continuous flow processing methods was investigated to improve the selectivity of this 
reaction. 
4.2.2 Laboratory scale continuous flow processes 
Reactions between liquid and gas phases often benefit from various continuous processing 
techniques195 and in the Durham Fluorine Group continuous flow microreactors have been 
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developed and used for a considerable time and their usefulness was demonstrated in the 
fluorination of a wide range of substrates.78–80,87 The single channel microreactor that was 
developed in our laboratory for selective fluorination is built from a nickel or stainless steel plate 
having a 100 mm long 0.5 mm deep and 0.5 mm wide channel which is covered with transparent 
fluoropolymer (poly(chlorotrifluoroethylene)) and stainless steel plates. The solution of the 
substrate in an appropriate solvent is introduced via a syringe pump, while fluorine gas is 
introduced via a mass-flow controller and the mixture from the reactor is collected in a round 
bottomed flask which is connected to a soda lime scrubber that is used to neutralise excess 
fluorine and HF in the gas stream. Using this continuous flow system, a 1M solution of cytosine 
was fluorinated with 10 % fluorine gas in nitrogen. The reactions were run for two hours at 2 
mmol/h cytosine flow, the solvent evaporated and the crude product recrystallised from water 
and the final product composition was determined by 1H and 19F NMR spectroscopy. 
Table 16: Continuous flow fluorination of cytosine. 
 
Cytosine flow Fluorine flow Crude product Crystallised product 
(1M in HCOOH) (10 % in N2), eq. 
141 : 6 : 144 
(1H and 19F NMR) 
141 : 6 
 (1H NMR) 
Yield (g, %) 
2 mL / h (2 
mmol / h) 
8 mL/min (2.0 
mmol/h), 1.0 
9 : 83 : 8 1 : 9 0.32 g, 62 % 
2 mL / h (2 
mmol / h) 
10 mL/min (2.5 
mmol/h) 1.5 
5 : 87 : 8 1 : 14 0.31 g, 61 % 
2 mL / h (2 
mmol / h) 
12 mL/min (3.0 
mmol/h) 1.75 
1 : 89 : 9* >99 % pure 6 0.27 g, 52 % 
 * Some other unidentified fluorinated side products also observed. 
Screening of fluorine to cytosine flow ratios showed that 1.5 equivalents of fluorine gas resulted 
in full conversion of cytosine and pure Flucytosine was obtained in higher yield (52-62 %) than 
previously in batch reactions. The 1H NMR spectrum of the crude products for all reactions 
showed that there is a significantly smaller amount of di-fluorinated side product (144) in the 
mixture, which clearly demonstrates the advantage of flow systems over batch reactions due to 
decreased contact time between F2 and reaction mixture (Figure 84).  




Figure 84: 19F NMR spectra of crude products from batch and continuous flow fluorinations.  
Despite having several multi-channel reactors that were developed for fluorinations, scaling up 
in microreactors can be challenging. Rather than multiplying the number of channels, increasing 
the diameter and the volume of the reactor could offer another, simpler option for scaling up.  
 
Figure 85: Single channel microreactor (left) and stainless steel coil reactor (right) used for fluorination. 
When the reaction was performed in a coiled 1 m long stainless steel tube reactor (1.4 mm ID), 
similar isolated yield (63 %) and complete conversion of the starting material were observed at 
4 mmol/h rate. The better conversion and lower fluorine excess required can be explained by 
the significantly longer residence time of the two reactors (approx. 5 minutes vs. 10-15 seconds) 
and the good initial mixing of the solutions in a T piece at the beginning of the reactor. 
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Table 17: Fluorination of cytosine in 1/8" stainless steel reactor. 
 
Cytosine flow Fluorine flow Crude product Crystallised product 
(1M in HCOOH) (10 % in N2), eq. 
141 : 6 : 144 
(1H and 19F NMR) 
141 : 6 
(1H NMR) 
Yield (g, %) 
4 mL / h  
(4 mmol / h) 
16 mL/min (4.0 
mmol/h), 1.0 
5 : 88 : 7 1 : 17.5 0.51 g, 66 % 
4 mL / h  
(4 mmol / h) 
18 mL/min (4.5 
mmol/h) 1.12 
1 : 92 : 7 1 : 79 0.50 g, 64 % 
4 mL / h  
(4 mmol / h) 
20 mL/min (5.0 
mmol/h) 1.25 
1 : 96 : 3 >99% pure 6 0.46 g, 59 % 
4 mL / h  
(4 mmol / h)* 
20 mL/min (5.0 
mmol/h) 1.25 
1 : 94 : 5 >99% pure 6 0.49 g, 63 % 
* HPLC pump used instead of syringe pump. 
The above discussed results raised the interest of several industrial members of the Chem21 
consortium and Sanofi decided to investigate the scalability of the continuous flow direct 
fluorination reaction in partnership with Maison Européenne des Procédés Innovants (MEPI), a 
flow chemistry specialist contract research organisation. 
4.2.3 Sanofi-MEPI collaboration 
At the beginning of the collaboration with Sanofi and MEPI several objectives were set and the 
project was divided into four work packages that covered all areas of the project from 
technology transfer to an extended length continuous pilot scale experiment. 
Work package one (WP1) consisted of knowledge transfer from Durham University to Sanofi and 
MEPI which was completed in the form of a face-to-face meeting and the transfer of various 
technical reports, as described above, and literature reviews to our partners. The aim of WP2 
was to transfer the continuous flow fluorination method to MEPI’s meso-scale reactor and to 
assess process variables and possible downstream processing methods. Process development 
work and further data collection for safety assessment was scheduled for WP3 and WP4, with 
the latter including longer reaction times, up to 8 hours continuous processing, and analytical 
assessment of the isolated product against Flucytosine API requirements. The following chapter 
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discusses the technology transfer and chemical development aspects of the project with a focus 
on process understanding and downstream processing. The author spent a three-week 
placement at MEPI carrying out all the reactions described below in collaboration with scientists 
from MEPI (Annelyse Conté and Jean-Paul Seuwin) and Sanofi (Alain Rabion and Sandrine 
Grenier). 
4.3 Direct fluorination of cytosine: pilot scale studies 
4.3.1 SiC Boostec® reactor setup 
The most critical element of scaling up the direct fluorination process is the selection of 
appropriate equipment that is both resistant to the corrosive reaction medium (fluorine, HF and 
acidic solvent) and has excellent heat exchange properties to remove the large amount of heat 
generated in the process. Silicon carbide is one of the materials that meets these criteria and a 
meso-scale Boostec® reactor was the equipment of choice for this fluorination process as it was 
used previously at MEPI with fluorine gas on larger scale.196 Another advantage of this system is 
that the manufacturing scale analogue, capable of processing up to 300 kg of material per hour, 
is commercially available from Corning.197 
 
Figure 86: SiC reactor plate of the Boostec® reactor. 
This reactor is built from alternating process plates, made of silicon carbide (Figure 86), and 
aluminium heat exchanger plates. For the fluorination of cytosine, a reactor built from six 
process plates was used with 16 m total channel length and 61 mL reactor volume. The 
processing plates are connected with SiC channels and the process fluids are only exposed to 
corrosion resistant materials, for example, hastelloy (pumps and tubing), passivated stainless 
steel (gas inlet connection) or PTFE/FEP (tubing). The reactor is equipped with twelve 
temperature probes, most of them located in the first (5 probes) and second (3 probes) reaction 
plates where most of the reaction takes place. 




Figure 87: Boostec® reactor used in the cytosine fluorination studies. 
Process fluids are introduced at the bottom of the reactor via mass flow controllers and a 
specialist software was used to monitor reactor temperatures, flow rates and pressures. The 
reactor temperature is controlled using an external thermostat unit (Julabo) and the reactor is 
also equipped with a back pressure regulating valve to enable slight pressurisation of the reactor 
contents. 
After passing the reaction mixture and fluorine through the reactor, the product stream could 
be sampled for analysis and isolation studies through a three-way valve or it is neutralised in a 
stirred tank reactor and a gas scrubber filled with 10% NaOH solution (Figure 88). This 
arrangement not only enables the safe handling of fluorine on larger scale but the collection of 
large amount of experimental data is also possible due to the in-line sampling system. 
 
Figure 88: Schematic diagram of the continuous flow equipment used for the fluorination of cytosine. 
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Before any work was undertaken, the reactor was leak and pressure tested to ensure safe 
operating conditions and in all experiments the following operating procedure was 
implemented: first, the thermostat unit was turned on to bring the reactor to the desired 
temperature then nitrogen flow was initiated at a prescribed flow rate. It is important to always 
initiate the gas flow first in gas-liquid reactions to avoid any liquid entering the gas flow-
controller unit, however, this latter is also protected by a one-way valve. When the temperature 
of the reactor had stabilised, formic acid was introduced at high flow rate until the liquid was 
detected at the outlet of the reactor, then the flow rate was adjusted to the liquid flow rate of 
the fluorination reaction. After the liquid and gas flow rates and pressures stabilised, typically 
10-15 minutes, the liquid inlet was changed to cytosine solution in formic acid and the flow rate 
was allowed to stabilise before switching from nitrogen to 10 % v/v fluorine in nitrogen. 
When experiments were finished, a reverse order shutdown procedure was followed: fluorine 
introduction was stopped by closing the valves between the cylinder and the flow controller and 
fluorine flow rate was allowed to drop to 0 g/h (10-15 seconds). Then, nitrogen flow was initiated 
and the cytosine solution was replaced with pure formic acid and after 5 minutes the nitrogen 
flow was stopped and the reactor was flushed with formic acid for a further 10 minutes. At this 
point, formic acid was replaced with water and was passed through the reactor for 30-45 
minutes until the solution at the outlet was close to neutral pH. After finishing the cleaning 
procedure, the reactor was kept filled with water until further use. 
Residence time is often an important factor in continuous flow reactions, therefore, it was 
important to experimentally measure this parameter because in the case of gas-liquid reactions 
it cannot be calculated easily. We determined residence time with a residence time distribution 
experiment: flow-rates were set at the desired values with formic acid and nitrogen and 2 mL of 
concentrated methylene blue solution was injected in the liquid flow at the inlet of the reactor. 
The time difference between injection and detection at the outlet of the reactor gave the 
residence time values and, as expected, with increasing the flow rates the residence time 
decreases. The experimental residence time measurements also allowed the calculation of the 
volume occupied by the liquid phase in the reactor that appears to be 25 % of the total volume 
(Table 18) irrespective of the operating conditions. 
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Table 18: Measurement of gas-liquid residence time. 
Flow rate (g/h) Theoretical residence 
time (100 % liquid) / s 
Experimental 
residence time / s 
Experimental  
Liquid volume ratio Liquid Gas 
600 133 447 108 0.24 
600 180 447 109 0.24 
600 224 447 112 0.25 
900 257 298 78 0.26 
1200 225 227 55 0.24 
600 0 447 445 - 
 
After the safety and operational testing of the reactor, direct fluorination studies were carried 
out to evaluate the process and identify critical parameters. 
4.3.2 Pilot scale fluorination: study of reaction parameters 
Initially, the best conditions identified during the development stage in Durham were directly 
transferred to the Boostec® reactor: 1M (8.9 % w/w) cytosine solution in formic acid was reacted 
with 1.3 equivalents of 10 % fluorine at 20 oC. This reaction was also used to measure the 
stabilisation time of the experiment to establish a representative sampling procedure in the 
steady state. After initiating the fluorine flow, samples were collected every five minutes and 
analysed by HPLC-UV. As it is shown in Table 19, after ten minutes the reaction profile did not 
change and the reaction showed excellent conversion and selectivity, therefore, in further 
experiments, after adjusting the reaction conditions, the mixture was allowed to stabilise for ten 
minutes before taking a sample for analysis. 
Table 19: Stabilisation time measurement of the direct fluorination of cytosine. 
 
Time T / oC Flow rate / g/h F2 molar 
ratio 
Conversion  
(HPLC % A/A) 
Selectivity  
(HPLC % A/A) 1M Cytosine 10 % F2/N2 
5 min 20 600 181 1.3 97.5 95.1 
10 min 20 600 181 1.3 99.1 95.4 
15 min 20 600 181 1.3 99.1 97.6 
20 min 20 600 181 1.3 99.3 95.7 




Although the initial results from the technology transfer were excellent, we set out to explore 
the reaction parameters to gain a better understanding of the fluorination reaction and to define 
a parameter space that leads to high conversion and selectivity.  
Temperature was expected to be an important factor in this process, therefore, the reaction was 
carried out at three different temperatures that were selected based on the freezing point of 
the solvent (8-9 oC) and previous experience with fluorination reactions. Two series of 
experiments were conducted, one at 8.9 % w/w cytosine concentration with 1.3 equivalents of 
fluorine and the other at 11 % w/w cytosine concentration using 1.1 equivalents of fluorine gas. 
In both cases a negative effect of temperature was observed (Figure 89): with increasing 
temperature, conversion of cytosine decreased noticeably.  
 
Figure 89: Effect of temperature on the fluorination of cytosine. 
There are a number of possible explanations to the observed drop in conversion, for example, 
the change of viscosity of the cytosine solution with increasing temperature potentially has an 
impact on mixing, gas inlet pressure and flow characteristics that can all lead to different 
conversion rates. There may also be a competing reaction of fluorine with formic acid with 
increasing reaction rates at higher temperatures. 
In order to investigate whether the observed effect is due to a distinct temperature effect or to 
changes in gas inlet pressure, a set of isobar experiments were also performed. In these 
reactions the drop in inlet pressure, caused by increasing temperature, was counteracted by the 
application of back pressure to maintain isobar conditions in the reactor and minimise the 
effects on hydrodynamics. When the results from these experiments were compared with the 
previously shown temperature effect without back pressure, they suggested that applying back 



















Temperature effect on the fluorination of 
cytosine
8.9 % cytosine, 1.3 eq. F2 11 % cytosine, 1.1 eq. F2
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application of back pressure had more influence on flow dynamics than the change in viscosity 
and lowering the inlet pressure. 
 
Figure 90: Comparison of the effect of temperature with and without applied back pressure. 
To further investigate the effect of back pressure, fluorination reactions were carried out at 
several temperatures and cytosine concentrations while changing the applied back pressure 
and, as shown in Figure 91, a significant negative effect was observed in all cases which is further 
enhanced by increasing the reaction temperature (grey line versus blue line in Figure 91). Such 
a large drop in conversion can only be explained by a dramatic decrease in mixing and change in 
flow characteristics. It is also important to highlight that to maintain the same fluorine to 
cytosine ratio throughout the different concentration reactions, the gas-liquid ratio was 
changed significantly which had unavoidable influence on the flow regime in the reactor. Thus, 
it is difficult to confirm whether the observed effects are derived from any single factor or arise 
from their combination. 
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Back pressure effect on conversion
8.9 %, 30 oC, 1.1 eq. F2
12 %, 10 oC, 1.1 eq. F2
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6 %, 10 oC, 1.1 eq. F2
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The above experiments gave a clear indication about the effect of back pressure and 
temperature, but the effect of inlet gas pressure was not determined. This parameter is also 
very important from a scalability point of view as larger scale equipment and higher flow rates 
would lead to higher pressure difference between the inlet and the outlet ends of the reactor. 
A simple way of increasing the inlet pressure without diluting the gas phase or changing the 
stoichiometry of the reaction is to increase the overall flow rate. Interestingly, we found that 
the overall starting pressure does not have any statistically significant effect on either 
conversion or selectivity (Table 20) which further supports the argument that the negative 
effects observed above were due to changes in the flow regime caused by the back pressure. 
During this series of reactions, with the maximum gas flow rate limited to 5 bar, liquid flow rates 
of over 1.2 kg/h were achieved equalling to over 100 g/h productivity in this large laboratory 
scale equipment. 
Table 20: Investigation of the effect of flow rates. 








(HPLC % A/A) 
Selectivitya 








10 8.9 600 181 1.3 99.5 92.1 
2.1 bar inlet 
pressure 
10 8.9 900 272 1.3 99.1 91.6 
3.3 bar inlet 
pressure 
10 8.9 1000 303 1.3 99.7 92.1 
3.6 bar inlet 
pressure 
10 8.9 1200 363 1.3 99.7 92.3 
4.5 bar inlet 
pressure 
10 8.9 600 157 1.1 90.6 93.0 
1.8 bar inlet 
pressure 
10 8.9 800 209 1.1 94.7 93.2 
2.6 bar inlet 
pressure 
10 8.9 1000 263 1.1 91.6 93.4 
3.3 bar inlet 
pressure 
10 8.9 1200 313 1.1 92.3 93.2 
4.0 bar inlet 
pressure 
10 8.9 1400 367 1.1 91.5 92.7 
4.8 bar inlet 
pressure 
a; Selectivity was determined by dividing Flucytosine peak area by the sum of all peaks except cytosine. 
To investigate the effect of cytosine concentration and keeping scalability, throughput and 
solvent use in mind, the fluorination of cytosine was carried out at concentrations between 6 
and 11 % w/w. 6 % was the lowest practical concentration selected (13 volumes of solvent) and 
11 % was the highest concentration where crystallisation of cytosine was not observed after 
allowing the solution to cool to ambient temperature. All reactions were conducted at 10 oC and 
600 g/h liquid flow rates with appropriate gas flow rates to provide 1.3 equivalents of fluorine 
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for all reactions. Figure 92 shows that it was only at lower concentrations (6-7 %) where a small 
negative effect (1-2 % lower conversion) was observed but between 8 and 11 % concentration 
the reaction conversion was consistently above 99.5 % indicating that using higher 
concentration solutions is viable and has no negative impact on conversion or selectivity. This 
observed effect also supports the hypothesis that increasing the gas-liquid ratio leads to 
enhanced mixing and flow properties that further facilitate the reaction. 
 
Figure 92: Effect of cytosine concentration on conversion in the direct fluorination of cytosine. 
The effect of fluorine stoichiometry was studied on a range between 1.0 to 1.5 equivalents using 
10 % v/v fluorine. However, as it was not possible to alter the F2 concentration, this also led to 
changes in flow characteristics and gas-liquid ratios. The experiments were carried out at 10 oC 
and 600 mL/h liquid flow rates at 8.9 and 11 % w/w cytosine concentrations and analysed to 
determine conversion of the starting material. The results clearly support the previously 
mentioned influence of gas-liquid ratio, for example, there is approximately 30 % difference in 
the conversion using 1.0 and 1.1 equivalents of fluorine in the case of the 8.9 % concentration 
experiment (Figure 93) which cannot be explained simply by the difference in stoichiometry. The 
higher observed conversions at 11 % cytosine concentration compared to the 8.9 % series also 
suggests better mixing of fluids due to the improved gas-liquid ratio. 
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Figure 93: Effect of fluorine stoichiometry on the fluorination of cytosine. 
From a manufacturing point of view there was another parameter that needed to be assessed 
which is more related to process economics than the chemistry itself. All of the above reactions 
were carried out in anhydrous formic acid, which is more expensive than industrial grade formic 
acid that has a water content of 5-15 %. To assess the effect of water on this fluorination 
reaction, 10 % w/w cytosine solutions with increasing water content up to 20 % w/w were 
reacted with 1.3 equivalents of fluorine at 10 oC and 600 mL/h flow rate. At higher than 20 % 
water content cytosine precipitated from solution after allowing the solution to cool to ambient 
temperature. The results obtained in this set of experiments indicate that additional water has 
a small negative effect on the fluorination of cytosine, however, conversion was high even in the 
case of 20 % added water (92 %). 
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In conclusion, this parametric study highlighted the importance of fluid mechanics as the most 
influential process parameters relating to changes in mixing and flow parameters. We also 
demonstrated that the fluorination efficiency does not change with increasing flow rate and 
excellent conversion was achieved over a broad range of operating conditions which all suggest 
the potential for further scale-up. However, all experiments focused on the conversion of 
cytosine only and to gain more understanding of this fluorination process, we sought to fully 
account for the amount of fluorine used, which is discussed in the next section. 
4.3.3 Fluorine mass balance 
To assess the mass balance of fluorine in the direct fluorination of cytosine, the conversion of 
fluorine gas needed to be measured. Knowing the amount of residual fluorine in the gas phase 
is also important for the safety assessment of any further processing of the exhaust gas stream. 
Quantitative measurement of elemental fluorine can only be achieved indirectly, using redox 
titration methods: first, fluorine oxidises iodide ions to elemental iodine which can subsequently 
be analysed by titration with a standardised thiosulfate solution. One fluorine molecule reacts 
with two iodide ions to form one molecule of iodine and two fluoride ions. As this reaction takes 
place in an aqueous solution, it is possible that fluorine first reacts with water to form HOF and 
HF, but HOF - a very strong oxidising agent - can also oxidise two iodide ions, giving identical net 
outcome. The liberated iodine is titrated with thiosulfate solution according to the equation in 
Figure 95. 
 
Figure 95: Redox processes in the determination of fluorine. 
For accurate analysis of the gas exhaust stream, purpose designed equipment was constructed. 
After the reactor outlet, a three-way valve was used to redirect the product flow into the 
sampling device where gas-liquid separation was achieved in a 1 L screw cap bottle equipped 
with a PTFE cap having a ¼” Swagelok inlet form the Boostec reactor and a ¼” Swagelok gas 
outlet. The gas outlet from the phase separator flask was connected to a custom made three 
necked 500 mL round bottomed flask (583 mL total volume). This flask was equipped with two 
PTFE taps to enable gases to pass through the system and a PTFE lined septum for injecting the 
KI solution into the sealed flask. 




Figure 96: Gas sampling system used for the determination of fluorine in the gas flow. 
For representative sampling the exhaust gas stream was allowed to flow through the sampling 
flask for 10 minutes (more than 25 volumes) to completely replace the starting atmosphere in 
the flask. After this the flow was stopped by turning the three-way vale to redirect the flow to 
the neutralising reactor, the flask sealed and 10 mL 1M KI solution injected (large excess of I-). 
After shaking the contents for 2 minutes to ensure complete reaction of any oxidant in the gas 
phase and iodide in the liquid phase, the contents of the flask were washed into a 250 mL conical 
flask with deionised water and were titrated with 0.1 M Na2S2O3 solution to determine the iodine 
content.  
To set a reference point to this study, first, the fluorine content of commercial 10 % v/v fluorine 
was determined using this equipment by passing the gas through the sampling equipment for 
15 minutes without any liquid flow. Titration of the liberated iodine showed that the flask 
contained 2.46 mmol F2 (average of three measurements) which is in good correlation with the 
theoretical 2.39 mmol (treating the gas mixture as an ideal gas at 20 oC).  
To determine whether there is any background reaction between formic acid and fluorine, pure 
formic acid was subjected to fluorination under optimal reaction conditions (204 g/h of 10% 
fluorine and 600 g/h formic acid at 10 oC), the gas phase was sampled and analysed as before. 
Titration showed that in this experiment, only 0.02 mmol of fluorine was present in the sampling 
flask showing that more than 99% of the fluorine had reacted with the solvent. To assess 
whether fluorine formed any O-F species in this reaction, the liquid phase was also analysed 
using the same iodometric method. The reaction mixture was collected for 5 minutes 
(approximately 60 mmol fluorine passed through the reactor), excess KI solution was added, 
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diluted with water and titrated with thiosulfate solution, which showed the presence of 0.1 
mmol of oxidant, probably in the form of HOF from the water content of formic acid. 
The reaction of fluorine and formic acid probably leads to the formation of HF and CO2, but 
attempts to demonstrate the presence of CO2 by in situ IR spectroscopy failed. The mechanism 
of the reaction is probably similar to that of chlorine and formic acid which has been described 
in the literature.198,199 This mechanism is further supported by the previously observed reaction 
of fluorine with aromatic aldehydes to produce acid fluorides.92 
 
Figure 97: Possible mechanism of the fluorine-formic acid reaction. 
To prove that most of the fluorine reacts in the cytosine fluorination reaction under typical 
operating conditions, the gas phase of a reaction was sampled and analysed using the same 
method as above. Titration of the released iodine indicated the presence of 0.04 mmol of 
fluorine, corresponding to higher than 98 % conversion. This measurement was repeated at 30 
oC (0.05 mmol residual fluorine) and at 10 and 30 oC with 1.5 bar applied back pressure (0.04 
and 0.01 mmol F2 respectively). Under all these reaction conditions over 98 % conversion of 
fluorine was observed.  
In conclusion, fluorine was shown to react not only with cytosine itself, but with neat formic acid 
as well, even at 10 oC leaving only a very low concentrations of fluorine (less than 0.1 % by 
volume) amounts that needs to be neutralised after the reaction. This suggests that a 
competition reaction between cytosine and formic acid with fluorine can also be a factor in the 
lower cytosine conversions at higher reaction temperatures.  
The analysis of fluoride was also carried out and it was found that the gas phase contains a low 
concentration of HF (26 - 40 mg/L) and, most of the fluoride remained in the reaction mixture. 
When formic acid was recovered from a crude fluorination mixture, the distilled formic acid 
contained only 50 mg/L fluoride, demonstrating the potential for formic acid solvent reuse. 
In this chapter we demonstrated that the direct fluorination of cytosine in a large scale 
continuous flow reactor is feasible and explored a broad range of operating conditions. The most 
important factors influencing the conversion of cytosine were fluorine stoichiometry, 
temperature and fluid mechanics. We also demonstrated that the solvent, formic acid, and 
cytosine are in a competing reaction with fluorine, as even at lower conversions of cytosine, only 
a trace amount of unreacted fluorine was detected. 
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After establishing a range of good operating conditions for the fluorination of cytosine, we 
focused on the development of a simple, scalable isolation procedure to separate Flucytosine 
from the formed side products. 
4.3.4 Isolation studies 
The laboratory scale isolation method – evaporation to dryness and recrystallisation from water 
– was deemed unsuitable for larger scale synthesis, therefore, we aimed to develop a practical, 
high yielding procedure for the isolation of pure 5-fluorocytosine from the post fluorination 
reaction mixture.  
During initial isolation studies, it was established that dilution of the reaction mixture with 
methanol, water or acetonitrile does not result in any solid precipitate, but neutralisation of 
acidic aqueous solution of fluorocytosine with ammonia enables the isolation of a solid product. 
To limit the number of potential solvents, the main criteria for a desirable anti-solvent were 
established: miscibility with formic acid, relative low polarity, low cost and relative greenness. 
For solvent assessment, a comparative solvent guide (Figure 98), based on the individual guides 
of 5 organisations, developed by the Chem21 consortium was used.111 
 
Figure 98: The relevant section of the comparative solvent guide.111 
Based on the above criteria n-butanol, i-propanol, acetone and ethyl acetate were selected for 
the study along with 30% NaOH and 25% NH3 solutions for the neutralisation approach. 
Flucytosine solution was prepared by fluorinating an 8.9 % w/w solution of cytosine in 
anhydrous formic acid using 1.5 equivalents of 10 % fluorine in nitrogen. Precipitations were 
performed by adding the ‘anti-solvent’ to the flucytosine solution drop-wise and stirring the 
mixture at 10-12°C for an hour. The precipitate was filtered, washed with the precipitation 
solvent (2x5mL) and the solid and liquid phases analysed by HPLC (Table 21). After drying in air 
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overnight the samples were weighed to compare yields. The best recoveries were achieved by 
the neutralisation approaches and when less-polar alcohol solvents were used.  




Precipitation conditions Notes 
1 10 mL 7 mL 30% NaOH solution 
1.00 g dry solid, white precipitate, pH 3, 
washed 2x5mL H2O 
2 10 g 10 mL 25% NH3 solution 
1.24 g wet solid, Light brown 
precipitate, washed with 2x5mL H2O 
3 10 g 10 mL n-Butanol 
0.65 g dry solid, White precipitate, 
washed with 2x5mL n-Butanol 
4 10 g 40 mL i-Propanol 
0.70 g dry solid, washed with 2x5mL i-
PrOH 
5 10 g 10 mL Acetone 
0.54 g dry solid, washed with 2x5 mL 
acetone 
6 10 g 10 mL Ethyl Acetate 
0.30 g dry solid, white precipitate, 
washed with 2x5 mL EtOAc 
 
 
Figure 99: The isolated solid products from the initial precipitation experiments. 
All precipitations yielded high purity (99.5 %+) Flucytosine crude product and, as shown by HPLC-
UV analysis and the only detectable impurity in the solid samples was cytosine (Table 22 and 
Figure 100). Analysis of the liquors showed varying concentrations of residual fluorocytosine and 
increased ratios of the impurities. From the further optimisation study, ethyl acetate and 
ammonia were excluded because of poor recovery (EtOAc) and quick formation of a strongly 
coloured impurity (ammonia). 




Figure 100: HPLC-UV chromatogram of the solid product precipitated using n-butanol. 
Table 22: HPLC analysis results of the liquors and the solid products. 
Sample Cytosine % Flucytosine % Difluoro % Others % 
Flucytosine 
concentration  
NaOH liq. 0.22 77.15 21.63 1.00 3 g/L 
NaOH solid 0.60 99.40 0 0 - 
NH3 liq. 0.28 77.06 20.75 1.91 11 g/L 
NH3 solid 0.50 99.50 0 0 - 
BuOH liq. 0.12 92.22 2.82 4.78 15 g/L 
BuOH solid 0.23 99.77 0 0 - 
iPrOH liq. 0.39 83.32 6.31 9.98 3 g/L 
iPrOH solid 0.24 99.76 0 0 - 
Acetone liq. 0.09 93.67 2.10 4.14 17 g/L 
Acetone solid 0.14 99.86 0 0 - 
EtOAc liq. 0.11 92.98 2.19  15 g/L 
EtOAc solid 0.14 99.86 0 0 - 
 
During the precipitation optimisation study a stock solution from the fluorination of 10% 
cytosine in formic acid was used that contained approximately 88% fluorocytosine, 0.5% 
cytosine, 8% difluorinated impurity and 3.5% other impurities as determined by HPLC analysis 
of the crude reaction mixture. In this study 500 L fractions of this stock solution were mixed 
with varying quantities of the precipitation solvents and were allowed to settle overnight at 4°C. 
After centrifuging the mixtures for 5 minutes at 104 rpm the liquid phases were analysed for 
flucytosine content and some representative solid products were also analysed for purity after 
decanting the liquor and washing with some fresh solvent. 
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As a reference point two samples were diluted with deionised water and, as expected, no 
precipiate formation was observed. HPLC analysis of these samples showed that they contained 
approximately 72 mg of fluorocytosine and from the analyses of the supernatant solution of the 
precipitation samples the amount of product left in solution was determined. Based on these 
results (Figure 101) acetone was discarded from further experiments as the solution flucytosine 
content indicated less than 50% recovery in all solvent ratios. 
 
Figure 101: Precipitation optimisation study. 
Fluorocytosine solubility in sodium hydroxide/sodium formate solution had a minimum point at 
pH 4 showing that a larger excess of NaOH also dissolves the amphoteric product, but despite 
the pH dependence, it is a very cost effective method for the isolation of the crude product. At 
higher solvent ratios n-butanol (2.5 volumes) and i-propanol (3 volumes) both gave excellent 
product recovery and they enable faster filtration and drying than the aqueous workup. In order 
to validate the optimisation results these three methods were further investigated on larger 
scale. 
50 mL (69.5 g, containing approximately 7 g of Flucytosine) fractions of the crude product 
solution from a direct fluorination reaction were treated with 30% NaOH solution (75 mL, 100 
g), i-propanol (150 mL, 117 g) and n-butanol (125 mL, 101 g) respectively. While the NaOH 
solution addition produced a significant exotherm (up to 75°C), which led to some coloured 
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of the other two solvents. After stirring the mixtures overnight, the solid product was collected 
by filtration and were washed with 10 mL solvent before being dried in air overnight.  




weighta / g 
Product 
purity / % 
Positive Negative 
30% NaOH 7.14 (wet) 99.6 
cost, close to 
neutral pH (4) 
large exotherm, highest 
solution FC content 
i-PrOH 6.58 99.8 Faster drying 
larger volume/mass 
required 




a; Approximately 7.5 g expected weight at 100 % yield and recovery. 
These larger scale experiments gave very similar results to the small scale trials and the HPLC 
purity of all products was above 99.5% A/A by HPLC-UV analysis, cytosine being the main 
impurity (0.2%), but in the NaOH precipitated product a small amount (0.2%) of the difluorinated 
impurity was also detected. 1H and 19F NMR spectroscopic analysis of the samples showed that 
none of the samples contained any solvent residue, but all of them showed varying levels of 
formic acid (probably as flucytosine formate) and fluoride (as HF). The highest levels of both 
impurities were found in the sample precipitated with 30% NaOH solution, but 15-20 mol% 
formic acid/formate was also present in the other samples. The fluoride content analysis is not 
accurate by NMR spectroscopy as the resonance (aprox. -130 ppm) is a broad singlet and the 
integration may not be quantitative.  
To demonstrate the scalability of this experiment, 10 % cytosine solution in formic acid and 
fluorine was passed through the reactor for one hour and the produced mixture (620 g) was 
treated with butanol (1 kg) to yield 62.8 g air dried product that was 99.8 % pure by HPLC.  
 
Figure 102: 1H NMR spectrum of isolated Flucytosine with formic acid impurity. 




Even though the large scale isolation experiment gave excellent results using n-butanol, because 
of its lower cost, further development was carried out with i-propanol. In these experiments the 
same fluorination conditions were used as before: 600 g/h 10 wt% cytosine in formic acid, 204 
g/h 10 % F2 V/V in N2, 10 oC, Boostec reactor. 
Previous results on small scale indicated that addition of three volumes of IPA is necessary to 
achieve the best results and to confirm these results, precipitation of Flucytosine using IPA was 
repeated on larger (50 mL product solution) scale (Table 24). 
Table 24: Room temperature precipitation experiments on 50 mL reaction mixture scale. 
FC solutiona / g IPA / mL T / oC 
c(FC) mg / mL, 
normalised 
Isolated massb / 
g 
- - - 130.5 - 
63.6 75 20 22.3 6.4 
64.7 100 20 13.3 6.7 
64.0 125 20 11.4 6.8 
63.7 150 20 8.6 6.9 
a; 600 g/h 10 % w/w cytosine in formic acid, 204 g/h 10 % F2 V/V in N2, 10 oC, b; 7.1 g expected at 100 % 
yield and recovery. 
The mixtures were stirred for three hours at ambient temperature, filtered and the filtrate 
diluted to 250 mL then analysed by HPLC-UV (sample further diluted 10 times). The results show 
that the addition of two volumes of IPA is enough to precipitate 90 % of the Flucytosine in 
solution, but with three volumes even better recovery is possible (93.5 % recovery). To 
investigate whether precipitation temperature has an effect on product recovery, the same 
sequence was repeated on 25 mL scale and was allowed to precipitate overnight in the 
refrigerator (4 oC). Control samples were kept at room temperature (23 oC) and in the freezer (- 
18 oC) (Table 25).  
Table 25: Effect of temperature on precipitation. 
FC solution / g IPA / mL T / oC c(FC) g / L  Isolated mass / g 
- - - 135.6 - 
32.0 37 4 33.0 2.7 
31.8 50 4 14.3 3.1 
31.9 62 4 11.5 3.3 
31.7 75 4 9.5 3.4 
31.9 50 23 19.3 3.1 
32.2 50 -18 14.6 3.1 
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From the data obtained it appears that the precipitation is not influenced significantly by 
temperature and allowing the samples to age for longer time has no significant benefit either. 
Recovering formic acid before precipitation is a desirable option, rather than attempting to 
recover and purify the solvents after the filtration of Flucytosine. The precipitation mixture is 
reactive, leading to a three component solvent mixture (formic acid, IPA and iso-propyl formate), 
making distillation of pure components more difficult. To assess the effect of formic acid 
removal on product recovery, two larger scale experiments were conducted. 400 mL samples of 
crude product solutions were distilled to concentrate to approximately half of the original 
volume. The solutions were analysed by HPLC and Flucytosine was precipitated by adding three 
volumes of IPA, stirring overnight at room temperature, filtering and washing with a further 
portion of IPA. After drying in air the solids were analysed by HPLC to confirm purity (Table 26). 
Table 26: Effect of solvent recovery on solution composition. 
Reaction number F132 F133 
Net weight / g 505.6 508.5 
Distillation temperature 
(external) / °C 
130-135 25-28 
Atmosphere Air Vacuum (20 mbar) 
Distillation time Approx. 3 h Approx. 3 h 
Weight after distillation / g 249.3 275.9 
Colour after distillation Dark brown Orange 
HPLC purity (before dist.) 94.5 % 93.1 % 
HPLC purity (after dist.) 93.0 % 95.4 % 
 
Although evaporation at atmospheric pressure left a darker residue, HPLC analysis showed that 
the colour did not correspond to a significantly lower Flucytosine content, the main difference 
was in the impurity profile of the mixture, some impurities are no longer observed, while the 
relative intensity of other impurities was increased (Figure 103). 




Figure 103: Impurities in crude Flucytosine solution before (top) and after (bottom) distillation of excess 
formic acid from the product mixture at atmospheric pressure. 
When the distillation was carried out under vacuum, the residue did not turn very dark, it had 
similar colour to the solutions that were left at room temperature for a longer period of time. 
HPLC analysis of the solution showed no change in impurities, therefore, this method is probably 
a better way to reduce the amount the amount of solvents used. 
NMR analysis of the solid samples obtained from these experiments showed that they are very 
similar in purity, the sample that was left to dry in air longer did not contain i-propanol or formic 
acid which shows that with adequate drying, all solvents can be removed from the solid sample 
before final purification. Fluorinated impurities (most likely fluoride) were still present in the 
samples, but previously it was demonstrated that these can be removed by a further re-
precipitation from hydrochloric acid solution. 
In summary, the large scale isolation studies discussed in this chapter provide several realistic 
alternative options to the original laboratory scale work-up procedure based on an anti-solvent 
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precipitation approach using environmentally acceptable solvents. Good product recovery 
(above 90 %) and excellent crude purity (99.5 % and higher by HPLC) were achieved using these 
methods and recovery of some of the reaction solvent formic acid was also possible leading to 
recycling opportunities and a decreased use of the precipitation solvent. 
4.3 Green metrics assessment of Flucytosine synthesis methods 
 
To evaluate the continuous flow synthesis of Flucytosine, mass based green metrics were used 
to compare the commercial process with the new, direct fluorination method. For the 
assessment of the literature process, some assumptions had to be made, for example, that the 
most likely used commercial method for the fluorination of uracil is the aqueous system, 
described in a patent183 which are mostly low yielding reactions (20-30 %) and the only large 
scale (100 g+) example available from the literature was used for the calculation of green 
metrics. The syntheses of uracil and cytosine are not included in this comparison as they are 
both synthesised from urea and a 1,3-dicarbonyl (or equivalent) acyclic precursor on the 
industrial scale and are both commercially available, inexpensive compounds. 
The direct fluorination of uracil has been described in several patents and this process is known 
to be used in production processes. The most likely method to be used on manufacturing scale 
is that of PCR who have been manufacturing this compound for decades, although, real yields 









× 100 = 𝟏𝟔. 𝟓  
𝑀𝐼(𝐹𝑙𝑢𝑜𝑟𝑖𝑛𝑎𝑡𝑖𝑜𝑛) =
1362 + 663 + 720 + 16020 + 20
335
= 𝟓𝟔. 𝟏 
Figure 104: Material balance and green metrics of the literature synthesis of 5-FU. 
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Even though the reaction is very atom efficient and relative high concentrations are applied 
throughout the synthesis, because of the low reported yield of the reaction, mass efficiency is 
low and the mass intensity value is relatively high (56.1 kg/kg). The next step of the literature 





130.08 + 2 × 153.32
× 100 = 𝟑𝟖. 𝟐 
𝑅𝑀𝐸(𝐶ℎ𝑙𝑜𝑟𝑖𝑛𝑎𝑡𝑖𝑜𝑛) =
112.5
104 + 2 × 123
× 100 =  𝟑𝟐. 𝟏 
𝑀𝐼(𝐶ℎ𝑙𝑜𝑟𝑖𝑛𝑎𝑡𝑖𝑜𝑛) =
104 + 166 + 1472 + 847 + 500
112.5




0.867 + 2 × 153.32





+ 2 × 123
× 100 = 𝟏𝟐. 𝟖 
𝑀𝐼(𝐶𝑢𝑚𝑢𝑙𝑎𝑡𝑖𝑣𝑒) =
104 × 56.1 + 106 + 1472 + 847 + 500
112.5
= 𝟕𝟕. 𝟗 
Figure 105: Green metrics and materials balance for the chlorination of 5-fluorouracil. 
The green metrics show that this reaction does not perform very well in terms of atom efficiency, 
but most of the Mass Intensity is derived from the large excess of POCl3 which can be recycled 
for further use in manufacturing processes and as with the previous step, in a real process the 
reaction would possibly be more concentrated and, a less hazardous solvent would be used. The 
following step in the synthesis is nucleophilic aromatic substitution of the chlorine atom at the 
4-position with ammonia. This reaction proceeds with good regio-selectivity and gives the 
desired 4-amino-2-chloro-5-fluoropyrimidine in good yield (79 %) after purification. 
  











× 100 =  𝟒𝟏. 𝟗 
𝑀𝐼(𝐴𝑚𝑖𝑛𝑎𝑡𝑖𝑜𝑛) =
10 + 78.9 + 22.5 + 125
6.83











× 100 = 𝟖. 𝟏 
𝑀𝐼(𝐶𝑢𝑚𝑢𝑙𝑎𝑡𝑖𝑣𝑒) =
10 × 77.9 + 78.9 + 22.5 + 125
6.83
= 𝟏𝟒𝟕. 𝟐 
Figure 106: Green metrics and material inventory of the SNAr reaction. 
The final step of the literature process is the hydrolysis of the 2-chloropyrimidine derivative 
which was achieved by heating the intermediate with aqueous hydrochloric acid. 5-
Fluorocytosine was isolated in excellent yield by precipitation from the concentrated reaction 
solution with aqueous ammonia solution.  
  











× 100 = 𝟕𝟓. 𝟎 
𝑀𝐼(𝐻𝑦𝑑𝑟𝑜𝑙𝑦𝑠𝑖𝑠) =
34 + 277 + 150 + 20.5 + 20 + 18
28.65










× 100 = 𝟔. 𝟖 
𝑷𝑴𝑰(𝑪𝒖𝒎𝒖𝒍𝒂𝒕𝒊𝒗𝒆) =
34 × 147.2 + 277 + 150 + 20.5 + 20 + 18
28.65
= 𝟏𝟗𝟏. 𝟔 
Figure 107: Material balance and green metrics of the synthesis of 5-fluorocytosine. 
The overall green metrics of the literature process (Figure 107) describe a highly inefficient 
method with four separate synthetic steps and large amounts of materials used to produce the 
desired product. Even though a large fraction of the material usage originates from the 
inefficient fluorination of uracil, the remaining three steps still contribute significantly to the 
results. 
In comparison, the continuous flow direct fluorination process described in this thesis is a single 
step transformation and the crude product can be isolated very easily by a simple precipitation. 
The green metrics of this process are very favourable, especially when compared with the 
alternative literature method. The PMI of 28.9 is a relatively low number, but with further 
optimisation of formic acid removal before precipitation this could potentially be reduced 
significantly. As elemental fluorine is used in both the literature and our methods, the safety 
requirements for both processes are similar, but handling hazardous, very exothermic reactions 
in a continuous process is considered safer than batch techniques.  












× 100 = 𝟔𝟔. 𝟗 
𝑴𝑰(𝑭𝒍𝒖𝒐𝒓𝒊𝒏𝒂𝒕𝒊𝒐𝒏) =
60 + 540 + 25.7 + 1049
58.0
= 𝟐𝟖. 𝟗 
Figure 108: Inventory and green metrics of the direct fluorination process. 
 
4.4 Conclusion 
In this chapter a new, continuous flow direct fluorination process for the synthesis of Flucytosine 
was discussed. After initial discovery work on laboratory scale the reaction was transferred to a 
pilot scale continuous flow reactor setup and optimisation studies were carried out to gain 
thorough process understanding.  
 Excellent conversion using a small excess of fluorine (1.2 – 1.3 equivalents). 
 Controlling the reaction temperature is important, highest conversions at 10 oC. 
 Reaction throughput is not limiting conversion: up to 1.4 kg solution per hour rate. 
 High cytosine concentrations are beneficial: 10 – 11 % solutions in formic acid used. 
 Back pressure influences the gas-liquid ratio and has a large negative effect on 
conversion. 
 Mixing of the gas and liquid phases is influenced by several parameters and has a large 
impact on cytosine conversion. 
The downstream processing of the fluorination mixture was also developed with an emphasis 
of reduced solvent usage and application of green solvent guides for solvent selection.  
 Formic acid recovery before isolation enables potential solvent recycling. 
 Environmentally friendly solvents i-PrOH and n-BuOH used for precipitations. 
 Excellent recovery (90% +) of high purity (99 % +) crude Flucytosine by precipitation.  
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Green metrics comparison of the new method with the existing fluorouracil based route 
highlighted the advantage of this methodology (Table 27). The most important metric, besides 
overall yield, is Process Mass Intensity which shows the total input material required per 
kilogram of product and in the case of these two processes the new route requires 
approximately 85 % less material and, of course, one synthetic step is probably more 
commercially viable than four. 
Table 27: Comparison of key green metrics of the two alternative processes. 
 Fluorouracil route Cytosine fluorination 
Steps 4 1 
Yield 13.5 % 83 % 
Atom Economy 30.5 % 86.6 % 
Reaction Mass Efficiency 6.8 % 66.9 % 
Process Mass Intensity 191.6 28.9 
 
Since the completion of this study, more scale up work has been carried out by the Sanofi/MEPI 
team to demonstrate feasibility of producing API grade Flucytosine on the manufacturing scale. 
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Chapter 5.: Synthesis and Reactivity of -Fluorotricarbonyl 
Compounds 
 
As discussed in earlier chapters, fluorinated aliphatic building blocks are very important for the 
synthesis of a range of fluorinated aliphatic and heterocyclic systems, thus, the development of 
robust and scalable methods for the synthesis of polyfunctional fluorinated building blocks 
continues to be of interest. Fluorinated carbonyl compounds bearing functionalities such as 
esters, amides, ketones and aldehydes may be used in further synthesis and the chemistry of -
fluorocarbonyl compounds, especially 2-fluoro-1,3-dicarbonyl derivatives, is well developed and 
understood as discussed above. However, despite their potential usefulness in synthesis the 
corresponding 2-fluorotricarbonyl compounds are very rare in the literature and their reactivity 
compared to the non-fluorinated analogues has not been described in any detail. 
Meldrum’s acid (83) is a very frequently used building block in organic synthesis as an alternative 
to dialkyl malonate esters and has been used extensively in the synthesis of complex organic 
systems and natural products.200 Acylation of Meldrum’s acid gives a particularly important class 
of compounds as they are versatile intermediates for the synthesis of a large range of -
dicarbonyl derivatives.201 
Acyl Meldrum’s acids are easily synthesised from carboxylic acids by using coupling reagents 
(DCC, CDI, etc.) or from the corresponding mixed anhydride or acid chloride202 and the desired 
product is often used without any purification in subsequent synthetic steps. 
 
Figure 109: Typical methods for the synthesis of acyl-Meldrum's acid derivatives. 
The acylation reaction is typically carried out in halogenated solvents (dichloromethane or 
chloroform) in the presence of two equivalents of base (usually pyridine or DMAP) and affords 
the desired product in high yields after removing residues of the coupling reagent and the base 
from the mixture. In the solid phase acyl Meldrum’s acid derivatives (145) exist primarily in the 
enol form which was demonstrated using X-ray crystallographic analysis.203  
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Acyl Meldrum’s acid derivatives react with a range of nucleophiles leading to a variety of 
different carbonyl compounds for example -keto(thio)esters, -ketoamides and methyl 
ketones after loss of acetone and CO2 (Figure 110). The generally accepted mechanism for these 
transformations is the thermal elimination of acetone to give the corresponding ketene which 
further reacts with the nucleophile reagents before or after losing CO2.201 
 
Figure 110: Reaction of acyl Meldrum's acids with various nucleophiles. 
Our aim was to prepare corresponding 2-fluorotricarbonyl compounds and use these building 
blocks to prepare a range of -fluorocarbonyl derivatives such as ketones, -keto-esters, amides 
and thioesters from a common synthetic intermediate. 
5.1 Chemistry of 2-fluorotricarbonyl compounds 
5.1.1 Aims 
In this chapter we aimed to synthesise acyl-Meldrum’s acid derivatives and fluorinate them in 
the -position using the electrophilic fluorinating reagent Selectfluor™ to gain access to the 
potentially polyfunctional fluorinated tricarbonyl compounds. 
 
Figure 111: Synthesis and potential use of -fluorotricarbonyl compounds derived from Meldrum’s acid. 
Subsequently, the chemistry of 2-acyl-2-fluoro-Meldrum’s acid derivatives could be established 
and reactions with a number of nucleophilic reactants could be explored with a main aim of 
developing a general procedure for the transformation of aromatic carboxylic acids to 
fluoromethyl ketones or -fluoroketoester derivatives. 
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5.1.2 -Fluorotricarbonyl compounds 
Despite the extensive use of tricarbonyl compounds, especially acyl Meldrum’s acid derivatives, 
in organic synthesis there is very little evidence in the literature on the synthesis and use of 
fluorinated derivatives. A few examples were synthesised by double acylation of ethyl 
fluoroacetate204 and by the fluorination of tricarbonyl compounds using perchloryl fluoride205, 
but there is only one general method available in the literature. Kim and co-workers reported 
that triethyl 2-fluorophosphonoacetate can be acylated twice using the MgCl2-Et3N system to 
afford the corresponding diketoesters in good yield. It was also reported that these compounds 
easily undergo de-acylation to the desired 2-fluoro-3-ketoester products in excellent yield (Table 
28).206,207 
Table 28: Synthesis of 2-fluoro-3-ketoesters via a fluorotricarbonyl intermediate. 
 










More recently, in our laboratory, the acylation of fluoromalonate esters was investigated in 
detail as part of a final year undergraduate research project.208 Contrary to non-fluorinated 
malonate esters, the acylation of fluoromalonate esters does not require addition of a Lewis-
acid catalyst and a simple base such as trimethylamine or DMAP is sufficient to generate the 
enolate system that reacts readily with aromatic acid chlorides (Table 29). 
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Table 29: Acylation of dimethyl fluoromalonate. 
 








Although the desired -keto-diesters could be isolated and characterised, these compounds 
were found to be highly moisture sensitive. The hydrolysis product was identified as dimethyl 
fluoromalonate showing that the cleavage of a C-C bond is the main reaction, however, when 
tricarbonyl compound derived from benzoyl chloride was heated in acidic solution, the 
formation of -fluoroacetophenone was observed in moderate conversion (30 %).  
The above results encouraged us to further investigate the synthesis and reactions of fluoro-
tricarbonyl compounds. Fluorinated acyl Meldrum’s acid derivatives were identified as suitable 
candidates that can be hydrolysed under acidic conditions, potentially reducing C-C bond 
cleavage products. This chapter discusses the synthesis and some reactions of these poly-
functional fluorinated building blocks. 
5.2 Synthesis and reactions of fluorinated acyl Meldrum’s acid derivatives 
In order to assess the properties and chemical reactivity of fluorinated acyl Meldrum’s acid 
derivatives a method for their synthesis needed to be developed as these compounds have not 
been described in the literature before. Our synthetic strategy involved acylation of Meldum’s 
acid followed by fluorination of the isolated product using an electrophilic fluorinating reagent 
to give the desired fluorotricarbonyl compounds that can be used in subsequent reactions. 




Figure 112: Synthetic strategy for the synthesis of fluorinated acyl Meldrum's acid derivatives. 
 
5.2.1 Acylation of Meldrum’s acid 
As it was described earlier, the acylation of Meldrum’s acid is typically carried out in halogenated 
hydrocarbon solvents (chloroform, dichloromethane, etc.) in the presence of a pyridine base 
and the crude product is often used without any further purification.202 To decrease the 
environmental impact of this reaction acetonitrile was used to replace chlorinated hydrocarbon 
solvents. After the reaction reached completion, aqueous hydrochloric acid was added to 
dissolve the precipitated DMAP hydrochloride and acetonitrile was evaporated from the mixture 
under reduced pressure to precipitate the desired product. After filtering off the solids and 
washing with water to remove traces of DMAP.HCl, the product was dried under vacuum (40 oC 
at 20 mbar) to afford the desired acyl Meldrum’s acid derivatives in good yield and purity (Table 
30). When the crude product purity was not sufficient, the solid was recrystallized from a 
minimum amount of acetone to yield high purity crystalline material. 
  
Chapter 5.: Synthesis and Reactivity of -Fluorotricarbonyl Compounds 
114 
 
Table 30: Synthesis of acyl Meldrum's acid derivatives. 
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The pure, solid products were all isolated as the enol form, as shown by 13C NMR spectroscopy 
(three distinct C=O environments) and X-ray crystallography, however, the equilibrium between 
the enol and keto tautomers was observed by 1H NMR spectroscopy that was acquired after the 
solution reached equilibrium (8-10 hours).  
 
Figure 113: Molecular structure of 160 confirming the enol form of the product. 




Figure 114: 1H NMR spectrum of 165 showing keto and enol tautomer forms (keto : enol, 1 : 9). 
The high enol content of these compounds, typically above 98 % in solid phase, suggests that 
the electrophilic fluorination should proceed easily, even without the addition of further base 
or Lewis acid catalyst. 
5.3.2 Fluorination of acyl Meldrum’s acids 
The fluorination of enolate derivatives can be carried out using a wide range of electrophilic 
fluorinating reagents and Selectfluor™ was chosen as the reagent of choice for its fluorinating 
power and ease of separation from the desired product. The fluorinations were carried out in 
acetonitrile, a typical solvent for fluorinations using Selectfluor™, at ambient temperature over 
16 hours when 19F NMR spectroscopic analysis of the mixture confirmed full conversion to the 
desired tricarbonyl product. 
Reaction of 2-nitrobenzoyl Meldrum’s acid with Selectfluor™ (Figure 115) was worked up in a 
conventional way: the reaction mixture was quenched into a large excess of water, the product 
extracted with ethyl acetate, washed with aqueous NaHCO3 solution, dried and evaporated to 
dryness to afford the crude product. The crude yield of the product was only 70 % and this 
contained several fluorinated impurities that weren’t present before the workup procedure. The 
purification of the crude product was carried out using column chromatography on silica gel, but 
instead of the desired product, 2-fluoro-2’-nitroacetophenone was isolated in 38 % yield which 
inspired the re-evaluation of the post-reaction treatment of the product. 
 
Figure 115: Fluorination of 163 and subsequent decomposition of the product during purification. 
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As the analysis of the crude product suggested that some of the product decomposition had 
occurred during the aqueous workup, we sought to eliminate this step from the procedure. After 
the reaction reached completion acetonitrile was removed under vacuum to leave a solid 
mixture of the desired product and depleted Selectfluor™. The isolation of the tricarbonyl 
product was achieved by selective dissolution into ethyl acetate and evaporation of the solvent 
after filtering off the Selectfluor™ salt residues. In some cases, the crude product was further 
purified by dissolving in a small volume of dichloromethane followed by the addition of a larger 
volume of hexane and the removal of dichloromethane by atmospheric pressure distillation. 
After cooling at 0-5 oC for 12-16 hours, the desired fluorotricarbonyl products were isolated in 
good yield as fine powders, and in some cases, crystalline products were obtained by further 
recrystallisation from acetone. 
Table 31: Fluorination of acyl Meldrum's acid derivatives. 
 


















Under these reaction conditions both aromatic substrates bearing electron withdrawing and 
electron donating substituents were successfully fluorinated and competing aromatic 
fluorination was not observed even in the case of the electron rich thiophene derivative. These 
compounds were found to be stable for a long time (over a month) as long as moisture was 
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excluded and the samples were kept in a refrigerator. X-ray crystallographic analysis of two 
fluorinated acyl Meldrum’s acid derivatives showed that the cyclohexane ring of these 
compounds takes a distorted boat conformation where the torsion angle between the fluorine 
atom and the C=O oxygen atoms of the ring is only approximately 30o (Figure 116). The 
difference between the conformations of the two methyl groups was also observed by 1H and 
13C NMR spectroscopy where the chemical shifts corresponded to one axial and one equatorial 
environment. 
 
Figure 116: Distorted boat conformation of fluorinated Meldrum's acid derivatives. 
5.3.3 Synthesis of 2-fluoroacetophenone derivatives 
Our first attempt at isolating a fluorinated acyl Meldrum’s acid derivative (Figure 115) indicated 
that the hydrolysis and decarboxylation of these systems could, in principle, easily be achieved 
and to develop and understand this reaction a range of conditions were screened on 1 mmol 
scale (Table 32). From the hydrolysis studies of dimethyl (benzoyl)fluoromalonate208 it was 
apparent that basic hydrolysis of this class of compounds would lead the cleavage of the C-C 
bond as the main reaction, therefore, in this study, acid catalysed hydrolysis conditions were 
investigated. The requirement for an acid catalyst was further confirmed when in the presence 
of water without additive (Table 32/1) only low conversion of the starting material was observed 
and the main fluorinated product from this reaction was fluorinated Meldrum’s acid. 
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Table 32: Screening conditions for the synthesis of 2-fluoroacetophenone. 
 
No Solvent Additive Water T / oC t / min Composition 
1 
Acetone - 0.1 mL 100 20 
91 % 173, 1 % 177,  
8 % 84 
2 
Acetone 0.1 mL 1M HCl - 90 20 
67 % 173, 23 % 177,  
5 % 84, 5 % 178 
3 
Acetone 1 eq. TsOH.H2O 0.1 mL 90 20 
68 % 177, 7 % 84,  
25 % 178 
4 
Acetone 1 eq. TsOH.H2O - 100 20 
11 % 173, 30 % 177,  
20 % 84, 38 % 178  
5 
Acetone 2 eq. TsOH.H2O - 100 20 
2 % 173, 36 % 177,  
62 % 178 
6 Acetone 1 eq. TsOH.H2O 0.1 mL 100 20 60 % 177, 40 % 178 
7 Acetone 1 eq. TsOH.H2O 0.1 mL 110 20 75 % 177, 25 % 178 
8 Acetone 1 eq. TsOH.H2O 0.2 mL 100 20 73 % 177, 27 % 178 
9 Acetone 1 eq. K2CO3 0.1 mL 100 20 No reaction 
10 
Acetone 
0.1 mL  
37 % HCl 
- 100 20 
34 % 173, 56 % 177,  
10 % 178 
11 
Acetone 
0.05 mL  
37 % HCl 
0.05 mL 100 20 
35 % 173, 48 % 177,  
3 % 84, 14 % 178 
12 Acetone 0.5 eq. TsOH.H2O 0.1 mL 100 30 76 % 177, 24 % 178 
13 AcOH 1 eq. TsOH.H2O - 100 20 36 % 177, 64 % 178 
14 AcOH 1 eq. TsOH.H2O 0.1 mL  100 20 55 % 177, 45 % 178 
 
Screening of reaction conditions revealed that p-toluenesulfonic acid monohydrate is a suitable 
catalyst for the reaction and larger than one equivalent quantity is not required, however, when 
only 50 mol% was used the reaction required a longer reaction time to reach full conversion. 
Additional water improved the selectivity and conversion of the reaction, but more than 0.1 mL 
water per mmol starting material did not have any further benefit. The overall selectivity of the 
reaction could not be improved further than 75 % in the case of this substrate and, after isolation 
and column chromatographic purification, this resulted in 56 % isolated yield of 2-
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fluoroacetophenone. The selectivity of this reaction can be explained with the difference in 
mechanism compared with the non-fluorinated analogues as in these compounds there is no 
acidic hydrogen atom in the  position, therefore, the formation of the ketene intermediate is 
not possible. However, in these compounds there are two different type of carbonyl centres 
that could react with a nucleophilic species such as water and the relative reaction rates 
between these centres determines the selectivity of the reaction.  
 
Figure 117: Possible mechanisms of the hydrolysis of fluorinated acyl Meldrum's acid derivatives. 
The best reaction conditions were applied to a range of aromatic and heteroaromatic 
fluorinated Meldrum’s acid derivatives to yield aryl-fluoromethyl ketones in good yield after 
flash column chromatographic purification (Table 33). The higher yields obtained in the 
synthesis of the 168 and 184 suggest that an ortho substituent capable of resonance stabilisation 
can improve the selectivity of the decarboxylation. The structure of the products was conformed 
using NMR spectroscopy and mass spectrometry and in the case of some products, such as 2-
fluoro-2’-nitroacetophenone, X-ray crystallography (Figure 118). 
 
Figure 118: Molecular structure of 168 as determined by X-ray crystallography. 
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Table 33: Synthesis of -fluoroacetophenone derivatives. 
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5.3.4 Ethanolysis of fluorinated acyl Meldrum’s acid derivatives 
After the decarboxylation of the fluorinated tricarbonyl compounds was successfully 
demonstrated, we sought to expand the synthetic utility of this system and an obvious direction 
was to replace water with another oxygen centered nucleophile such as ethanol.  
Table 34: Screening conditions for the ethanolysis of 5-benzoyl-5-fluoro-1,3-dioxane-4,6-dione. 
 
T / oC t / min Composition 
60 30 38 % 157, 61 % 185, 1 % 59  
70 30 25 % 157, 72 % 185, 3 % 59 + 83 
80 30 12 % 157, 84 % 185, 4 % 59 + 83 
90 30 10 % 157, 84 % 185, 5% 59 + 83, 1 % 177 
100 30 3 % 157, 86 % 185, 10 % 59 + 83, 1 % 177 
60 60 97 % 185, 3 % 59 + 83 
80 60 94 % 185, 6 % 59 + 83 
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Reaction of 157 with ethanol was carried out without the addition of acid catalyst and even at 
60 oC, good conversion of the starting material was observed. The results in Table 34 show that 
the conversion could be increased by either increasing the temperature or the reaction time, 
but at higher temperatures the selectivity of the reaction decreases, therefore, for best results 
longer reaction time (60 minutes) and lower reaction temperature (60 oC) are preferred.  
The corresponding reaction of the furoyl derivative was carried out on preparative scale and 
ethyl 2-fluoro-3-(2-furyl)-3-oxopropionate was obtained in good yield (55 %) after column 
chromatography. Despite the high selectivity (90 %+, Figure 119), the yield of the reaction is 
relatively low due to the difficult chromatographic separation from the side product 2-
(fluoroacetyl)furane. 
 
Figure 119 19F NMR spectrum of a crude ethanolysis product. 
5.4 Conclusion 
In this chapter the synthesis and reactivity of fluorinated acyl Meldrum’s acid derivatives was 
described. With modification of literature conditions, Meldrum’s acid was acylated under more 
environmentally friendly conditions and the product isolation was significantly simplified. 
Fluorination was carried out using Selectfluor™ and the desired fluorotricarbonyl compounds 
were obtained in good yield. Hydrolysis of these intermediates led to fluoroacetophenone 
derivatives in a simple process, overall providing a multistep approach for the transformation of 
carboxylic acids to the corresponding fluoromethyl ketones. In initial experiments, it was 
demonstrated that fluorotricarbonyl compounds can also be transformed into the ketoester 
analogues by simply heating them in ethanol, showing that they are useful building blocks that 
are suitable for the rapid generation of a variety of ketoester derivatives. 
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In this thesis the selective direct fluorination of a range of life-science building blocks was 
described with an aim to identify high yielding, selective processes that can be analysed using 
the green metrics package124 developed by the Chem21 consortium.  
Following optimisation and process intensification, a copper catalysed direct fluorination 
process for the synthesis of fluoromalonate esters afforded these important, polyfunctional 
building blocks in excellent yields (95-97 %) on larger laboratory scale. Subsequent green metrics 
comparison with existing methodologies showed that this method is comparable with the 
industrially used halogen exchange reaction and is superior to the sequential solvolysis of 
hexafluoropropene. A potential extension of this research could be to optimise the direct 
fluorination of other, synthetically important, dicarbonyl compounds and to compare these 
reactions with alternative synthetic methods, for example, halogen exchange or fluoroacetic 
acid based processes. 
Attempts to fluorinate a structurally more complex system, progesterone, showcased the 
limitations of elemental fluorine: even though the desired products were identified by HPLC 
analysis of the crude reaction mixture, isolation of pure product was not possible because of a 
large number of unidentified sire products. Despite these results, the synthesis of more simple 
-fluoroketones from the corresponding enolate compounds using fluorine gas is still an 
attractive approach and after some optimisation it would be interesting to compare this reaction 
with the existing alternative methods from a green metrics point of view. 
 
Figure 120: Overview of direct fluorination studies. 
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The fluorination of aromatic systems was carried out on a range of systems and we found that 
the reaction outcome needs to be balanced between conversion and selectivity, but despite all 
efforts to purify the investigated systems, the few reactions that were investigated were 
developed to a stage where green metrics analysis was possible. Future research in this area 
could focus on the fluorination of some more activated aromatic systems such as aniline or 
phenol derivatives which have been shown to give the desired products in higher selectivity and 
yield both under batch and continuous flow fluorination conditions.91 Optimising such a reaction 
would allow the green metrics comparison of a direct fluorination process with the typically used 
Balz-Schiemann reaction. 
In contrast, direct fluorination of cytosine, a highly activated heterocyclic system, was shown to 
be a viable reaction under batch fluorination conditions and was subsequently transferred to 
continuous flow which further improved the reaction selectivity. In order to assess the scalability 
of this reaction, the process was transferred to a meso-scale silicon carbide reactor in a 
collaboration project with Sanofi and MEPI and was further optimised to yield high purity 
Flucytosine in higher than 80 % yield. Comparison of green metrics against the industrially used 
four step process showed that our method is clearly superior not just in overall yield and step 
count but it’s PMI value is significantly lower too. In further work this fluorination reaction is 
being investigated by our Sanofi/MEPI collaborators to assess the commercial viability of this 
process. 
Overall, using the Chem21 green metrics package we demonstrated that in cases when the 
direct fluorination process could be optimised it is comparable or better than existing synthetic 
methods. Although these examples only covered areas where fluorinated bioactive compounds 
are known, with the ever increasing number and diversity of new fluorinated systems it is 
important to bear in mind that elemental fluorine is a very economical reagent in synthesis and 
its use should be investigated whenever a cost effective solution is sought.  
Finally, previously unknown fluorinated acyl Meldrum’s acid derivatives were synthesised in 
good yield in two steps from aromatic acid chlorides and were shown to undergo reactions with 
nucleophiles such as water or ethanol. A distinct advantage of this approach over the 
fluorination of dicarbonyl systems is the potentially increased selectivity as -difluorination is 
not possible. 
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One of the areas for potential future research is the further exploration of the reactions of these 
polyfunctional building blocks and to extend the range of substrates to heterocyclic and aliphatic 
carboxylic acid derivatives. 
 
Figure 121: Possible reactions of fluorinated acyl Meldrum's acid systems. 
To investigate the scalability of the synthesis of these Meldrum’s acid derivatives, their 
fluorination using elemental fluorine could be of potential interest. As the enol content of acyl 
Meldrum’s acids is very high, the direct fluorination process may even proceed without any 
added Lewis acid catalyst or base. 
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Chapter 7.: Experimental 
 
7.1. General 
Hydrogen, fluorine and carbon nuclear magnetic resonance spectra (1H, 19F and 13C NMR) were 
obtained using Bruker 400 Ultrashield spectrometers (1H NMR at 400 MHz, 19F NMR at 376 MHz 
and 13C NMR at 101 MHz). HSQC, HMBC and NOESY experiments were recorded on Varian 
VNMRS-600 and VNMRS-700 instruments, using residual solvent peaks as the internal standard 
(1H NMR; CHCl3 at 7.26 ppm, 19F NMR; CFCl3 at 0.00 ppm and 13C NMR; CDCl3 at 77.16 ppm). 
NMR spectroscopic data are reported as follows: chemical shift (ppm), integration, multiplicity 
(s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), coupling constant (Hz) and 
assignment. 
GC-MS data were obtained using a Trace GC-MS (Thermo-Finnigan) or a QP2010-Ultra 
(Shimadzu) instrument operating in electron impact ionization (EI) mode. Accurate mass 
analyses were performed on a Xevo QtoF mass spectrometer (Waters Ltd, UK) with an accurate 
solids analysis probe (ASAP) or a TQD UPLC (Waters) instrument operating in electrospray 
ionisation mode. 
Melting point data were obtained using a Gallenkamp apparatus at atmospheric pressure and 
are uncorrected. Infra-red (IR) spectroscopy was performed on a Perkin Elmer 1600 Series FTIR 
with an ATR probe. In-situ IR spectroscopy was performed using a Mettler Toledo React IR 
instrument equipped with a diamond probe. 
HPLC analysis of steroid samples was carried out on a PerkinElmer instrument with UV detection 
at 237 nm using an XBridge C18, 100x4.6 mm, 3.5m (Waters) column at 25 oC with the following 
method: elution started with 60 % water/40 % acetonitrile with 0.1 % TFA which was increased 
to 5% water/95 % acetonitrile with 0.1 % TFA over 15 minutes at 1.5 mL/min flow rate. 
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HPLC analysis of Flucytosine samples was carried out on a Thermo ACCELA600 instrument with 
UV detection at 260 nm using a Phenomenex LUNA® C18(2), 250x4 mm, 5m (Waters) column 
at 40 oC with isocratic elution using the following eluent at 0.6 mL/min flow rate: 13.6g KH2PO4, 
20 mL MeOH, Ultra Pure Water QSP 1L, pH adjusted to 2 with H3PO4. 
Fluorinations were carried out in a glass fluorination reactor (100 mL, 250 mL or 500 mL) unless 
otherwise stated. The reactors were built from a standard glass bottle with GL 45 thread joint 
and a PTFE screw cap or a glass flange head, equipped with a gas inlet/outlet head built of 
Stainless Steel, PTFE and FEP Swagelok components. 
 
  
Chapter 7.: Experimental 
127 
 
7.2. Experimental to Chapter 2. 
7.2.1 Direct fluorination of malonate esters  
Diethyl malonate fluorination: general reaction (59) 
 
Diethyl malonate (3.20 g, 20 mmol) and copper nitrate hydrate (Cu(NO3)2.2.5H2O; 0.46 g, 2 
mmol) were dissolved in acetonitrile (17 mL) and placed into the fluorination reactor and the 
mixture was cooled to 0-5 °C. After purging the system with N2 for 5 minutes, fluorine gas (10 % 
v/v in N2, 45 mL/min, 22 mmol) was passed into the stirred mixture for 2h. The reactor was 
purged with nitrogen for 10 minutes, the solvent was removed in vacuo and the residue 
partitioned between water (10 mL) and ethyl acetate (10 mL). The aqueous phase was extracted 
with ethyl acetate (10 mL) and the combined organic layers were washed with saturated brine 
(10 mL). After drying over sodium sulfate, the solvent was evaporated to leave diethyl 2-
fluoromalonate (3.37 g, 94 % yield, 93.5 % purity) as a colourless liquid. IR (neat, cm-1): 2986, 
1747, 1243, 1187, 1097, 1020; δH (CDCl3, 400 MHz) 1.31 (6H, t, 3JHH 7.2, CH3), 4.31 (4H, q, 3JHH 
7.2, CH2), 5.26 (1H, d, 2JHF 48.3, CHF); δF (CDCl3, 376 MHz):  - 195.58 (d, 2JHF 48.3, CH-F); δC (CDCl3, 
100 MHz) 14.04 (CH3), 62.80 (CH2), 85.39 (d, 1JCF 198.2, C-F), 164.20 (d, 2JCF 24.1, C=O); m/z (EI+) 
179 (5 %, [M+H]+), 133 (44 %, [M-OEt]+), 105 (49 %, [M-COOEt]+), 78 (100 %, [CH2FCOOH]+). 
Spectroscopic data were identical with those previously reported and side products were 
identified from their reported 19F NMR shifts.163 
Diethyl fluoromalonate large scale fluorination (59) 
 
Diethyl malonate (40.0 g, 0.25 mol) and copper nitrate hydrate (Cu(NO3)2.2.5H2O; 5.81 g, 25 
mmol) were dissolved in acetonitrile (200 mL) and placed in 500 mL fluorination vessel, cooled 
to 0-5 °C and stirred at 650 rpm using an overhead stirrer. After purging the system with N2 for 
5 minutes, fluorine gas (20 % v/v in N2, 80 mL/min, 265 mmol) was introduced into the mixture 
for 6 hours and 30 minutes. The reactor was purged with nitrogen for 10 minutes, the solvent 
removed in vacuo and the residue partitioned between water (50 mL) and ethyl acetate (50 mL). 
The aqueous phase was extracted once more with ethyl acetate (50 mL) and the combined 
organic layers were washed with saturated aqueous NaHCO3 (25 mL) and brine (20 mL). After 
drying over sodium sulfate, the solvent was evaporated to leave diethyl 2-fluoromalonate (44.4 
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g, 99% yield, 95 % purity) as a light yellow, transparent liquid. This crude product was distilled 
to afford high purity fluoromalonate (34.7 g, 77 % yield, 99%+ purity) as a colourless liquid, bp. 
102-103 °C (18 mbar), (lit.: 110-112 °C, 29 mbar)163, spectroscopic data as above. 
Dimethyl 2-fluoromalonate (63) 
 
Dimethyl malonate (19.8 g, 0.15 mol) and Cu(NO3)2.2.5H2O (3.50 g, 15 mmol) were dissolved in 
acetonitrile (85 mL), the mixture was cooled to 0-5 °C and stirred at 650 rpm using an overhead 
stirrer. After purging the system with N2 for 5 minutes, fluorine gas (20 % v/v in N2, 50 mL/min, 
170 mmol) was introduced into the reaction mixture for 7 h. After purging with nitrogen for 20 
minutes, the solvent was removed in vacuo and the residue was partitioned between water (30 
mL) and ethyl acetate (20 mL). The aqueous phase was extracted with ethyl acetate (2 x 20 mL) 
and the combined organic layer was washed with saturated brine (20 mL). After drying over 
sodium sulphate, the solvent was evaporated under reduced pressure to give dimethyl 2-
fluoromalonate (21.8 g, 97% yield, 95 % purity) as a colourless oil; IR (neat, cm-1) 2962, 1748, 
1438, 1250, 1206, 1112, 1016; δH (CDCl3, 400 MHz) 3.85 (6H, s, CH3), 5.31 (1H, d, 2JHF 48.0, CHF); 
δF (CDCl3, 376 MHz):  -195.73 (d, 2JHF 48.0, CH-F); δC (CDCl3, 100 MHz) 53.48 (CH3), 85.19 (d, 1JCF 
197.2, C-F), 164.39 (d, 2JCF 24.0, C=O); m/z (EI+) 150 (3 %, [M]+), 119 (42 %, [M-OMe]+), 91 (73 %, 
[M-COOMe]+), 59 (100 %, [COOMe]+). Spectroscopic data in agreement with previously 
published data.163  
Di-tert-butyl 2-fluoromalonate (99) 
 
Di-tert-butylmalonate (12.0 g, 55 mmol) and copper nitrate catalyst (1.16 g, 5 mmol) were 
dissolved in acetonitrile (50 mL), placed in a fluorination vessel and the mixture was cooled to 
0-5 °C. After purging the system with N2 for 5 minutes, fluorine gas (20 % v/v in N2, 44 mL/min, 
60 mmol) was introduced for 5 h. The reaction was then purged with nitrogen for 10 minutes, 
the solvent was removed under reduced pressure and the residue was partitioned between 
water (10 mL) and ethyl acetate (25 mL). The aqueous phase was extracted with ethyl acetate 
(25 mL) then the combined organic layer was washed with saturated brine (10 mL). After drying 
over sodium sulphate, the solvent was evaporated under reduced pressure to leave di-tert-butyl 
2-fluoromalonate (12.57 g, 96% yield, 97 % purity) as a colourless liquid; IR (neat, cm-1) 2980, 
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1744, 1369, 1252, 1143; δH (CDCl3, 400 MHz) 1.49 (18H, s, CH3), 5.01 (1H, d, 2JHF 48.9, CHF); δF 
(CDCl3, 376 MHz):  -193.79 (d, 2JHF 48.9, CH-F); δC (CDCl3, 100 MHz) 27.95 (CH3), 84.01 (C-CH3), 
85.97 (d, 1JCF 196.5, C-F), 163.32 (d, 2JCF 24.5, C=O); m/z (EI+) 162 (20 %, [M-OtBu+H]+), 57 (100 
%, [tBu]+). 
7.2.2 Synthesis of 5-fluoropyrimidine derivatives from diethyl fluoromalonate 
5-Fluoro-4,6-dihydroxypyrimidine (60) 
 
Formamidine acetate (2.06 g, 20 mmol) was added to the solution of sodium (1.38 g, 60 mmol) 
in anhydrous ethanol (40 mL) and the mixture was heated to reflux. Diethyl 2-fluoromalonate 
(3.20 g, 18 mmol) was added dropwise over 20 minutes and the mixture was heated at reflux 
for 6 h. After cooling to room temperature, the solution was evaporated to dryness, the residue 
was dissolved in water (20 mL), acidified with HCl (5 mL), the precipitate was filtered, washed 
with water (5 mL), ethanol (2x5 mL) and diethyl ether (2x5 mL). After drying in vacuo, 5-fluoro-
4,6-dihydroxypyrimidine (1.50 g, 64 %) was obtained as a brown powder. m.p.: > 300 °C; ([M+H]+, 
131.0244, C4H4FN2O2 requires: [M]+, 131.0257); IR (neat, cm-1) 3053, 2639, 1633, 1547, 1388, 
1213; δH (DMSO d6, 400 MHz) 7.90 (1H, s, C-H), 12.38 (2H, bs, OH); δF (DMSO d6, 376 MHz): - 
178.06 (s); δC (DMSO d6, 100 MHz) 132.79 (d, 1JCF 235.6, C-F), 144.46 (d, 4JCF 7.7, C-H), 155.83 (d, 
2JCF 15.0, C-OH); m/z (ASAP) 131 (100 %, [M+H]+). 
5-Fluorobarbituric acid (105) 
 
Urea (1.50 g, 25 mmol) was added to the solution of sodium (1.2 g, 53 mmol) in anhydrous 
ethanol (50 mL) and the mixture was heated to reflux. Diethyl 2-fluoromalonate (4.45 g, 25 
mmol) was added dropwise over 10 minutes and the mixture was heated at reflux for 1 h. After 
cooling to room temperature, the solution was filtered, the residue was washed with ethanol 
(20 mL), dissolved in water (30 mL) and acidified with HCl to pH 1. The precipitated product was 
recrystallized from the liquor to afford 5-fluorobarbituric acid (1.87 g, 51 %) as a tan powder. 
m.p.: >300 °C; ([M+H]+, 147.0206, C4H4FN2O3 requires: [M]+, 147.0204); IR (neat,cm-1) 2926, 
2828, 1578, 1383, 1241, 1128;  δF (D2O + NaOD, 376 MHz): - 191.95 (s); δC (D2O + NaOD, 100 
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MHz) 131.89 (d, 1JCF 214.4, C-F), 157.77 (d, 4JCF 6.2, C-NH), 164.59 (d, 2JCF 13.4, C=O); m/z (ASAP) 
147 (25 %, [M+H]+).  
2-Amino-5-fluoro-4,6-dihydroxypyrimidine (106) 
 
Guanidine sulfate (5.95 g, 55 mmol) was added to the solution of sodium (2.50 g, 110 mmol) in 
anhydrous ethanol (100 mL) and the mixture was heated to reflux. Diethyl 2-fluoromalonate 
(8.90 g, 50 mmol, 93 % pure) was added dropwise over 20 minutes and the mixture was heated 
at reflux for 6 h. After cooling to room temperature, the solution was evaporated to dryness, 
the residue was dissolved in water (20 mL), neutralised with HCl to pH 7, the precipitated 
product was filtered, washed with water (5 mL), ethanol (2x5 mL) and diethyl ether (2x5 mL). 
After drying in vacuo, 2-amino-5-fluoro-4,6-dihydroxypyrimidine (6.21 g, 86 %) was obtained as 
a pink powder. m.p.: >300 °C ([M+H]+, 146.0357, C4H5FN3O2 requires: [M]+, 146.0366); IR 
(neat,cm-1) 3343, 3100, 2916, 2731, 1600, 1557, 1415, 1358, 1204; δH (DMSO d6, 400 MHz) 7.00 
(2H, bs, N-H), 11.1 (2H, bs, OH); δF (DMSO d6, 376 MHz): - 197.05 (s); δC (DMSO d6, 100 MHz) 
125.13 (d, 1JCF 208.6, C-F), 149.26 (d, 4JCF 2.3, C-H), 155.12 (d, 2JCF 18.0, C-OH); m/z (ASAP) 146 
(100 %, [M+H]+). 
3-Fluoro-1-H-1,5-benzodiazepine-2,4-dione (107) 
 
o-Phenylenediamine (2.70 g, 25 mmol) was added to the solution of sodium (1.2 g, 53 mmol) in 
anhydrous ethanol (50 mL) and the mixture was heated to reflux. Diethyl 2-fluoromalonate (4.45 
g, 25 mmol) was added dropwise over 10 minutes and the mixture was heated at reflux for 2 h. 
After cooling to room temperature, the solution was filtered, the residue was washed with 
ethanol (20 mL), dissolved in water (30 mL) and acidified with HCl to pH 1. The mixture was 
cooled in ice, filtered, washed with water (2x10mL) and dried in vacuo to afford 3-fluoro-1-H-
1,5-benzodiazepine-2,4-dione (3.23 g, 68 %) as a tan powder. m.p.: >300 °C, ([M+H]+, 195.0567, 
C9H8FN2O2 requires: [M]+, 195.0570); IR (neat,cm-1) 3084, 2951, 1727, 1681, 1500, 1159;  δH 
(DMSO d6, 400 MHz): 5.57 (1H, d, 2JHF 46.4, CHF), 7.15-7.19 (2H, m, Ar-H), 7.22 (2H, dt, 3JHH 6.6, 
4JHH 3.5, Ar-H), 10.81 (2H, bs N-H); δF (DMSO d6, 376 MHz): - 207.99 (d, 2JHF 46.4 C-F); δC (DMSO 
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d6, 100 MHz) 85.12 (d, 1JCF 184.5, C-F), 122.55, 125.52, 128.41, 163.36 (d, 2JCF 23.2, C=O), 164.59 
(d, 2JCF 13.4, C=O); m/z (ASAP) 195 (100 %, [M+H]+), 135 (23 %, [M-COCHF]+).  
7.3 Experimental to Chapter 3. 
7.3.1 Synthesis of progesterone derivatives 
Progesterone enol acetate (121) 
 
Progesterone (14.65 g, 46.5 mmol) was dissolved in the mixture of acetyl chloride (30 mL, 420 
mmol) and acetic anhydride (40 mL, 250 mmol) and was heated to 100 °C for 1 h. After allowing 
the mixture to cool to room temperature, the mixture was concentrated to one third of the 
original volume under reduced pressure at 25 °C when a white precipitate formed. The product 
was filtered and washed with cold acetonitrile (2x10 mL) and dried under vacuum at 35 °C to 
afford progesterone enol acetate (10.74 g, 65 %) as a white solid, mp. 119-123 °C (lit. 130-132 
oC, cryst from methanol)172; ([MH]+, 357.2452. C23H33O3 requires: [M]+, 357.2430); IR (cm-1): 
2939, 1748, 1703, 1365, 1219, 1202, 1188, 1119; 1H NMR (CDCl3, 600 MHz): 0.65 (3H, s, C18H3), 
1.00 (3H, s, C19H3), 1.04-1.10 (1H, m, C9-H), 1.18-1.29 (2H, m, C14H, C15H), 1.30-1.38 (1H, m, 
C1H), 1.43-1.50 (2H, m, C11H, C12H), 1.58-1.73 (5H, m, C11H, C16H, C15H, C7H, C8H), 1.85 (1H, 
dd, 2JHH 12.5, 3JHH 5.5; C1H), 2.03-2.06 (1H, m, C12H), 2.12 (3H, s, C23H3), 2.13 (3H, s, C21H3), 
2.14-2.22 (3H, m, C16H, C2H, C7H), 2.41-2.47 (1H, m, C2H), 2.54 (1H, t, 3JHH 9.0, C17H), 5.39 (1H, 
m, C4H), 5.69 (1H, d, 4JHH 1.9, C6H); 13C NMR (CDCl3,151 MHz): 13.50 (C18), 19.00 (C19), 21.24 
(C23), 21.37 (C11), 22.99 (C16), 24.55 (C15), 24.93 (C2), 31.69 (C2), 31.87 (C7), 31.89 (C8), 33.93 
(C1), 35.04 (C10), 38.96 (C12), 44.24 (C13), 48.02 (C9), 57.16 (C14), 63.83 (C17), 117.08 (C6), 
123.81 (C4), 139.50 (C5), 147.18 (C3), 169.52 (C22), 209.64 (C20).; m/z (ASAP): 357 (15 %, 
[M+H]+), 314 (92 %, [M+H-CH3CO]+), 297 (56 %, [M-CH3COO]+). 
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Progesterone enol acetate (1.50 g, 4.2 mmol) was dissolved in the mixture of acetonitrile (20 
mL) and acetone (30 mL), Selectfluor (1.56 g, 4.4 mmol) was added and the mixture was stirred 
at ambient temperature for 2 hours. Water (150 mL) was added, the precipitate was filtered and 
re-dissolved in ethyl acetate (30 mL). After washing with brine (15 mL) and drying over Na2SO4, 
the solvent was evaporated in vacuum and after column chromatography (silica, hexanes : ethyl 
acetate, 10:1 to 3:1, Rf.: 0.18 in 3:1 mixture) 6-fluoroprogesterone (0.65 g, 46% yield) was 
isolated as a white solid. Crystals suitable for X-ray crystallographic analysis were obtained by 
slow evaporation an acetone solution of 6-fluoroprogesterone. Mp.: 152-156 °C (lit.: 159-161 
oC, from benzene)174, ([MH]+, 333.2204. C21H30FO2 requires: [M]+, 333.2230); IR (cm-1): 2932, 
1700, 1682, 1386, 1355, 1228, 1193, 1161; 1H NMR (CDCl3, 600 MHz): 0.69 (3H, s, C18H3), 0.99 
(1H, td, 2JHH 11.4, 3JHH 3.9, C9H), 1.10-1.27 (2H, m, C7H, C14H), 1.30 (3H, d, 5JFH 1.3, C19H3), 1.30-
1.34 (1H, m, C15H), 1.44 (1H, td, 2JHH 12.7, 3JHH 3.9 Hz, C12H), 1.48-1.54 (1H, m, C11H), 1.62-1.77 
(4H, m, C1H, C11H, C15H, C16H), 1.90-1.94 (1H, m, C8H), 2.05-2.11 (2H, m, C1H, C12H), 2.12 (3H, 
s, C21H3), 2.17-2.24 (2H, m, C11H, C7H), 2.43 (1H, dt, 2JHH 16.9, 3JHH 3.3, C2H), 2.51-2.58 (2H, m, 
C2H, C17H), 4.99 (1H, dt, 2JHF 48.6, 3JHH 2.5, C6HF), 5.87 (1H, d, 4JHF 5.0, C4H); 19F NMR (376 MHz): 
-166.0 (td, 2JHF 47.8, 3JHF 12.6);  13C NMR (CDCl3,151 MHz): 13.45 (C18), 18.53 (C19), 20.98 (C11), 
22.99 (C16), 24.37 (C15), 30.09 (C8), 31.59 (C21), 34.34 (C2), 37.04 (C1), 37.35 (d, 2JFC 23.5, C7), 
37.97 (C10), 38.65 (C12), 44.11 (C13), 53.21 (C9), 55.99 (C14), 63.55 (C17), 93.41 (d, 1JFC 166.0, 
C6), 128.57 (C4), 161.67 (d, 2JFC 12.6, C5), 199.88 (C3), 209.19 (C20); m/z (ASAP): 333 (100%, 
[M+H]+), 313 (98%, [M-F]+), .  
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-Fluoroprogesterone (0.65 g, 1.9 mmol) was dissolved in glacial acetic acid (25 mL) and dry 
HCl gas was bubbled into the solution for 1.5 hours (approx. 20 bubbles/min). The solvent was 
evaporated and the crude product (19:1 ) was recrystallized from methanol (5mL) to give 
6-fluoroprogesterone (0.48 g, 74% yield) as colourless needles. Mp.: 144-147 oC (lit.: 146-148, 
from acetone-hexane)174; IR (cm-1): 2948, 1700, 1680, 1357, 1269, 1225, 1186, 1059; 1H NMR 
(CDCl3, 600 MHz): 0.66 (3H, s, C18H3), 0.99 (1H, m, C9H), 1.18 (3H, d, C19H3), 1.23-1.33 (3H, m, 
C7H, C14H, C15H), 1.39-1.46 (2H, m, C11H, C12H), 1.56-1.62 (1H, m, C8H), 1.62-1.67 (1H, m, 
C11H), 1.67-1.76 (2H, m, C15H, C16H), 1.76-1.82 (1H, m, C1H), 2.03-2.10 (2H, m, C1H, C12H), 
2.12 (3H, s, C21H3), 2.16-2.22 (1H, m, C16H), 2.26-2.32 (1H, m, C7H), 2.35-2.39 (1H, m, C2H), 
2.44 (1H, td, 2JHH 14.5, 3JHH 3.4, C2H), 2.54 (1H, t, 3JHH 8.5, C17H), 5.09 (1H, ddd, 2JFH 47.9, 3JHH 
12.3, 3JHH 5.6, C6HF), 6.09 (1H, s, C4H); 19F NMR (376 MHz): - 183.37 (ddd, 2JFH 47.9, 3JHH 12.3, 3JHH 
5.6, C6HF);  13C NMR (CDCl3,151 MHz): 13.41 (C18), 18.20 (C19), 21.03 (C11), 22.96 (C16), 24.47 
(C15), 31.60 (C21), 33.52 (C8), 33.83 (C2), 36.42 (C1), 38.48 (d, 2JFC 17.7, C7), 38.49 (C12), 39.24 
(C10), 44.00 (C13), 53.56 (C9), 55.74 (C14), 63.41 (C17), 88.22 (d, 1JFC 183.9, C6), 119.88 (d, 3JCF 
14.8 C4), 165.80 (d, 2JFC 11.2, C5), 198.79 (C3), 209.09 (C20); m/z (ESI): 333 (100 %, [M+H]+). 
Direct fluorination of progesterone enol acetate 
Progesterone enol acetate (1.07 g, 3.0 mmol) was dissolved in formic acid (98 %, 30 mL) in a 100 
mL glass fluorination reactor and cooled to 0-5 oC in a water bath. The solution was purged with 
nitrogen for 5 minutes (20 mL/min) then fluorine (10 % v/v in nitrogen, 20 mL/min) was 
introduced for 50 minutes (1.4 equivalents), the initially colourless solution turned yellow. After 
the fluorination, the vessel was purged with nitrogen, the contents transferred to a round 
bottomed flask and evaporated to dryness to leave a yellow, viscous oil behind (1.02 g). The 
product was dissolved in acetonitrile (25 mL) in a volumetric flask, a 1 mL aliquot was diluted 
twentyfold and analysed by HPLC-UV. 
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7.3.2 Direct fluorination of aromatic systems 
Direct fluorination of 4-fluorobenzonitrile (small scale screening) 
 
Method A: 4-Fluorobenzonitrile (1.22 g, 10 mmol) was dissolved in sulfuric acid (98 %, 20 mL) in 
a 100 mL glass fluorination reactor and cooled in a 0 oC water bath. The solution was stirred 
vigorously and purged with nitrogen for 5 minutes before the fluorine flow (40 mL/min, 10 
mmol/h) was initiated. Fluorine was introduced for the desired time (between 1.5 and 4.5 hours) 
then the mixture was purged with nitrogen and poured in ice (100 g). The precipitated product 
was filtered, washed with water (10 mL) and dried under vacuum. The dry product was analysed 
by 1H and 19F NMR spectroscopy. 19F NMR (DMSO d6, 376 MHz): - 103.18 (tt, 3JHF 8.9, 4JHF 5.3 Hz) 
for 4-fluorobenzamide and - 128.81 (dddd, 3JFF 22.6, 3JHF 10.5, 4JHF 7.6 5JHF 4.3 Hz), - 135.51 (dddd, 
3JFF 22.6, 3JHF 10.6, 4JHF 8.0, 5JHF 1.4 Hz) for 131.  
Method B: 4-Fluorobenzonitrile (1.22 g, 10 mmol) was dissolved in formic acid (98 %, 20 mL) in 
a 100 mL glass fluorination reactor and cooled in a 0 oC water bath. The solution was stirred 
vigorously and purged with nitrogen for 5 minutes before the fluorine flow (40 mL/min, 10 
mmol/h) was initiated. Fluorine was introduced for the desired time (between 1.5 and 4.5 hours) 
then the mixture was purged with nitrogen and poured into water (100 mL) and extracted with 
ethyl acetate (2x30 mL). The combined organic fractions were washed with water (20 mL) and 
brine (20 mL) and dried over Na2SO4. After evaporation of the solvent in vacuum, the product 
was obtained as a dark oil and was analysed by 1H and 19F NMR spectroscopy. 
 Direct fluorination of 4-fluorobenzonitrile (larger scale) 
 
4-Fluorobenzonitrile (4.85 g, 40 mmol) was dissolved in concentrated sulfuric acid (50 mL, 98 %) 
in a 250 mL fluorination reactor equipped with a mechanical overhead stirrer. The mixture was 
placed in a room temperature (20 oC) water bath, purged with nitrogen for 5-10 minutes then 
fluorine (20 %v/v in nitrogen) was introduced for 3 hours (80 mL/min, 40 mmol/h, 120 mmol). 
The reactor was purged free of fluorine with nitrogen (10-15 minutes) and the mixture was 
poured into ice (350 g). A small amount of precipitate was formed, filtered then concentrated 
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ammonia solution (28 %, 100 mL) was added in small portions to precipitate the product. After 
filtration, the solid was washed with water (50 mL) and dried in vacuum to afford a brown 
powder (3.9 g). The solid was analysed by 1H and 19F NMR spectroscopy then 1 g samples were 
recrystallized from ethanol (1 mL), aqueous ethanol (5 mL of 1:1 mixture) and 
methylcyclohexane (5 mL). The crystallised solids were filtered, dried and analysed by 1H and 19F 
NMR spectroscopy. 
Direct fluorination of 4-fluorobenzoic acid 
 
4-Fluorobenzoic acid (14.0 g, 100 mmol) was dissolved in concentrated sulfuric acid (60 mL, 98 
%) in a 250 mL fluorination reactor equipped with a mechanical overhead stirrer. The mixture 
was placed in a cooled (0-5 oC) water bath, purged with nitrogen for 5-10 minutes then fluorine 
(20 %v/v in nitrogen) was introduced for 5 hours (80 mL/min, 40 mmol/h, 0.2 mol). The reactor 
was purged free of fluorine with nitrogen (10-15 minutes) and the mixture was poured on ice 
(500 g). The precipitate was filtered, the solid dissolved in ethyl acetate (200 mL), the residual 
water was separated and the organic phase was dried on Na2SO4. The solvent was evaporated 
under vacuum to leave the crude product (13.8 g) as a tan solid which was analysed by NMR 
spectroscopy. 19F NMR (CDCl3, 378 MHz): - 103.90 – (- 103.98) (1F, m, 4-fluorobenzoic acid); - 
128.37 – (- 128.50) (0.6 F, m, 3,4-difluorobenzoic acid), - 135.94 – (- 136.09) (0.6 F, m, 3,4-
difluorobenzoic acid). The solid was suspended in methanol (80 mL), concentrated sulfuric acid 
was added (2 mL) and the mixture was heated to reflux for 16 hours. After cooling to room 
temperature, the solvent was removed in vacuum, the residue was dissolved in ethyl acetate 
(100 mL), washed with saturated NaHCO3 solution (2x30 mL) and water (30 mL) then dried on 
Na2SO4 and evaporation of the solvent gave a crude product (11.6 g) as a brown oil and 11.46 g 
was transferred to the Fisher Spaltrohr® distillation equipment. After evacuating the equipment 
to 19 mbar pressure, the reflux valve was closed and the mixture was refluxed in the column for 
an hour to equilibrate the mixture. The collection of the distillate was started at approximately 
10 drops/minute speed with a reflux ratio of 1:5 to 1:10. After collecting eight, approximately 1 
mL samples the distillation was terminated and all fractions were analysed by NMR spectroscopy 
to determine the composition of the fractions. 19F NMR (CDCl3, 378 MHz): - 105.87 (1F, t, 3JHF 7.4 
Hz, methyl 4-fluorobenzoate), - 130.38 (0.6 H, dd, 3JFF 21.0, 3JHF 10.5 Hz, methyl 3,4-
difluorobenzoate), - 136.62 (dt, 3JFF 21.0, 3JHF 8.9 Hz, methyl 3,4-difluorobenzoate). 
Chapter 7.: Experimental 
136 
 








Fraction mass  
/ g 
Starting mixture 59 37 4 11.46 
Fr. 1 66 33 1 0.95 
Fr. 2 66 33 1 1.08 
Fr. 3 66 33 1 1.1 
Fr. 4 65 33 2 1.03 
Fr. 5 65 33 2 1.02 
Fr. 6 66 33 1 1.38 
Fr. 7 65 34 1 1.16 
Fr. 8 64 34 2 1.69 
Residue 52 36 12 1.27 
 
Direct fluorination of 4-fluoronitrobenzene (high conversion) 
 
4-Fluoronitrobenzene (5.71 g, 40 mmol) was dissolved in sulfuric acid (50 mL) in a 250 mL batch 
fluorination reactor, placed in a room temperature water bath and purged with nitrogen for 5 
minutes. Fluorine (20 % v/v in nitrogen, 80 mL/min, 40 mmol/h) was introduced to the vigorously 
stirred mixture (650 rpm) for 4.5 hours then the reactor was purged free from fluorine with 
nitrogen (15 minutes) and poured in ice water (200 mL).  
Workup A: The product was extracted into ethyl acetate (2x50 mL), washed with saturated 
NaHCO3 solution (50 mL), water (50 mL) and brine (50 mL) then dried over Na2SO4. Evaporation 
of the solvent under vacuum afforded a brown oil (5.42 g, 5.50 g and 5.46 g from three identical 
batches).  
Workup B: The aqueous mixture was further diluted with water and was set up for distillation. 
Water was distilled out from the mixture until only one phase was observed in the distillate 
(approximately 150 mL) then extracted with ethyl acetate (40 mL), dried on Na2SO4 and 
evaporated under reduced pressure to afford a clear yellow oil (4.10 g). 
Four separate batches were analysed by 19F NMR and GC-MS then combined and distilled under 
reduced pressure (65-70 oC at 1 mbar), 7 fractions were collected. Products were identified by 
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their 19F NMR shifts: 4-fluoronitrobenzene (- 102.03 ppm)209, 3,4-difluoronitrobenzene (- 126.6 
ppm, - 133.0 ppm)90, 3,4,5-trifluoronitrobenzene (- 130.66 ppm (2F), - 150.24 ppm (1F))210.  
Table 36: Fraction from the distillation of crude 3,4-difluoronitrobenzene. 









1 1.87 5 80 7 8 
2 1.82 7 78 3 12 
3 1.76 8 77 2 13 
4 1.88 9 76 2 13 
5 1.68 10 75 1 14 
6 1.54 13 72 0 15 
7 0.76 17 65 0 18 
 
Direct fluorination of 4-fluoronitrobenzene (low conversion) 
 
4-Fluoronitrobenzene (14.1 g, 100 mmol) was dissolved in sulfuric acid (70 mL) in a 250 mL batch 
fluorination reactor, placed in 0 oC water bath and purged with nitrogen for 5 minutes. Fluorine 
(20 % v/v in nitrogen, 80 mL/min, 40 mmol/h) was introduced to the vigorously stirred mixture 
(650 rpm) for 5 hours (200 mmol F2) then the reactor was purged free from fluorine with 
nitrogen (15 minutes) and poured in ice water (300 mL). Two separate batches were combined, 
extracted with ethyl acetate (3x100 mL), washed with saturated NaHCO3 solution (100 mL), 
water (100 mL) and brine (100 mL). After drying over Na2SO4, the solvent was removed under 
reduced pressure, the product filtered through a pad of Celite to remove insoluble tarry material 
to give a dark oil (17.7 g). The product was distilled using the Fischer Spaltrohr® column (20 
mbar, 88-90 oC) to afford 7 fractions (12.59 g in total) that were analysed using 19F NMR 
spectroscopy. 
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Table 37: Composition of distillate fractions as determined by 19F NMR spectroscopy. 









1 1.75 17 78 5 trace 
2 2.11 38 60 1 1 
3 1.75 46 52 trace 2 
4 2.09 52 47 trace 1 
5 1.58 56 42 trace 2 
6 1.7 61 37 trace 2 
7 1.61 66 32 trace 2 
 
Direct fluorination of 4-fluoronitrobenzene – solvent screen  
 
4 –Fluoronitrobenzene (14.1 g, 100 mmol) was dissolved in the appropriate solvent or solvent 
mixture (70 mL), cooled to 0-5 oC and purged with nitrogen or 5 minutes. Fluorine (20 % v/v, 80 
mL/min) was introduced into the mixture for 5 hours (2 equivalents), then the mixture was 
purged with nitrogen to remove traces of fluorine. The mixture was poured into water (250 mL) 
and extracted with ethyl acetate (3x50 mL). The combined organic phases were washed with 
saturated NaHCO3 solution (2x30 mL) and brine (30 mL) then dried over Na2SO4. After 
evaporation of the solvent in vacuum, the crude product was treated to remove tar and analysed 
by 19F NMR spectroscopy to determine composition.  
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Table 38: Composition of isolated product in the solvent screening experiments. 
 






H2SO4 0 °C Extraction Vac. dist. 11.60 g 
56 % B, 40 % A, 
4% others 
H2SO4 0 °C Extraction Vac. dist. 11.56 g 




-10 °C extraction Kugelrohr 4.57 g 




-10 °C Evaporation Steam dist. 7.00 g 
14 % A, 70 % B, 4 
% C, 9 % other 
monofluoro(!), 3 
% other 
MeCN -10 °C evaporation Vac. Dist. 3.07 g 
63 % A, 34 % B, 
3% others* 
MeCN -10 °C evaporation Steam dist.  10.90 g 




-10 °C evaporation 
Steam dist. 
(in) 
8.02 g 95 % A, 5 % B 
H2SO4/MeOH 
1/9 
-10 °C evaporation 
Steam Dist. 
(in) 
10.26 g 96 % A, 4 % B 
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7.4 Experimental to Chapter 4. 
7.4.1 Synthesis of cytosine (141) 
 
Urea (15.6 g, 0.26 mol) and sodium ethoxide (16.3 g, 0.24 mol) were suspended in m-xylene 
(60.0 g) in a 250 mL three necked flask equipped with overhead stirrer and the mixture was 
heated in a 130 °C oil bath (reflux of xylene-ethanol azeotrope). Cyanoacetaldehyde diethyl 
acetal (28.6 g, 0.20 mol) was added over 1 hour via a syringe pump and the mixture was refluxed 
(difficult to stir, yellow slurry). After 1.5 hours, the condenser was replaced by a distillation head 
and ethanol was distilled until the head temperature reached 90 °C. By this point 27.2 g distillate 
was collected. After the mixture was allowed to cool below 80 °C, water (50 mL) was added to 
dissolve all solids. The phases were separated and the aqueous phase was cooled in ice while 
acetic acid (13.7 mL, 14.4 g, 0.24 mol) was added in small portions (yellow precipitate forms). 
After filtration, the solid was washed with water (2x10 mL) and dried in vacuum at 40 °C to leave 
cytosine (19.8 g, 89 %) as a yellow solid. 1H NMR (400 MHz, D2O + DCl): 6.02 (1H, d, 3JHH 7.5 Hz, 
C5-H);. 7.60 (1H, d, 3JHH 7.5 Hz, C6-H); 13C NMR (101 MHz, D2O + DCl): 93.9 (C5-H), 146.17 (C5-H), 
149.29 (C2=O), 160.15 (C4-NH2); in agreement with the literature values211. 
7.4.2 Batch fluorination – typical procedure 
Cytosine (1.11 g, 10 mmol) was dissolved in formic acid (25 mL) and was kept at 20 °C in a water 
bath. Fluorine (10 % in N2) was introduced to the vigorously stirred solution at 25 mL/min (7.5 
mmol / h) for 160 minutes (2 equivalents of fluorine). The mixture was purged with nitrogen to 
remove traces of fluorine, the solvent was removed in vacuo and the residue was recrystallized 
from water (10 mL) to yield 5-fluorocytosine (0.49 g, 38 % yield) as a tan crystalline solid. M.p.: 
295 - 300 °C (decomposes), ([M]+ 129.0337, [M]+ requires: 129.0338); IR (cm-1): 3384, 3092, 
2724, 1665, 1624, 1551, 1454, 1216; 1H NMR (400 MHz, D2O+DCl) 7.83 (1H, d, 3JHF 4.8 Hz); 19F 
NMR (400 MHz, D2O+DCl) -169.7 (1F, d, 3JHF 4.8 Hz); 13C NMR (100 MHz, D2O+DCl): 130.67 (d, 2JCF 
29.6 Hz), 135.25 (d, 1JCF 232 Hz), 147.88, 153.65 (d, 2JCF 23.4 Hz); MS (ASAP): 111 (37 %, [M+H-
F]+), 129 (8 %, [M]+), 130 (100 %, [M+H]+); all analytical data identical with that of a commercial 
sample. 
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7.4.3 Small scale continuous fluorination 
Continuous flow fluorination: ideal conditions for microreactor 
 
A 1 M stock solution of cytosine in formic acid was prepared and used for fluorinations. The 
solution was introduced to the microreactor at 2 mL/h (2 mmol/h) while the flow of fluorine was 
set according to Table 16. Fractions were collected for 120 minutes, the solvent was evaporated 
and the product was recrystallized from water (5 mL). The product was filtered, dried in vacuo 
and analysed using 1H and 19F NMR spectroscopy. 
Synthesis of Flucytosine in the microreactor 
 
1 M cytosine solution was introduced at 2 mL/h while fluorine (10 % in N2) was introduced at 15 
mL/min (3.75 mmol/h). The reaction was conducted for 12 minutes, the collected fraction was 
evaporated and recrystallised from water (4 mL). The crystallised product was filtered and dried 
to afford tan crystals of 5-fluorocytosine (0.27 g, 52 % yield, 99 % purity). 
Synthesis of Flucytosine in the stainless steel tube reactor 
 
1.0 M cytosine solution in formic acid was introduced at 4.0 mL/h (4.0 mmol/h) while fluorine 
(10 % in N2) was introduced at 20 mL/min (5 mmol/h). The reaction was conducted for 90 
minutes, the collected fraction was evaporated and the residue was recrystallized from water (7 
mL). After filtration, the product was dried under reduced pressure to afford 5-fluorocytosine 
(0.49 g, 63 % yield, 99%+ pure) as a tan powder.  
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7.4.4 Scale-up of the continuous flow fluorination of cytosine 
Fluorination in Boostec SiC reactor: typical procedure 
Cytosine solution in formic acid (10 wt%, 600 g/h) and fluorine (10 vol. % in nitrogen, 204 g/h) 
were passed through the SiC reactor at 10 oC and after reaching steady state (15 minutes) the 
product liquid phase was collected for 60 minutes to yield a yellow solution (620 g). To this 
solution n-butanol (1000 g, 1.23 L) was added in five portions (no exotherm observed) and the 
mixture was stirred at room temperature overnight. After filtration, the solid was washed once 
with n-butanol (60 mL) and dried in air to leave Flucytosine (58.0 g, 99.8 % by HPLC, 83 % yield). 
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Results of direct fluorinations in the Boostec® reactor 
After adjusting reaction conditions, the reaction was allowed to stabilise for ten minutes then 
sampled for HPLC analysis to determine conversion and selectivity. 
 















10 8.9 600 181 1.3 99.4 92.0 2.1 bar 
20 8.9 600 181 1.3 99.0 92.2 1.9 bar 
30 8.9 600 181 1.3 89.9 91.7 1.7 bar 
10 11.0 600 194 1.1 97.6 92.6 2.3 bar 
20 11.0 600 194 1.1 82.1 92.7 2.2 bar 
30 11.0 600 194 1.1 69.0 93.2 2.0 bar 
10 8.9 600 181 1.3 99.6 92.2 2.2 bar 
20 8.9 600 181 1.3 98.0 92.4 
2.3 bar with 0.3 
bar back pressure 
30 8.9 600 181 1.3 61.9 95.0 
2.4 bar with 0.9 
bar back pressure 
30 8.9 600 153 1.1 68.1 94.6 1.5 bar  
30 8.9 600 153 1.1 61.9 95.0 
2.4 bar with 0.9 
bar back pressure 
30 8.9 600 153 1.1 20.5 94.6 
4.5 bar with 3.0 
bar back pressure 
30 8.9 600 153 1.1 18.6  
4.8 bar with 3.3 
bar back pressure 
10 12.0 600 206 1.1 88.2 93.5 2.5 bar  
10 12.0 600 206 1.1 83.2 93.1 
3.0 bar with 0.5 
bar back pressure 
10 12.0 600 206 1.1 80.1 93.3 
3.7 bar with 1.2 
bar back pressure 
10 12.0 600 206 1.1 61.1 93.2 
4.3 bar with 1.8 
bar back pressure 
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10 8.9 600 153 1.1 87.5 94.2 1.8 bar  
10 8.9 600 153 1.1 83.0 94.0 
2.7 bar with 0.9 
bar back pressure 
10 8.9 600 153 1.1 78.3 93.9 
4.0 bar with 2.2 
bar back pressure 
10 6.0 600 103 1.1 98.7 94.7 1.3 bar  
10 6.0 600 103 1.1 90.9 94.5 
2.5 bar with 1.2 
bar back pressure 
10 6.0 600 103 1.1 89.6 94.6 
3.0 bar with 1.8 
bar back pressure 
10 8.9 600 181 1.3 99.6 92.2 2.2 bar  
20 8.9 600 181 1.3 98.0 92.4 
2.3 bar with 0.3 
bar back pressure 
30 8.9 600 181 1.3 61.9 95.0 
2.4 bar with 0.9 
bar back pressure 
10 8.9 600 181 1.3 99.5 92.1 
2.1 bar inlet 
pressure 
10 8.9 900 272 1.3 99.1 91.6 
3.3 bar inlet 
pressure 
10 8.9 1000 303 1.3 99.7 92.1 
3.6 bar inlet 
pressure 
10 8.9 1200 363 1.3 99.7 92.3 
4.5 bar inlet 
pressure 
10 8.9 600 157 1.1 90.6 93.0 
1.8 bar inlet 
pressure 
10 8.9 800 209 1.1 94.7 93.2 
2.6 bar inlet 
pressure 
10 8.9 1000 263 1.1 91.6 93.4 
3.3 bar inlet 
pressure 
10 8.9 1200 313 1.1 92.3 93.2 
4.0 bar inlet 
pressure 
10 8.9 600 181 1.3 99.5 92.1 
2.1 bar inlet 
pressure 
10 8.9 1400 367 1.1 91.5 92.7 
4.8 bar inlet 
pressure 
 



















10 6.0 600 122 1.3 98.0 92.6 1.4 bar 
10 7.0 600 143 1.3 99.0 93.2 1.5 bar 
10 8.0 600 163 1.3 99.8 92.5 1.9 bar 
10 9.0 600 184 1.3 99.4 92.6 2.0 bar 
10 10.0 600 204 1.3 99.7 92.3 2.3 bar 
10 11.0 600 224 1.3 99.6 91.4 2.6 bar 
10 8.9. 600 133 1.0 58.6 94.0 1.8 bar 
10 8.9 600 157 1.1 88.5 93.3 1.9 bar 
10 8.9 600 181 1.3 99.7 92.8 2.1 bar 
10 8.9 600 206 1.5 99.8 91.4 2.3 bar 
10 11.0 600 179 1.0 86.2 93.0 2.1 bar 
10 11.0 600 194 1.1 97.0 92.6 2.3 bar 
10 11.0 600 209 1.2 99.7 92.1 2.4 bar 
10 11.0 600 224 1.3 99.6 91.4 2.6 bar 
 
  




To a sample (500 L) of a crude reaction mixture, from the fluorination of an 8.9 % cytosine 
solution in formic acid with 1.5 equivalents of fluorine, a known volume of the anti-solvent was 
added in a 2 mL Eppendorf vial, the sample shaken then allowed to stand overnight at 4 oC. The 
samples then were centrifuged for 5 minutes at 10000 rpm and a 250 L sample of the 










FC mass in 
solution / mg 
Solid 
purity / % 
30 % NaOH 0.250 0.750 39.9 29.9 - 
30 % NaOH 0.375 0.875 19.5 17.1 - 
30 % NaOH 0.500 1.000 9.6 9.6 - 
30 % NaOH 0.625 1.125 5.8 6.5 - 
30 % NaOH 0.750 1.250 4.4 5.5 - 
30 % NaOH 0.875 1.375 6.1 8.4 99.0 
Acetone 0.500 1.000 51.1 51.1 - 
Acetone 0.750 1.250 39.0 48.8 - 
Acetone 1.000 1.500 33.4 50.1 - 
Acetone 1.250 1.750 30.0 52.5 99.5 
Acetone 1.500 2.000 20.8 41.6 99.4 
n-Butanol 0.250 0.750 63.9 47.9 - 
n-Butanol 0.500 1.000 24.3 24.3 - 
n-Butanol 0.750 1.250 10.3 12.9 - 
n-Butanol 1.000 1.500 6.6 9.9 - 
n-Butanol 1.250 1.750 2.3 4.0 99.6 
n-Butanol 1.500 2.000 2.0 4.0 99.4 
i-Propanol 0.500 1.000 27.5 27.5 - 
i-Propanol 0.750 1.250 13.3 16.6 - 
i-Propanol 1.000 1.500 11.6 17.4 - 
i-Propanol 1.250 1.750 5.2 9.1 99.5 
i-Propanol 1.500 2.000 2.2 4.4 99.5 
Water 0.750 1.250 54.5 68.1 - 
Water 1.500 2.000 38.6 77.2 - 
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7.4.4 Literature syntheses for metrics calculations 
Literature synthesis of 5-Fluorouracil (5)189 
 
Experimental procedure (US 3954758): “To a Teflon lined reactor equipped with gas bubblers, 
demineralised water (3.78 L) and uracil (454 g) were added. While bubbling nitrogen through 
the system (260 mL/min), the slurry was heated by an internal Teflon coil to 50-60 oC. Fluorine 
flow was started at 0.354 g/min from each of four bubblers. As the temperature started to rise, 
water at 0 oC was passed through the internal coil. The temperature was maintained between 
60-70 oC throughout the reaction. The addition of fluorine was stopped after 221 g (5.81 mol) 
were added. The resultant clear solution was removed from the reactor, filtered then cooled to 
about 0 oC for 18 hours. The white crystalline product was removed by filtration, washed with 
ice water and dried yielding 192 g of uracil fluorohydrin monohydrate (C4H7FN2O4). The uracil 
fluorohydrin monohydrate was divided in two parts, placed in a pyrex vessel and conc. HCl (100 
mL) was added to each. The slurry was heated between 90-100 oC for about 15 minutes. After 
cooling to 0 oC, the white solid was removed by filtration and washed with cold water (assume 
50 mL). Several runs were combined (assumed 3 identical batches), 425 g, slurried in 
demineralised water (assume 500 mL), filtered then dissolved in demineralised water (3.79 L) at 
95-100 oC. The solution was passed through a column of 20 g of activated carbon. The product 
was crystallised at 0 oC, removed by filtration and dried at 100 oC yielding 335 g pure (99 %+) 5-
fluorouracil.” 
Literature synthesis of 2,4-dichloro-5-fluoropyrimidine (142)178 
 
Experimental procedure (US3040026): “A mixture of 5-fluorouracil (104 g, 0.8 mol) and N,N-
dimethylaniline (166 g, 1.37 mol) in POCl3 (1472 g, 9.6 mol) was heated to reflux for two hours. 
After cooling to room temperature, POCl3 was removed under reduced pressure (18-22 mmHg, 
22-37 oC). The residue was then poured into a vigorously stirred mixture of diethyl ether (500 
mL) and ice (500 g). After separating the ether layer, the aqueous layer was extracted with ether 
(500 mL then 200 mL). The combined fractions were dried over sodium sulfate, filtered and the 
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ether removed by vacuum distillation (10-22 0C). The residue, a yellow solid melting at 37-38 oC, 
weighed 120 g, corresponding to 90% yield. Vacuum distillation of 115 g of this material (74-80 
0C, 16 mmHg) gave a white solid (108 g, 84.5 %) melting at 38-39 oC.” 
Literature synthesis of 4-amino-2-chloro-5-fluoropyrimidine (143)178 
 
Experimental procedure (US3040026): “To a solution of 2,4-dichloro-5-fluoropyrimidine (10.0 g, 
0.06 mol) in ethanol (100 mL), concentrated ammonia solution (25 mL) was slowly added. A 
slightly opalescent solution resulted. The temperature gradually rose to 35 oC, the solution was 
then cooled in ice to 18 oC and thereafter remained below 30 oC. After three hours, a Volhard 
titration showed that 0.0545 mol of chlorine was present in ionic form. Storage in a refrigerator 
overnight resulted in some crystallisation of ammonium chloride. A white sludge, resulting from 
the evaporation of the reaction mixture at 40 oC, was slurried with water (75 mL), filtered and 
washed free of chloride (assume another 50 mL water). After drying in vacuo, the product 
melted at 196.5-197.5 oC, yield 6.44 g. Evaporation of the mother liquors yielded a second crop 
of 0.38 g, raising the total yield to 6.82 g (79.3 %).” 
Literature synthesis of 5-fluorocytosine (6)178 
 
Experimental procedure (US3040026): “A slurry of 2-chloro-4-amino-5-fluoropyrimidine (34.0 g, 
0.231 mol) in concentrated hydrochloric acid (231 mL) was heated in a water bath at 93-95 oC 
for 125 minutes. The reaction was followed by means of ultraviolet spectrophotometry using 
the absorption at 245, 285 and 300 m as a guide. The absorption at 300 m rose to a maximum 
after 120 minutes and then dropped slightly. The clear solution was cooled to 25 oC in an ice 
bath then evaporated to dryness under vacuum at 40 oC. After slurrying with water three times 
(assume 3x20 mL) and re-evaporating, the residue was dissolved in water (100 mL). To this 
solution, concentrated ammonia (29 mL) was added dropwise, the resulting precipitate was 
filtered, washed free of chloride with water (assume 50 mL), then with alcohol (assume ethanol, 
25 mL) and ether (assume diethyl ether, 25 mL). After drying in vacuo at 65 oC, the product 
Chapter 7.: Experimental 
149 
 
weighed 22.3 g. An additional 6.35 g was obtained by evaporation of the mother liquor, thus 
yielding a total of 28.65 g (96 %).” 
 
7.5 Experimental to Chapter 5. 
7.5.1 Synthesis of acyl Meldrum’s acid derivatives 
5-Benzoyl-2,2-dimethyl-1,3-dioxane-4,6-dione (157) - general procedure 
 
Meldrum’s acid (14.4 g, 100 mmol) and DMAP (24.4 g, 200 mmol) were dissolved in acetonitrile 
(250 mL) and cooled in ice-water. Benzoyl chloride (14.1 g, 11.5 mL, 100 mmol) was dissolved in 
acetonitrile (50 mL) and added dropwise over 40 minutes. The mixture was stirred overnight 
then 1M HCl (200 mL) was added, the mixture stirred for 5 minutes (clear solution) and was 
concentrated to approximately 150 mL under vacuum. The precipitated product was filtered, 
washed with water (15 mL) and dried in vacuum to yield 5-benzoyl-2,2-dimethyl-1,3-dioxane-
4,6-dione (22.5 g, 90 % yield) as a yellow solid. Mp. 95-97 °C (with decomposition) (lit. 103-104 
oC, from acetone)212, ([M-H]-, 247.0605. C13H11O5 requires: [M]+, 247.0606); IR (cm-1): 2998, 1736, 
1652, 1549, 1379, 1201, 1136; 1H NMR (400 MHz, CDCl3): 1.84 (6H, s, CH3), 7.47 (2H, t, 3JHH 7.9, 
C3-H), 7.60 (1H, tm, 3JHH 7.5, C4-H), 7.66-7.69 (2H, m, C2-H), 15.47 (1H, bs, OH); 13C NMR (100 
MHz, CDCl3): 26.91 (CH3), 91.06 (C(CH3)2), 106.11 (C=COH), 128.17 (C3-H), 129.58 (C2-H), 132.82 
(C1-C), 133.44 (C4-H), 159.90 (C=COH), 171.09 (C=O), 189.37 (C=O). m/z (ESI): 247 [M-H]- , 207 
(100 %, [M-C3H5]-). 
5-(3-Nitrobenzoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (158) 
 
3-Nitrobenzoyl chloride (9.27 g, 50 mmol) was reacted according to the general procedure to 
afford 5-(3-nitrobenzoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (12.46 g, 85 % yield) as a yellow 
solid. Mp.: 87-89 oC; ([M-H]-, 292.0443. C13H10NO7 requires: [M]+, 292.0457); IR (cm-1): 3083, 
2951, 1742, 1671, 1526, 1346, 1199; 1H NMR (600 MHz, CDCl3): 1.86 (6H, s, CH3), 7.67 (1H, t, 3JHH 
8.0, C5-H), 7.96 (1H, dm, 3JHH 8.0, C6-H), 8.43 (1H, dm, 3JHH 8.0, C4-H), 8.49 (1H, m, C2-H); 13C 
NMR (151 MHz, CDCl3): 27.12 (CH3), 92.05 (C(CH3)2), 105.82 (C=COH), 124.56 (C2-H), 127.35 (C4-
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H), 129.35 (C5-H), 134.42 (C6-H), 135.10 (C1-C), 147.88 (C3-NO2), 159.46 (C=COH), 170.91 (C=O), 
186.51 (C=O). m/z (ESI): 292 (100 %, [M-H]-). 
5-(3-Trifluoromethylbenzoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (159) 
 
3-Trifluoromethylbenzoyl chloride (6.25 g, 4.52 mL, 30 mmol) was reacted according to the 
general procedure to afford 5-(3-trifluoromethyl-benzoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione 
(8.18 g, 86 % yield) as a yellow solid. Mp. 102-104°C, ([M-H]-, 315.0480 C14H10F3O5 requires: [M-
H]-, 315.0487); IR (cm-1) 3000, 1734, 1560, 1136, 1075; 1H NMR (400 MHz, CDCl3): 1.85 (6H, s, 
CH3), 7.60 (1H, t, 3JHH 7.9 Hz, C5-H), 7.82-7.84 (1H, m, Ar), 7.84-7.85 (1H, m, Ar-H), 7.91 (1H, s, 
C2-H), 15.62 (1H, bs, OH); 19F NMR (376 MHz, CDCl3): - 62.81 (s, 3F, CF3); 13C NMR (101 MHz, 
CDCl3): 26.92 (CH3), 91.56 (C(CH3)2), 106.43 (CH=COH), 123.48 (q, 1JCF 273 Hz, CF3), 126.22 (q, 3JCF 
3.9 Hz, C4-H), 128.60 (C5-H), 129.56 (q, 3JCF 3.6 Hz, C2-H), 130.79 (q, 2JCF 33.1 Hz, C3-CF3), 132.74 




4-Methoxybenzoyl chloride (5.12 g, 30 mmol) was reacted according to the general procedure 
to afford 5-(4-methoxybenzoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (3.36 g, 40 % yield) as a 
yellow solid after recrystallisation from acetone (20 mL). Mp. 99-102 oC (lit. 111-112 oC)212; ([M-
H]-, 277.0712 C14H13O6 requires: [M]+, 277.0712); IR (cm-1): 3057, 2981, 2847, 1733, 1599, 1505, 
1377, 1263, 1133; 1H NMR (400 MHz, CDCl3): 1.84 (6H, s, CH3), 3.89 (3H, s, OCH3), 6.95 (2H, d, 
3JHH 8.8, C3-H), 7.74 (2H, d, 3JHH 8.8, C2-H), 15.48 (1H, bs, OH); 13C NMR (101 MHz, CDCl3): 26.85 
(CH3), 55.69 (OCH3), 89.78 (C(CH3)2), 104.81 (C=COH), 113.64 (C3-H), 124.64 (C2-H), 132.61 (C1-
C), 160.54 (C4-OCH3), 164.44 (C=COH), 171.30 (C=O), 188.33 (C=O). m/z (ESI): 277 (100%, [M-H]-
) , 175 (89 %, [M-CH3COCH3-CO2]-). 
5-(4-Fluorobenzoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (161) 
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4-Fluorobenzoyl chloride (4.76 g, 30 mmol) was reacted according to the general procedure to 
afford 5-(4-fluorobenzoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (4.83 g, 60 % yield) as a white 
solid after recrystallization from acetone. Mp. 97-100 °C, ([M-H]-, 265.0526 C13H10FO5 requires: 
[M-H]-, 265.0512); IR (cm-1): 3003, 1726, 1601, 1387, 1299, 1201, 1135; 1H NMR (400 MHz, 
CDCl3): 1.84 (6H, s,CH3), 7.12-7.17 (2H, m, C3-H), 7.71-7.74 (2H, m, C2-H), 15.56 (1H, bs,OH); 19F 
NMR (376 MHz, CDCl3): - 103.74 (m); 13C NMR (101 MHz, CDCl3): 26.95 (CH3), 90.87 (C(CH3)2), 
105.18 (C=COH), 115.58 (d, 2JCF 22.2 Hz, C3-H), 128.80 (C1-C), 132.49 (d, 3JCF 9.5 Hz, C2-H), 160.00 
(C=COH), 165.95 (d, 1JCF 255.9 Hz, C4-F), 171.15 (C=O), 188.05 (C=O); m/z (ESI): 265 (100 %, [M-
H]-), 163 (71 %, [M-CH3COCH3-CO2)]-). 
5-(2-Thiophenecarbonyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (162) 
 
2-Thiophenecarbonyl-chloride (4.40 g, 3.2 mL, 30 mmol) was reacted according to the general 
procedure to afford 5-(2-thiophenecarbonyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (5.97 g, 78 %) 
as a brown solid. Mp.: 79-80°C, ([M-H]-, 253.0171 C11H9O5S requires: [M-H]-, 253.0171); IR (cm-
1) 3099, 1722, 1648, 1476, 1373, 1071; 1H NMR (400 MHz, CDCl3): 1.83 (6H, s, CH3), 7.21 (1H, dd, 
3JHH 5.0, 3JHH 4.1 Hz, C4-H); 7.84 (1H, dd, 3JHH 5.0, 4JHH 1.2 Hz, C5-H), 8.46 (1H, dd, 3JHH 4.1, 4JHH 1.2 
Hz, C3-H), 15.96 (1H, bs, OH); 13C NMR (101 MHz, CDCl3): 26.64 (CH3), 88.69 (C(CH3)2), 104.80 
(CH(C=O)), 128.18 (C4-H), 134.74 (C2-C), 137.27 (C5-H), 138.61 (C3-H), 160.33 (C=COH), 171.75 
(C=O), 179.37 (C=O) , m/z (ESI) 253 (100 %, [M-H]-). 
5-(2-Nitrobenzoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (163) 
 
2-Nitrobenzoyl chloride (7.43 g, 40 mmol) was reacted according to the general procedure to 
afford 5-(2-nitrobenzoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (6.95 g, 59 % yield) as a yellow 
solid. Mp. 105-107 °C (with decomposition), ([M-H]-, 292.0446. C13H10NO7 requires: [M]+, 
292.0457); IR (cm-1): 3087, 2970, 1744, 1681, 1537, 1355, 1201, 1137; 1H NMR (400 MHz, CDCl3): 
1.77 (6H, s, CH3), 7.46 (1H, dd, 3JHH 7.6, 4JHH 1.5, C4-H), 7.71 (1H, ddd, 3JHH 8.3, 3JHH 7.6, 4JHH 1.5, 
C5-H), 7.79 (1H, td, 3JHH 7.6, 4JHH 1.2, C6-H), 8.27 (1H, dd, 3JHH 8.3, 4JHH 1.2, C3-H), 15.32 (1H, bs, 
OH); 13C NMR (101 MHz, CDCl3): 27.12 (CH3), 99.69 (C(CH3)2), 106.20 (C=COH), 124.77 (C6-H), 
128.95 (C3-H), 130.04 (C1-C), 131.61 (C4-H), 134.19 (C5-H), 146.25 (C2-NO2), 159.48 (C=COH), 
170.64 (C=O), 187.34 (C=O); m/z (ESI): 292 (100 %, [M-H]-).  
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5- (3-Bromobenzoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (164) 
 
3-Bromobenzoyl chloride (6.58 g, 3.96 mL, 30 mmol) was reacted according to the general 
procedure to afford 5-(3-bromobenzoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (7.75 g, 79 % yield) 
as a yellow solid. Mp. 92-93°C, ([M-H]-, 324.9712 C13H10O5Br requires: [M-H]-, 324,9721;); IR (cm-
1): 3062, 2942, 1730, 1650, 1540, 1137, 1031; 1H NMR (400 MHz, CDCl3): 1.84 (6H, s, CH3), 7.34 
(1H, t, 3JHH 7.9 Hz, C5-H), 7.58 (1H, dm, 3JHH 7.7 Hz, C4-H), 7.71 (1H, dm, 3JHH 8.04 Hz, C6-H), 7.78 
(1H, s, C2-H), 15.49 (1H, bs, OH); 13C NMR (101 MHz, CDCl3): 27.03 (CH3), 91.51 (C(CH3)2), 105.45 
(C=COH), 122.19 (C3-Br), 128.19 (C6-H), 129.69 (C5-H), 132.06 (C2-H), 134.68 (C1-C), 136.11 (C4-




4-Nitrobenzoyl chloride (9.27 g, 50 mmol) was reacted according to the general procedure to 
afford 5-(4-nitrobenzoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (13.43 g, 91 % yield) as a yellow 
solid. Mp.: 98-101 oC (lit. 113-114 oC)212 ([M-H]-, 292.0463. C13H10NO7 requires: [M]+, 292.0457); 
IR (cm-1): 3074, 2999, 2952, 1739, 1662, 1516, 1349, 1195, 1138; 1H NMR (700 MHz, CDCl3): 1.85 
(6H, s, CH3), 7.79 (2H, d, 3JHH 8.8, C2-H), 8.31 (2H, d, 3JHH 8.8, C3-H); 13C NMR (175 MHz, CDCl3): 
27.15 (CH3), 92.36 O(C(CH3)2), 105.86 (C=COH), 123.40 (C3-H), 130.37 (C2-H), 138.70 (C1-C), 
150.17 (C4-NO2), 159.34 (C=COH), 170.70 (C=O), 186.85 (C=O). m/z (ESI): 292 (100 %,[M-H]-). 
5-(4-Chlorobenzoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (166) 
 
4-Chlorobenzoyl chloride (5.25 g, 30 mmol) was reacted according to the general procedure to 
afford 5-(4-chlorobenzoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (5.54 g, 65 % yield) as an off 
white solid after recrystallization from acetone. Mp. 100-103 oC (lit. 106 oC)212; ([M-H]-, 281.0219 
C13H10ClO5 requires: [M]+, 281.0217); IR (cm-1): 3001, 1729, 1662, 1582, 1549, 1384, 1284, 1135; 
1H NMR (400 MHz, CDCl3): 1.84 (6H, s, CH3), 7.42-7.46 (2H, m, C3-H), 7.61-7.64 (2H, m, C2-H), 
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15.54 (1H, bs, O-H); 13C NMR (101 MHz, CDCl3): 26.99 (CH3), 91.16 (C(CH3)2), 105.28 (C=COH), 
128.61 (C2-H), 131.10 (C3-H), 131.12 (C1-C), 139.96 (C4-Cl), 159.83 (C=COH), 171.08 (C=O), 




2-Furoyl-chloride (3.91 g, 2.95 mL, 30 mmol) was reacted according to the general procedure to 
afford 5-(2-furoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (5.28 g, 74 % yield) as a pale brown solid. 
Mp.: 79-80°C, ([M-H]-, 237.0399 C11H9O6 requires: [M-H]-, 237.0405); IR (cm-1) 3127, 2995, 1725, 
1646, 1550, 1376; 1H NMR (400 MHz, CDCl3): 1.81 (6H, s, CH3), 6.66 (1H, dd, 3JHH=3.8, 3JHH 1.6 Hz, 
C4-H), 7.77 (1H, dd, 3JHH 1.6, 4JHH 0.8 Hz, C5-H), 8.12 (1H, dd, 3JHH=3.8, 4JHH 0.8 Hz, C3-H), 15.80 
(1H, bs, OH); 13C NMR (101 MHz, CDCl3): 26.64 (CH3), 88.44 (C(CH3)2), 104.97 (C=(C-OH)), 113.44 
(C4-H), 126.20 (C3-H), 146.05 (C2-H), 148.80 (C5-C), 159.47 (C=C-OH), 171.65 (C=O), 173.62 
(C=O); m/z (ESI): 237 (100 %, [M-H]-). 
7.5.2 Fluorination of acyl Meldrum’s acid derivatives 
5-Fluoro-5-(2-nitrobenzoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (169) - general procedure 
 
5-(2-Nitrobenzoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (4.40 g, 15.0 mmol) was dissolved in 
acetonitrile (50 mL), Selectfluor (5.50 g, 15.5 mmol) was added then the mixture was stirred at 
room temperature for 16 hours. The reaction mixture was evaporated to dryness under vacuum, 
the solids suspended in ethyl acetate (50 mL) filtered and washed with ethyl acetate (30 mL). 
The ethyl acetate solution was evaporated under reduced pressure, the residue dissolved in 
dichloromethane (20 mL), hexane (60 mL) was added and the solution was concentrated at 
atmospheric pressure until solids started to appear (approximately 30 mL). After cooling at 4 oC 
overnight the product was filtered and dried under vacuum to afford 5-fluoro-5-(2-nitrobenzoyl)-
2,2-dimethyl-1,3-dioxane-4,6-dione (3.50 g, 75 % yield) as a tan powder. Mp. 125-127 °C (with 
decomposition); IR (cm-1): 3009, 1795, 1753, 1729, 1535, 1350, 1316, 1133; 1H NMR (600 MHz, 
CDCl3): 1.86 (3H, s, CH3), 2.04 (3H, s, CH3), 7.52 (1H, d, 3JHH 7.6 Hz, C6-H), 7.77 (1H, m, C4-H), 7.84 
(1H, tm, 3JHH 7.6 Hz, C5-H), 8.27 (1H, dm, 3JHH 8.2 Hz, C3-H); 13C NMR (151 MHz, CDCl3): 27.99 
(CH3 axial), 30.29 (CH3 equatorial), 90.50 (d, 1JCF 209.0 Hz, C-F), 109.98 (d, 4JCF 2.0 Hz, C(CH3)2), 
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124.69 (C3), 129.22 (d, 4JCF 3.6 , C6), 130.84 (d, 3JCF 2.5, C1), 132.41 (C4), 134.78 (C5), 145.80 (C2), 
157.90 (d, 2JCF 23.2 HZ, C=O), 189.15 (d, 2JCF 32.6, C=O); 19F NMR (376 MHz, CDCl3): - 162.56 (1F, 




5-Fluoro-5-(4-nitrobenzoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (4.40 g, 15.0 mmol) was 
reacted according to the general procedure to afford 5-fluoro-5-nitrobenzoyl-2,2-dimethyl-1,3-
dioxane-4,6-dione (3.32 g, 75 % yield) as a tan solid. Mp.: 135-137 oC (with decomposition); IR 
(cm-1): 3120, 3056, 1787, 1742, 1699, 1525, 1322, 1157; 1H NMR (400 MHz, CDCl3): 1.89 (3H, s, 
CH3), 1.95 (3H, s, CH3), 8.42 – 8.33 (4H, m, C2-H, C3-H); 19F NMR (376 MHz, CDCl3): - 158.17 (1F, 
t, 5JHF 1.4 Hz, C-F).; 13C NMR (101 MHz, CDCl3): 27.96 (CH3), 30.28 (CH3), 91.48 (d, 1JCF 213 Hz, C-
F), 109.94 (d, 4JCF 1.6 Hz, C(CH3)2), 124.01 (C3-H), 132.08 (d, 4JCF 6.3 Hz, C2-H), 136.69 (d, 3JCF 4.1 
Hz, C1-C), 151.43 (C4-NO2), 158.81 (d, 2JCF 23.2, C=O), 188.15 (d, 2JCF 27.9, C=O); m/z (ASAP): [M]+ 
not detected, 268 (100 %, [M-C3H7]+); 210 (35 %, [M-CH3COCH3-CO2]+), 150 (15 %, [M-C6H6FO4]+). 
5-(3-Nitrobenzoyl)-5-fluoro-2,2-dimethyl-1,3-dioxane-4,6-dione (171) 
 
5-(3-Nitrobenzoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (4.40 g, 15 mmol) was reacted according 
to the general procedure to afford 5-(3-nitrobenzoyl)-5-fluoro-2,2-dimethyl-1,3-dioxane-4,6-
dione (2.10 g, 45 %) as a tan powder. Mp.: 129-133 °C; IR (cm-1): 3098, 1790, 1756, 1695, 1528, 
1314, 1297, 1150; 1H NMR (400 MHz, CDCl3): 1.89 (3H, s, CH3), 1.95 (3H, s, CH3), 7.78 (1H, t, 3JHH 
8.1 Hz, C5-H), 8.54 (1H, ddd, 3JHH 8.2, 5JFH 2.3, 4JHH 1.4 Hz, C6-H), 8.58 (1H, dm, 3JHH 7.9 Hz, C4-H), 
9.01 (1H, dd, 4JHH 1.4, 5JFH 3.0 Hz, C2-H); 19F NMR (376 MHz, CDCl3): - 157.91 (1F, dd, 5JHF 3.0, 5JHF 
2.3 Hz, C-F); 13C NMR (101 MHz, CDCl3): 27.81 (CH3), 30.11 (CH3), 91.31 (d, 1JCF 213 Hz, C-F), 
109.78 (d, 4JCF 1.7 Hz, C(CH3)2), 125.63 (d, 5JCF 5.9 Hz, C2-H), 129.37 (C4-H), 130.26 (d, 5JCF 1.2 Hz, 
C5-H), 133.21 (d, 3JCF 4.1 Hz, C1-H), 136.20 (d, 4JCF 7.3 Hz, C6-H), 148.41 (C3-NO2), 158.68 (d, 2JCF 
23.2 Hz, C=O), 187.19 (d, 2JCF 27.3 Hz, C=O); m/z (ASAP): [M]+ not detected, 268 (100 %, [M-
C3H7]+), 210 (27 %, [M-CH3COCH3-CO2]+), 150 (10 %, [M-C6H6FO4]+). 
5-(2-Furoyl)-5-fluoro-2,2-dimethyl-1,3-dioxane-4,6-dione (172) 




5-(2-furoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (4.76 g, 20 mmol) was reacted according to the 
general procedure to afford 5-(2-furoyl)-5-fluoro-2,2-dimethyl-1,3-dioxane-4,6-dione (4.43 g, 92 
%) as a brown solid and was used without any further purification. Mp.: 124-126 °C, IR (cm-1): 
3146, 1793, 1751, 1666, 1455, 1288, 1143; 1H NMR (400 MHz, CDCl3): 1.87 (3H, s, CH3), 1.93 (3H, 
s, CH3), 6.69 (1H, dd, 3JHH 3.7, 3JHH 1.7 Hz, C4-H), 7.78 (1H, dd, 3JHH 1.7, 4JHH 0.8 Hz, C5-H), 7.83 (1H, 
td, 3JHH 3.7, 4JHH 0.8 Hz, C3-H); 19F NMR (376 MHz, CDCl3): - 160.73 (1F, d, 5JHF 3.3 Hz, C-F); 13C 
NMR (101 MHz, CDCl3): 27.99 (CH3), 30.11 (CH3), 89.90 (d, 1JCF 209 Hz, C-F), 109.55 (d, 4JCF 1.5 Hz, 
C(CH3)2), 113.695 (d, 5JCF 1.9 Hz, C4-H), 125.91 (d, 4JCF 10.7 Hz, C3-H), 147.40 (d, 3JCF 3.9 Hz, C2-
C), 150.17 (C5-H), 158.94 (d, 2JCF 23.1 Hz, C=O), 174.05 (d, 2JCF 25.9 Hz, C=O); m/z (ASAP): [M]+ 
not detected, 214.0 (100 %, [M-CH2=CH-CH3]+). 
5-Benzoyl-5-fluoro-2,2-dimethyl-1,3-dioxane-4,6-dione (173) 
 
5-Benzoyl-2,2-dimethyl-1,3-dioxane-4,6-dione (2.48 g, 10.0 mmol) was reacted according to the 
general procedure to afford 5-benzoyl-5-fluoro-2,2-dimethyl-1,3-dioxane-4,6-dione (1.98 g, 74 
% yield) as a yellow solid. Mp.: 109-112 oC; IR (cm-1): 3071, 3019, 1797, 1756, 1675, 1305, 1202, 
1146; 1H NMR (400 MHz, CDCl3): 1.86 (3H, s, CH3), 1.92 (3H, s, CH3), 7.53 (2H, m, C3-H), 7.69 (1H, 
m, C4-H), 8.22 (2H, m, C2-H); 19F NMR (376 MHz, CDCl3): - 157.97 (t, 5JHF 1.9 Hz); 13C NMR (101 
MHz, CDCl3): 27.67 (CH3), 30.19 (CH3), 92.13 (d, 1JCF 216 Hz, C-F), 109.43 (C(CH3)2), 128.90 (C3-H), 
130.87 (d, 4JCF 6.1 Hz, C2-H), 132.06 (d, 3JCF 4.1 Hz, C1-C), 135.51 (C4-H), 159.15 (d, 2JCF 23.2, C=O), 




5-(4-Fluorobenzoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (4.00 g, 15.0 mmol) was reacted 
according to the general procedure to afford 5-fluoro-5-(4-fluorobenzoyl)-2,2-dimethyl-1,3-
dioxane-4,6-dione (3.01 g, 70 % yield) as an off white solid. Mp.: 91-95 oC; IR (cm-1): 3076, 1796, 
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1751, 1684, 1589, 1304, 1238, 1144; 1H NMR (400 MHz, CDCl3): 1.86 (3H, s, CH3), 1.91 (3H, s, 
CH3), 7.16 – 7.25 (2H, m, C3-H), 8.29 (2H, ddt; 2JHH 7.1, 3JHF 5.3, 3JHH 1.9 Hz, C2-H) 19F NMR (376 
MHz, CDCl3): - 99.41 (1F, m, Ar-F), -157.36 (1F, m); 13C NMR (101 MHz, CDCl3): 27.81 (CH3), 30.26 
(CH3), 92.10 (d, 1JCF 213 Hz, C-F), 109.66 (d, 4JCF 1.9 Hz, C(CH3)2), 116.48 (d, 2JCF 22.1 Hz, C3-H), 
128.52 (dd, 3JCF 4.2, 4JCF 3.1 Hz, C1-C), 134.22 (dd, 3JCF 10.0, 4JCF 6.4 Hz, C2-H), 159.18 (d, 2JCF 23.4, 
C=O), 167.27 (d, 1JCF 260.1 Hz, C4-F), 186.84 (d, 2JCF 26.1, C=O); m/z (ASAP): [M]+ not detected, 
241 (100 %, [M-C3H7]+); 183 (92 %, [M-CH3COCH3-CO2]+), 123 (48 %, [M-C6H6FO4]+). 
5-(3-Bromobenzoyl)-5-fluoro-2,2-dimethyl-1,3-dioxane-4,6-dione (175) 
 
5-(3-Bromobenzoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (6.53 g, 20 mmol) was reacted 
according to the general procedure to afford 5-(3-bromobenzoyl)-5-fluoro-2,2-dimethyl-1,3-
dioxane-4,6-dione (4.43 g, 64 %) as a tan powder, crystalline product suitable for X-ray 
crystallography was obtained by recrystallisation from acetone. Mp. 104-106 °C; IR (cm-1): 3111, 
1751, 1685, 1565, 1398, 1308, 1142; 1H NMR (400 MHz, CDCl3): 1.89 (3H, s, CH3), 1.94 (3H, s, 
CH3), 7.44 (1H, t, 3JHH 8.0 Hz, Ar-H), 7.84 (1H, ddd, 3JHH 8.0, 4JHH 2.0, 4JHH 1.0 Hz, C4-H), 8.20 (1H, 
dm, 3JHH 7.9 Hz, C6-H), 8.28 (1H, q, 4JHH 1.7 Hz, C2-H); 19F NMR (376 MHz, CDCl3): - 158.06 (dd, 1F, 
5JHF 2.1, 5JHF 1.4 Hz, C-F); 13C (101 MHz, CDCl3): 27.85 (CH3), 30.28 (CH3), 91.78 (d, 1JCF 214 Hz, C-
F), 109.69 (d, 4JCF 1.5 Hz, C(CH3)2), 123.20 (C3-Br), 129.59 (d, 4JCF 7.4 Hz, C6-H), 130.54 (C5-H), 
133.51 (d, 4JCF 5.3 Hz, C2-H), 133.78 (d, 3JCF 4.1 Hz, C1-C), 138.44 (C4-H), 159.00 (d, 2JCF 23.4 Hz, 
C=O), 187.52 (d, 2JCF 26.8 Hz, C=O); m/z (ASAP): [M]+ not detected, 183 (96 %, [M(79Br)-




5-(2-Thiophenecarbonyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (5.08 g, 20 mmol) was reacted 
according to the general procedure to afford 5-(2-thiophenecarbonyl)-5-fluoro-2,2-dimethyl-1,3-
dioxane-4,6-dione (5.07 g, 93 %) as a light brown solid and was used without any further 
purification. Mp.:98 – 100 °C; IR (cm-1) 3104, 3005, 1751, 1653, 1407, 1308, 1092; 1H NMR 
(400MHz, CDCl3): 1.85 (3H, s, CH3), 1.92 (3H, s, CH3), 7.25 (1H, dd, 3JHH 4.9, 3JHH 4.0 Hz, C4-H), 7.91 
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(1H, dd, 3JHH 4.9, 4JHH 1.1 Hz, C5-H), 8.37 (1H, ddd, 3JHH 4.0, 5JHF 3.0, 4JHH 1.1 Hz, C3-H); 19F NMR 
(376 MHz, CDCl3): - 157.78 (1F, d, 5JHF 3.0 Hz, C-F); 13C NMR (101 MHz, CDCl3): 27.91 (CH3), 30.22 
(CH3), 91.32 (d, 1JCF 213 Hz, C-F), 109.62 (d, 5JCF 1.7 Hz, C(CH3)2), 129.51 (d, 5JCF 2.0 Hz, C4-H), 
137.42 (d, 3JCF 5.2 Hz, C2-C), 138.71 (d, 4JCF 11.3 Hz, C3-H), 138.81 (d, 5JCF 2.2 Hz, C5-H), 158.99 
(d, 2JCF 23.4 Hz, C=O), 180.10 (d, 2JCF 26.4 Hz, C=O); m/z (ASAP): [M]+ was not detected, 111 (100 
%, [M-C6H6FO4]+), 171 (86 %, [M-CH3COCH3-CO2]+), 229 (16 %, [M-CH2=CH-CH3]+). 
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7.5.3 Synthesis of 2-fluoroacetophenone derivatives 
Screening of hydrolysis conditions 
5-Benzoyl-5-fluoro-2,2-dimethyl-1,3-dioxane-4,6-dione (0.27 g, 1 mmol) was weighed in a 5 mL 
microwave vial, all other additives and solvent (5 mL) were added, the vial sealed with a cap and 
heated at the desired temperature (T) for the reaction time (t) in a Biotage™ microwave. After 
cooling to room temperature, a sample (0.1 mL) sample was diluted with deuterochloroform 
and analysed by 19F NMR spectroscopy. 
 
No Solvent Additive Water T / oC t / min Composition 
1 
Acetone - 0.1 mL 100 20 
91 % 173, 1 % 177,  
8 % 84 
2 
Acetone 0.1 mL 1M HCl - 90 20 
67 % 173, 23 % 177,  
5 % 84, 5 % 178 
3 
Acetone 1 eq. TsOH.H2O 0.1 mL 90 20 
68 % 177, 7 % 84,  
25 % 178 
4 
Acetone 1 eq. TsOH.H2O - 100 20 
11 % 173, 30 % 177,  
20 % 84, 38 % 178  
5 
Acetone 2 eq. TsOH.H2O - 100 20 
2 % 173, 36 % 177,  
62 % 178 
6 Acetone 1 eq. TsOH.H2O 0.1 mL 100 20 60 % 177, 40 % 178 
7 Acetone 1 eq. TsOH.H2O 0.1 mL 110 20 75 % 177, 25 % 178 
8 Acetone 1 eq. TsOH.H2O 0.2 mL 100 20 73 % 177, 27 % 178 
9 Acetone 1 eq. K2CO3 0.1 mL 100 20 No reaction 
10 
Acetone 
0.1 mL  
37 % HCl 
- 100 20 
34 % 173, 56 % 177,  
10 % 178 
11 
Acetone 
0.05 mL  
37 % HC 
0.05 mL 100 20 
35 % 173, 48 % 177,  
3 % 84, 14 % 178 
12 Acetone 0.5 eq. TsOH.H2O 0.1 mL 100 30 76 % 177, 24 % 178 
13 AcOH 1 eq. TsOH.H2O - 100 20 36 % 177, 64 % 178 
14 AcOH 1 eq. TsOH.H2O 0.1 mL  100 20 55 % 177, 45 % 178 
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2-Fluoro-2’-nitroacetophenone (168) - general procedure 
 
5-Fluoro-5-(2-nitrobenzoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (1.24 g, 4.0 mmol) and p-
toluenesulfonic acid monohydrate (0.76 g, 4.0 mmol) were dissolved in acetone (20 mL) in a 
microwave vial (25 mL). Water (0.4 mL) was added, the vial sealed and irradiated at 100 oC for 
30 minutes. After the mixture was allowed to cool to ambient temperature, the pressure was 
carefully released by piercing the rubber septum with a needle. The mixture was evaporated to 
dryness, the residue dissolved in ethyl acetate (50 mL), washed with saturated NaHCO3 solution 
(2x20 mL) and brine (20 mL). After drying over Na2SO4, the solvent was removed under reduced 
pressure and the product was purified by silica gel column chromatography (hexanes : ethyl 
acetate, 5 : 1, Rf.: 0.15) to afford 2-fluoro-2’-nitroacetophenone (0.65 g, 89 % yield) as an off 
white solid. Mp.: 69-71 oC; ([M+H]+, 184.0407 C8H7FNO3 requires: [M+H]+, 184.0410); IR (cm-1): 
2945, 1724, 1421, 1517, 1348, 1221, 1094, 1076; 1H NMR (700 MHz, CDCl3): 5.14 (2H, d, 2JHF 47.2 
Hz, CH2F), 7.47 (1H, dd, 3JHH 7.5, 4JHH 1.4 Hz, C6-H), 7.69 (1H, ddd, 3JHH 8.2, 3JHH 7.5, 4JHH 1.4 Hz, 
C4-H), 7.80 (1H, td, 3JHH 7.5, 4JHH 1.2 Hz, C5-H), 8.19 (1H, dd, 3JHH 8.2, 4JHH 1.2 Hz, C3-H); 19F NMR 
(376 MHz, CDCl3): - 225.74 (1F, t, 2JHF 47.3 Hz, CH2F); 13C NMR (176 MHz, CDCl3): 84.34 (d, 1JCF 
185.4 Hz, CH2F), 124.01 (C3-H), 128.50 (d, 4JCF 1.2 Hz, C6-H), 131.65 (C4-H), 133.63 (d, 3JCF 2.1 Hz, 
C1-C), 134.70 (C5-H), 146.77 (C2-NO2), 199.11 (d, 2JCF 25.2 Hz, C=O); m/z (ASAP): 184 (100 %, 
[M+H]+), 164 (15 %, [M-F]+). 
2-Fluoroacetophenone (177) 
 
5-Fluoro-5-(benzoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (1.07 g, 4.0 mmol) was reacted 
according to the general procedure to afford 2-fluoroacetophenone (0.31 g, 56 % yield) as a 
yellow oil. Rf.: 0.27 (hexanes : ethyl acetate, 5 : 1); ([M+H]+, 139.0559 C8H8FO requires: [M+H]+, 
139.0559); IR (cm-1): 3066, 2938, 1703, 1598, 1450, 1231, 1086; 1H NMR (400 MHz, CDCl3): 5.53 
(2H, d, 2JHF 46.9 Hz, CH2F), 7.45 – 7.54 (2H, m, C3-H), 7.58 – 7.66 (1H, m, C4-H), 7.83-7.92 (2H, m, 
C2-H); 19F NMR (376 MHz, CDCl3): - 231.44 (t, 2JHF 47.0 Hz, CH2F);. 13C NMR (101 MHz, CDCl3): 
83.64 (d, 1JCF 182.6 Hz, CH2F), 127.94 (d, 4JCF 2.6 Hz, C2-H), 129.03 (C3-H), 133.80 (C1-C), 134.24 
(C4-H), 193.52 (d, 2JCF 15.5 Hz, C=O); m/z (ASAP): 139 (49 %, [M+H]+). 
 





5-Fluoro-5-(4-nitrobenzoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (1.24 g, 4.0 mmol) was reacted 
according to the general procedure to afford 2-fluoro-4’-nitroacetophenone (0.30 g, 41 % yield) 
as a yellow crystalline solid. Mp.: 90 - 93 oC; ([M+H]+, 184.0412 C8H7FNO3 requires: [M+H]+, 
184.0410); IR (cm-1): 2945, 1724, 1421, 1517, 1348, 1221, 1094, 1076; 1H NMR (600 MHz, CDCl3): 
5.52 (2H, d, 2JHF 46.8 Hz, CH2F), 8.05-8.14 (2H, m, C2-H), 8.30-8.40 (2H, m, C3-H); 19F NMR (376 
MHz, CDCl3): - 229.21 (t, 2JHF 46.9 Hz, CH2F); 13C NMR (176 MHz, CDCl3): 84.02 (d, 1JCF 185.1 Hz, 
CH2F), 124.23 (C3-H), 129.47 (d, 4JCF 3.5 Hz, C2-H), 138.34 (d, 3JCF 1.2 Hz, C1-C), 150.97 (C4-NO2), 
192.75 (d, 2JCF 17.0 Hz, C=O); m/z (ASAP): 184 (53 %, [M+H]+), 150 (37 %, [M-CH2F]+). 
3’-Bromo-2-fluoroacetophenone (181) 
 
5-(3-Bromobenzoyl)-5-fluoro-2,2-dimethyl-1,3-dioxane-4,6-dione (1.04 g, 3 mmol) was reacted 
according to the general procedure to afford 3’-bromo-2-fluoroacetophenone (0.23 g, 35 % yield) 
as a white crystalline solid. Mp. 39-40 °C; Rf.: 0.27 (hexane : ethyl acetate, 5 : 1); ([M+H]+, 
216.9664 C8H7BrFO requires: [M]+, 216.9661), IR (cm-1): 3068, 2932, 1708, 1590, 1567, 1424, 
1223, 1096; 1H NMR (400 MHz, CDCl3): 5.48 (2H, d, 2JHF 46.8 Hz, CH2F), 7.37 (1H, t, 3JHH 7.9 Hz, 
C5-H), 7.74 (1H, ddd, 3JHH 8.0, 4JHH 2.0, 4JHH 1.0 Hz, C4-H), 7.80 (1H, ddd, 3JHH 7.8, 4JHH 1.6, 4JHH 1.0 
Hz, C6-H), 8.02 (1H, t, 4JHH 2.0 Hz, C2-H); 19F NMR (376 MHz, CDCl3): - 230.17 (1F, t, 2JHF 47.0 Hz, 
CH2F); 13C NMR (101 MHz, CDCl3): 83.62 (d, 1JCF 183.6 Hz, CH2F), 123.34 (C3-Br), 126.55 (d, 4JCF 
2.9 Hz, C6-H), 130.61 (C5-H), 131.09 (d, 4JCF=2.9 Hz, C2-H), 135.46 (C1-C), 137.09 (C4-H), 192.43 
(d, 2JCF 16 Hz, C=O); m/z (ASAP): 216.9 (98%, [M(79Br)+H]+), 218,9 (100%, [M(81Br)+H]+).2,4’-
Difluoroacetophenone (182) 
 
5-Fluoro-5-(4-fluorobenzoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (1.00 g, 3.5 mmol) was 
reacted according to the general procedure to afford 2,4’-difluoroacetophenone (0.34 g, 62 % 
yield) as a white crystalline solid. Mp.: 52-53 oC; Rf.: 0.26 (hexanes : ethyl aceate, 5 :1) ([M+H]+, 
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157.0465 C8H7F2O requires: [M+H]+, 157.0464); IR (cm-1): 2951, 1685, 1593, 1508, 1406, 1231, 
1159, 1080; 1H NMR (400 MHz, CDCl3): 5.48 (2H, d, 2JHF 47.0 Hz, CH2F), 7.08-7.22 (2H, m, C2-H), 
7.89-8.02 (2H, m, C3-H); 19F NMR (376 MHz, CDCl3): - 103.17 (1F, m, Ar-F), - 229.89 (1F, t, 2JHF 
46.9 Hz, CH2F); 13C NMR (101 MHz, CDCl3): 83.55 (d, 1JCF 183.3 Hz, CH2F), 116.16 (d, 2JCF 22.0 Hz, 
C3-H), 130.19-130.26 (m, C1-C), 130.76 (dd, 3JCF 9.5, 3JCF 3.2 Hz, C2-H), 166.21 (d, 1JCF 256.7 Hz, 
C4-F), 192.03 (d, 2JCF 16.0 Hz, C=O); m/z (ASAP): 157 (100 %, [M+H]+), 123 (16 %, [M-CH2F]+). 
2’-(2-Fluoroacetyl)furane (183) 
 
5-(2-Furoyl)-5-fluoro-2,2-dimethyl-1,3-dioxane-4,6-dione (1.02 g, 4 mmol) was reacted 
according to the general procedure to afford 2’-(2-fluoroacetyl)furane (0.26 g, 51 %) as a pale 
yellow crystalline solid. Mp.: 28-30°C; Rf.: 0.14 (hexane : ethyl acetate, 5 : 1); ([M+H]+, 129.0352 
C6H6O2F requires: [M]+, 129.0345); IR (cm-1): 3126, 1671, 1464, 1293, 1027; 1H NMR (400 MHz, 
CDCl3): 5.32 (2H, d, 2JHF 46.9 Hz, CH2F), 6.60 (1H, dd, 3JHH 3.6, 4JHF 1.8, C4-H), 7.38 (1H, ddd, 3JHH 
3.6, 4JHF 1.6, 4JHH 0.8 Hz, C3-H), 7.64 (1H, dd, 3JHH 1.8, 4JHH 0.7 Hz, C4-H); 19F NMR (376 MHz, CDCl3): 
- 232.32 (1F, t, 2JHF 46.9 Hz, CH2F); 13C NMR (101 MHz, CDCl3): 83.29 (d, 1JCF 183.4 Hz, CH2F), 
112.70 (d, 5JCF 1.2 Hz, C4-H), 119.49 (d, 4JCF 6.4 Hz, C3-H), 147.40 (C5-H), 150.06 (C2-C), 182.82 
(d, 2JCF 17.9 Hz, C=O) ; m/z (ASAP) 129 (100 %, [M+H]+). 
2’-(2-Fluoroacetyl)thiophene (184) 
 
5-(2-Tiophenecarbonyl)-5-fluoro-2,2-dimethyl-1,3-dioxane-4,6-dione (1.09 g, 4 mmol) was 
reacted according to the general procedure to afford 2’-(2-fluoroacetyl)thiophene (0.42 g, 73 %) 
as a yellow solid. Mp.: 54-56 °C; Rf.: 0.22 (hexane : ethyl acetate, 5 : 1); ([M+H]+, 145.0123, 
C6H6FOS requires: [M]+, 145.0112); IR (cm-1): 3086, 2940, 1671, 1516, 1414, 1250, 1096; 1H NMR 
(400 MHz, CDCl3): 5.33 (2H, d, 2JHF 47.2 Hz, CH2F), 7.19 (1H, dd, 3JHH 4.9, 3JHH 3.9 Hz, C4-H), 7.75 
(1H, ddd, 3JHH 4.9, 4JHH 1.1, 5JHF 0.6 Hz Hz, C3-H), 7.88 (1H, dt, 3JHH 3.9, 4JHH 1.1 Hz, C5-H); 19F NMR 
(376 MHz, CDCl3): -226.66 (1F, t, 2JHF 47.1 Hz, CH2F); 13C NMR (101 MHz, CDCl3): 84.09 (d, 1JCF 
185.4 Hz, CH2F), 128.59 (d, 5JCF 1.3 Hz, C4-H), 133.37 (d, 4JCF 6.6 Hz, C3-H), 135.10 (d, 5JCF 1.7 Hz, 
C5-H), 140.12 (d, 3JCF 2.7 Hz, C2-C), 187.32 (d, 2JCF 18.2 Hz, C=O) ; m/z (ASAP): 145 (100 %, [M+H]+). 
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7.5.4 Synthesis of 2-fluoro-3-ketoesters 
Ethanolysis of 5-benzoyl-5-fluoro-2,2-dimethyl-1,3-dioxane-4,6-dione  
5-Benzoyl-5-fluoro-2,2-dimethyl-1,3-dioxane-4,6-dione (0.26 g, 1.0 mmol) was dissolved in 
anhydrous ethanol (5 mL) and heated to the prescribed temperature for a pre-determined time. 
The mixture was allowed to cool to ambient temperature, a 0.1 mL sample was diluted with 
CDCl3 (0.6 mL) and analysed by 19F NMR spectroscopy.  
19F NMR (376 MHz, CDCl3): - 158.8 (157), - 191.4 (185)213, - 194.8 (59), - 207.3 (83), -231.4 (177).  
 
T / oC t / min Composition 
60 30 38 % 157, 61 % 185, 1 % 59  
70 30 25 % 157, 72 % 185, 3 % 59 + 83 
80 30 12 % 157, 84 % 185, 4 % 59 + 83 
90 30 10 % 157, 84 % 185, 5% 59 + 83, 1 % 177 
100 30 3 % 157, 86 % 185, 10 % 59 + 83, 1 % 177 
60 60 97 % 185, 3 % 59 + 83 




5-Fluoro-5-(2-Furoyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (1.02 g, 4 mmol) was dissolved in 
ethanol (20 mL) and heated at 60°C for 60 minutes with microwave irradiation. After cooling to 
ambient temperature, the solvent was evaporated, the residue dissolved in ethyl-acetate (20 
mL) and washed with saturated NaHCO3 solution (10 mL). After evaporation, silica gel column 
chromatography afforded ethyl 2-fluoro-3-(furan-2-yl)-3-oxopropanoate (0.45 g, 55 %) as a 
yellow oil. Rf.: 0.05 (dichloromethane : hexane, 2 : 3);  ([M+H]+, 201.0563 C9H10FO4 requires: 
[M+H]+, 201.0569); IR (cm-1): 3137, 2985, 1760, 1678, 1568, 1462, 1258, 1017; 1H NMR (400 
MHz, CDCl3): 1.23 (3H, t, 3JHH 7.1 Hz, CH3), 4.25 (2H, m, CH2), 5.69 (1H, d, 1JHF 48.3 Hz, CHF), 6.59 
(1H, dd, 3JHH 3.7, 3JHH 1.7 Hz, C4-H), 7.46 (1H, ddd, 3JHH 3.7, 5JHF 2.0, 4JHH 0.7 Hz, C3-H), 7.69 (1H, 
dd, 3JHH 1.7, 4JHH 0.7 Hz, C5-H); 19F NMR (376 MHz, CDCl3): -193.48 (1F, d, 1JHF 48.4 Hz); 13C NMR 
(101 MHz, CDCl3): 13.96 (CH3), 62.79 (CH2), 89.14 (d, 1JCF 196.9 Hz, CH-F), 112.97 (C4-H), 121.99 
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(d, 4JCF 6.1 Hz, C3-H), 148.60 (C5-H), 149.2d (d, 3JCF 1.5 Hz, C2-C), 164.46 (d, 2JCF 24.5 Hz, C=O), 
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X-ray crystallographic data related to all compounds analysed can be found in the electronic 
appendix. 
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Appendix III. Fluorinated Compounds in Late Stage Clinical 
Trials 
 
The following list contains the identifiable structures from the following companies’ pipeline: 
J&J, Pfizer, Novartis, Roche, Sanofi, Merck, GSK, Bayer, BMS, AbbVie, Eli Lilly, AZ, Takeda, 
Astellas, Gilead, Celgene, Vertex. Data is accurate as of 2/9/15. 
Name Structure Other data 
Losmapimod 
 
GSK Phase II. for 
COPD 

















GSK Phase II. 
Alzheimer’s 































































































































































































Takeda Phase II. 
cancer (T cell 
lymphoma) 













Astellas Phase III. 
type 2 diabetes 
Omecamtiv 
 
Amgen  
Cardiac 
Eleclazine 
 
Gilead 
(Phase 2) 
 
VX-661 
 
Vertex 
Phase 3 
 
